<SEC-DOCUMENT>0000886744-25-000054.txt : 20250806
<SEC-HEADER>0000886744-25-000054.hdr.sgml : 20250806
<ACCEPTANCE-DATETIME>20250806161640
ACCESSION NUMBER:		0000886744-25-000054
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250801
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
FILED AS OF DATE:		20250806
DATE AS OF CHANGE:		20250806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GERON CORP
		CENTRAL INDEX KEY:			0000886744
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				752287752
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20859
		FILM NUMBER:		251189820

	BUSINESS ADDRESS:	
		STREET 1:		919 EAST HILLSDALE BOULEVARD
		STREET 2:		SUITE 250
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6504737700

	MAIL ADDRESS:	
		STREET 1:		919 EAST HILLSDALE BOULEVARD
		STREET 2:		SUITE 250
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GERON CORPORATION
		DATE OF NAME CHANGE:	19960521
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gern-20250801.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:25fa4f69-406d-4151-a9ea-b9f9bcd7abef,g:efe183ff-839b-4971-a706-0b89d8e1c50a,d:e30f2026f81f4d4eb54f6e014a3828f2-->
<html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>gern-20250801</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0000886744</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="gern-20250801.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-01</xbrli:startDate><xbrli:endDate>2025-08-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie30f2026f81f4d4eb54f6e014a3828f2_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">___________</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE </span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">August&#160;1, 2025</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">GERON CORPORATION</ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.174%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-20859</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">75-2287752</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction of<br/>incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(IRS Employer Identification <br/>No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">919 E. HILLSDALE BLVD</ix:nonNumeric>., <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">SUITE 250</ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">FOSTER CITY</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-10">CA</ix:nonNumeric>LIFORNIA <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">94404</ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">650</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">473-7700</ix:nonNumeric> </span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.022%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-17">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock, $0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">GERN</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-21">o</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ie30f2026f81f4d4eb54f6e014a3828f2_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Item 5.02&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2025, the Board of Directors (the &#8220;Board&#8221;) of Geron Corporation (the &#8220;Company&#8221;), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the &#8220;Nominating and Corporate Governance Committee&#8221;), appointed Harout Semerjian as President and Chief Executive Officer of the Company and as a director, effective August 7, 2025 (the &#8220;Effective Date&#8221;). On the Effective Date, Mr. Semerjian will be appointed to the Board to fill the existing vacancy as a Class I director for a term expiring at the Company&#8217;s 2027 annual meeting of stockholders. Mr. Semerjian replaces Dawn C. Bir, who ceased serving as Interim President and Chief Executive Officer of the Company immediately prior to Mr. Semerjian&#8217;s appointment. Ms. Bir will continue to serve as a member of the Board. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Semerjian, age 54, most recently served as President and Chief Executive Officer of GlycoMimetics, Inc., a late-stage clinical biotechnology company subsequently combined with Crescent Biopharma, Inc., from August 2021 until February 2025. He also previously served on the board of directors of GlycoMimetics. Since October 2023, Mr. Semerjian has also served as a member of the board of directors at the Biotechnology Innovation Organization. From June 2020 to July 2021, Mr. Semerjian served as an independent healthcare consultant at Emerge Bio Consulting, advising private equity firms on healthcare investment projects. Mr. Semerjian served as President and Chief Executive Officer of Immunomedics Inc., a biotechnology company specializing in antibody-drug conjugates for cancer treatment, from April 2020 to May 2020, prior to its acquisition by Gilead Sciences, Inc. From March 2018 to April 2020, Mr. Semerjian served as Executive Vice President, Chief Commercial Officer of Ipsen Pharma, a global, pharmaceutical company focusing on areas of high unmet medical need, leading and executing Ipsen&#8217;s global commercial strategy and functions across oncology, neurosciences and rare diseases. From February 2017 to February 2018, he served as President and Head of Ipsen&#8217;s Specialty Care International Region &amp; Global Franchises. From 1994 to January 2017, Mr. Semerjian held several commercial, marketing and sales positions of increasing responsibility within Novartis Pharmaceuticals, a global pharmaceutical company, including serving as Senior Vice President and Global Launch Leader for KISQALI</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, in regional vice president hematology and oncology roles in the U.S., MENA and the Nordics, and as global brand director for Gleevec</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, as well as for Merck, a global pharmaceutical company, and Solvay, a multinational chemical and materials company. Mr. Semerjian holds an MBA from Cornell University and Queen's University in Canada, and a B.S. in Biology from Lebanese American University. The Board believes Mr. Semerjian&#8217;s deep commercial and hematology expertise, broad leadership experience, and global perspective qualify him to serve on the Board. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Mr. Semerjian&#8217;s appointment as the Company&#8217;s President and Chief Executive Officer, the Board, acting upon the recommendation of the Compensation Committee of the Board (the &#8220;Compensation Committee&#8221;), approved the Company&#8217;s entry into an employment agreement with Mr. Semerjian, effective as of the Effective Date (the &#8220;Employment Agreement&#8221;). The Employment Agreement provides for an annual base salary of $800,000 and an annual performance target bonus of 70% of his annual base salary, which will be prorated for 2025. In addition, the Company has agreed to grant Mr. Semerjian a stock option to purchase 11,000,000 shares of the Company&#8217;s common stock (the &#8220;Stock Options&#8221;) pursuant to the Company&#8217;s 2018 Inducement Award Plan (as defined below). The Stock Options will vest and become exercisable as follows: (i) 7,000,000 of the Stock Options will vest as to 12.5% of the shares underlying the grant on the six-month anniversary of the grant date, with the remaining shares vesting in equal monthly installments over the following 42 months; and (ii) 4,000,000 of the Stock Options will vest as to 25% of the shares underlying the grant on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments over the following 36 months, in each case subject to Mr. Semerjian&#8217;s continued service to the Company on the vesting dates. The Stock Options will be granted as a material inducement to Mr. Semerjian&#8217;s employment under the Company&#8217;s 2018 Inducement Award Plan and will have an exercise price equal to the closing price of the Company&#8217;s common stock on the Nasdaq Global Select Market on his start date, which will be the grant date. The Stock Options will fully vest upon the occurrence of a Change in Control (as defined in the Employment Agreement). Under the terms of the Employment Agreement, Mr. Semerjian is not eligible for an annual equity award until 2027.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Employment Agreement also provides that Mr. Semerjian is entitled to severance benefits consistent with the Company&#8217;s other executive officers. In the event Mr. Semerjian&#8217;s employment is terminated due to a Covered Termination (as defined in the Employment Agreement), (i) he will be paid his target annual bonus for the fiscal year in which the termination occurs, prorated for length of service during the year, and a lump-sum severance payment equal to 18 months of his base salary then in effect as of such termination; (ii) he and his covered dependents will also be eligible to continued healthcare coverage as permitted by COBRA for a period of up to 18 months following a Covered Termination, at the Company&#8217;s expense; and (iii) the vested portion of any stock options granted to Mr. Semerjian by the Company shall remain outstanding and exercisable until the earlier of the second anniversary of the date of termination or the original </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">expiration date of such award. Mr. Semerjian is also eligible to participate in the Amended Severance Plan (as defined below).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the Employment Agreement is a summary of its material terms, does not purport to be complete and is qualified in its entirety by reference to the full text of the Employment Agreement, which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There is no arrangement or understanding between Mr. Semerjian and any other person pursuant to which Mr. Semerjian was appointed as President, Chief Executive Officer and a director of the Company, and there is no family relationship between Mr. Semerjian and any of the Company&#8217;s other directors or executive officers. In addition, Mr. Semerjian is not party to any transaction, or series of transactions, required to be disclosed pursuant to Item 404(a) of Regulation S-K.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with his appointment, the Company and Mr. Semerjian will enter into the Company&#8217;s standard form of indemnification agreement. Pursuant to the terms of the indemnification agreement, the Company may be required, among other things, to indemnify Mr. Semerjian for certain expenses, including attorneys&#8217; fees, judgments, fines and settlement amounts incurred by him in any action or proceeding arising out of his service as President, Chief Executive Officer and a director of the Company. The foregoing is only a brief description of the terms of the indemnification agreement with Mr. Semerjian, does not purport to be complete and is qualified in its entirety by reference to the form of indemnification agreement, previously filed as Exhibit 10.1 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2011, as filed on March 7, 2012.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Amended and Restated Severance Plan</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 1, 2025, the Compensation Committee approved the Company&#8217;s Amended and Restated Severance Plan (as so amended and restated, the &#8220;Amended Severance Plan&#8221;), which Amended Severance Plan amends and restates, in its entirety, the amended and restated severance plan previously approved by the Board on December 23, 2021. The Amended Severance Plan applies to (i) eligible employees of the Company who were hired by the Company on or before December 31, 2021, and (ii) certain designated key employees of the Company, including the Company&#8217;s executive officers, in each case, who are not subject to a performance improvement plan. The only change to the existing severance plan is to add a payment to the Chief Executive Officer of 150% of his or her annual target bonus upon a Separation of Service (as defined in the Amended Severance Plan) in connection with a Change of Control (as defined in the Amended Severance Plan), as further described below.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Severance Plan, upon a Change of Control Triggering Event (and provided such Triggering Event constitutes a Separation from Service (as defined therein)), each of the Company&#8217;s executive officers, including Mr. Semerjian, is entitled to: (i) a severance payment equal to 15 months (18 months, with respect to Mr. Semerjian) of his or her base salary then in effect; (ii) payment of his or her target annual bonus, at the target bonus percentage in effect immediately prior to the termination, prorated for length of service during the year (plus an additional payment equal to 150% of his target annual bonus, with respect to Mr. Semerjian); and (iii) payment of COBRA premiums for up to 15 months (18 months, with respect to Mr. Semerjian). The Company&#8217;s executive officers will continue to receive the greater of the severance benefits set forth in their employment agreements or the severance benefits provided for in the Amended Severance Plan (without duplication).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the Amended Severance Plan does not purport to be complete and is qualified in its entirety by the full text of the Amended Severance Plan, which is attached hereto as Exhibit 10.2 and is incorporated herein by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Amendment to 2018 Inducement Award Plan</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 1, 2025, the Compensation Committee approved an amendment to the Company&#8217;s 2018 Inducement Award Plan to increase the number of shares of the Company&#8217;s common stock issuable thereunder by 11,000,000 shares (as so amended and restated, the &#8220;Amended 2018 Inducement Plan&#8221;) to be used exclusively for grants of inducement awards to individuals who were not previously employees or directors of the Company, other than following a bona fide period of non-employment, as a material inducement within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules to each such individual&#8217;s entry into employment with the Company.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing description of the Amended 2018 Inducement Plan does not purport to be complete and is qualified in its entirety by the full text of the Amended 2018 Inducement Plan, which is attached hereto as Exhibit 10.3 and is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="ie30f2026f81f4d4eb54f6e014a3828f2_10"></div><div style="-sec-extract:summary;margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements and Exhibits. </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits. </span></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.363%"><tr><td style="width:1.0%"/><td style="width:8.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:76.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.480%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 2.44pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit101-employmentagree.htm">Employment Agreement by and between the Company and Harout Semerjian, effective August 7, 2025.</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit102-arseveranceplan.htm">Geron Corporation Amended and Restated Severance Plan, as amended. </a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit103-2018inducementp.htm">Geron Corporation 2018 Inducement Award Plan, as amended. </a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ie30f2026f81f4d4eb54f6e014a3828f2_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.173%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">GERON CORPORATION</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date: August&#160;6, 2025</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ Scott A. Samuels</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Name:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Scott A. Samuels</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Chief Legal Officer and<br/>Secretary</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-employmentagree.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i8358199e64ff4ac29a6dd38065b56f80_1"></div><div style="min-height:72pt;width:100%"><div><img alt="image_0a.jpg" src="image_0a.jpg" style="height:124px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"></div></div><div><font><br></font></div><div style="padding-left:360pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 10.1</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">EMPLOYMENT AGREEMENT</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">This Employment Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is made effective as of August 7, 2025 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), by and between Harout Semerjian (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and Geron Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Whereas</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, the Company desires to employ Executive to provide personal services to the Company and to provide Executive with certain compensation and benefits in return for Executive&#8217;s services&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Whereas</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, Executive wishes to be employed by the Company and provide personal services to the Company in return for certain compensation and benefits&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Now, Therefore</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, in consideration of the mutual promises and covenants contained herein, it is hereby agreed by and between the parties hereto as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE I</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:9.7pt"> DEFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">For purposes of the Agreement, the following terms are defined as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Cause</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any willful act or omission by Executive constituting dishonesty, fraud or other malfeasance against the Company&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">Executive&#8217;s conviction of a felony under the laws of the United States or any state thereof or any other jurisdiction in which the Company conducts business&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Executive&#8217;s debarment by the U.S. Food and Drug Administration (FDA) from working in or providing services to any pharmaceutical or biotechnology company under the Generic Drug Enforcement Act of 1992, or other ineligibility under any law or regulation to perform Executive&#8217;s duties to the Company&#59; or </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">Executive&#8217;s breach of any of the material policies of the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Equity Incentive Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Geron Corporation, any wholly-owned subsidiaries, and its successors in interest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Comparable Employment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means employment on terms that provide (a) the same or greater rate of base pay or salary as in effect immediately prior to Executive&#8217;s termination, (b) the same, equivalent or higher job title and level of responsibility as Executive had prior to Executive&#8217;s termination, (c) equivalent or higher bonus opportunity as the bonus opportunity for the year preceding the year in which the termination occurs, and (d) a principal work location that is both (i) no more than forty-five (45) miles from Executive&#8217;s principal work location immediately prior to Executive&#8217;s termination and (ii) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">no more than thirty (30) miles farther from Executive&#8217;s principal weekday residence than was Executive&#8217;s principal work location immediately prior to the termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Covered Termination</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an Involuntary Termination Without Cause that occurs at any time, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%"> that such termination constitutes a &#8220;separation from service&#8221; within the meaning of Section 409A of the Code and the regulations promulgated thereunder, including Treasury Regulation Section 1.409A-1(h) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Involuntary Termination Without Cause</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Executive&#8217;s dismissal or discharge other than (i) for Cause, or (ii) after an involuntary or voluntary filing of a petition under chapter 7 or 11 of 11 USC Section 101 et. seq., an assignment for the benefit of creditors, a liquidation of the company&#8217;s assets in formal proceeding or otherwise or any other event of insolvency by the Company, in any case, without an offer of Comparable Employment by the Company or a successor, acquirer, or affiliate of the Company. For purposes of this Agreement, the termination of Executive&#8217;s employment due to Executive&#8217;s death or disability will not constitute a termination for Cause.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">&#8220;Inducement Plan</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Company&#8217;s 2018 Inducement Award Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Equity Incentive Plan</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Company&#8217;s 2018 Equity Incentive Award Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:54pt;padding-right:54pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE II</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:5.04pt"> EMPLOYMENT BY THE COMPANY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Position and Duties. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%"> Subject to the terms set forth herein, the Company agrees to employ Executive in the position of President and Chief Executive Officer.  During the Executive&#8217;s employment in this position, Executive will report to the Board.  Executive shall serve in an employee capacity and shall perform such duties as are assigned to Executive by the Board.  During Executive&#8217;s employment with the Company, Executive will devote Executive&#8217;s best efforts and substantially all of Executive&#8217;s business time and attention (except for vacation periods as set forth herein and reasonable periods of illness or other incapacities permitted by the Company&#8217;s general employment policies or as otherwise set forth in this Agreement) to the business of the Company.  During any period of time that Executive is serving as Chief Executive Officer, Executive will also serve as a member of the Board.  Executive agrees to resign from the Board immediately in the event Executive&#8217;s employment ends for any reason, or if Executive ceases to serve as the Chief Executive Officer. Executive&#8217;s principal place of employment will be his home office in New Hampshire, subject to normal business travel requirements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Employment at Will.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  Both the Company and Executive acknowledge and agree that Executive&#8217;s employment with the Company is &#8220;at-will&#8221; and not for any specified period of time, and may be terminated at any time by Executive or the Company, with or without Cause, and with or without prior notice&#59; provided, however, that if Executive&#8217;s employment with the Company is terminated under circumstances that constitute a Covered Termination, Executive will be eligible to receive certain severance payments and benefits as set forth in Article IV below. Executive is also eligible for severance benefits under the Amended and Restated Severance Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Employment Policies.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  The employment relationship between the parties shall also be governed by the general employment policies and practices of the Company, including but not limited to those policies relating to protection of confidential information and assignment of inventions.  In the event of a conflict between the terms of this Agreement and the Company&#8217;s general employment policies or practices, this Agreement shall control. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">2.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Indemnification.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">The Company shall provide for indemnification of the Executive as set forth in the Indemnification Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">.    </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE III</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:0.38pt"> COMPENSATION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">3.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">.  Executive shall receive for services to be rendered hereunder such annual base salary as is approved by the Board or the Compensation Committee of the Board, payable on the regular payroll dates of the Company, subject to increase in the sole discretion of the Board or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Compensation Committee of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).&#160; As of the Effective Date of this Agreement, Executive&#8217;s Base Salary is $800,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">3.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Bonus</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">.  As of the Effective Date of this Agreement, Executive shall be eligible to earn, for each fiscal year of the Company ending December 31 during Executive&#8217;s employment with the Company, an annual discretionary cash bonus (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) targeted at seventy percent (70%) of Executive&#8217;s Base Salary.  Executive&#8217;s discretionary Annual Bonus will be paid during the standard timing for year-end performance bonuses, with the eligibility cutoff date for participation being October 1st in the performance year for which any bonus may be paid. The Annual Bonus is tied to the achievement of certain corporate performance goals established for the Company and prorated for the individual&#8217;s initial performance period (assuming commencement of employment in the middle of a calendar year).</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%"> The establishment and achievement of corporate performance goals in each year is determined by the Board.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#160; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">If the Company determines, in its reasonable discretion, that Executive has engaged in any misconduct intended to affect the payment of Executive&#8217;s Annual Bonus or has otherwise engaged in any act or omission that would constitute Cause for termination of employment, as defined by Section 1.2 of the Agreement, Executive will automatically and immediately forfeit Executive&#8217;s entire Annual Bonus.&#160; If the Annual Bonus has already been paid to Executive, such Annual Bonus will be deemed unearned, and the Company shall have the right to recover the entire amount of the Annual Bonus paid to Executive for the calendar year(s) in which such misconduct or other act or omission constituting Cause occurred. &#160;Without limiting the foregoing, any such misconduct or other act or omission constituting Cause will subject Executive to disciplinary action up to and including termination of employment.&#160; In addition, any Annual Bonus paid to Executive for the calendar year(s) in which such misconduct or other Cause occurred is subject to recoupment in accordance with The Dodd&#8211;Frank Wall Street Reform and Consumer Protection Act and any implementing regulations, any other clawback policy adopted by the Company and any compensation recovery policy otherwise required by applicable laws, regulations, or statutes.  Recovery by the Company of an Annual Bonus in accordance with this Section shall not constitute an event giving rise to a right by Executive to voluntarily terminate Executive&#8217;s employment for Cause based on such recovery by the Company, nor shall it constitute &#8220;constructive termination&#8221;, or any similar term or circumstance under the Agreement or any other plan or agreement with the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">3.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Inducement Stock Option</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">In accordance with the terms approved by Board or the Company&#8217;s Compensation Committee of the Board, the Executive shall receive a time-based option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Inducement Option</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to purchase eleven million shares (11,000,000) of Company common stock having an exercise price equal to the fair market value of Company common stock, as reported by the Nasdaq Global Select Market, on the first date of Executive&#8217;s employment, and vesting as follows&#58; (i) with respect to 7,000,000 of the shares, 12.5% (875,000) of such shares on the date that is six months following the Executive&#8217;s first date of employment and with respect to the remainder of such shares on each monthly date of the Executive&#8217;s first date of employment in equal installments over 42 months thereafter&#59; and (ii) with respect to 4,000,000 of the shares, 25.0% (1,000,000) of such shares on the first anniversary of the Executive&#8217;s first date of employment and with respect to the remainder of such shares on each monthly date of the Executive&#8217;s first date of employment in equal installments over 36 months thereafter. The Inducement Option serves as an inducement material to Executive entering into employment with the Company and will be granted under the Company&#8217;s Inducement Plan as non-statutory stock options.  The vesting of the Inducement Option shall be subject to Executive&#8217;s continued service to the Company through the applicable vesting dates, provided, that upon the occurrence of a Change of Control, subject to Executive&#8217;s continued service to the Company through the date of such Change of Control, the Inducement Option shall vest and become exercisable with respect to one hundred percent (100%) of the unvested shares subject thereto. The Inducement Option otherwise shall be subject to and governed in all respects by the terms of the Inducement Plan and the stock option agreement for the option grant to be entered into between the Company and Executive.  Executive will not be eligible for an annual equity award until 2027.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">3.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Standard Company Benefits&#59; Vacation.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  Executive shall be entitled to all rights and benefits for which Executive is eligible under the terms and conditions of the Company&#8217;s benefit and compensation plans, practices, policies, and programs, as in effect from time to time, that are provided by the Company to its executive employees generally.  Except as specifically provided herein, nothing in this Agreement is construed or interpreted to provide greater rights, participation, coverage, or benefits under such benefit plans or programs provided to executive employees pursuant to the terms and conditions of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">such benefit plans and programs. Executive will be eligible for vacation accruals in accordance with the Company&#8217;s current time off policy, starting with twenty (20) days per year.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE IV</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:1.04pt"> SEVERANCE BENEFITS AND RELEASE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">4.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Severance Benefits.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  If Executive&#8217;s employment terminates due to a Covered Termination after the date of execution of this Agreement, Executive shall receive&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Payment of Accrued Obligations Upon Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon a termination of Executive&#8217;s employment for any reason at any time following the Effective Date, the Company shall pay to Executive in a single lump-sum cash payment as soon as administratively practicable following the date of termination, the aggregate amount of Executive&#8217;s (A) earned but unpaid Base Salary and Annual Bonus for the prior completed fiscal year (if unpaid), and (B) accrued but unpaid vacation pay.  In addition, Executive shall be promptly paid for incurred but unreimbursed business expenses upon Executive&#8217;s submission of such expenses in accordance with the Company&#8217;s expense reimbursement policies.  The amounts set forth in this Section 4.1(i) are collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Accrued Obligations</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt;text-decoration:underline">Severance Upon a Covered Termination</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">.  If Executive&#8217;s employment terminates due to a Covered Termination at any time after the Effective Date, then, in addition to the Accrued Obligations&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Executive shall be paid target Annual Bonus for the fiscal year in which the termination occurs, prorated for the length of service provided during the calendar year through the termination date, payable in a single lump-sum payment within thirty (30) days following the date of termination&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">Executive shall be paid an aggregate amount equal to eighteen (18) months of Executive&#8217;s Base Salary in effect on the date of termination, payable to Executive in a single lump-sum amount on the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">) day following the date of termination&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Executive and Executive&#8217;s covered dependents will be eligible to continue their health care benefit coverage as permitted by COBRA (Internal Revenue Code Section 4980B) at the Company&#8217;s expense for the lesser of (i) eighteen (18) months following the Covered Termination, or (ii) until the Executive and&#47;or Executive&#8217;s covered dependents are no longer eligible for COBRA (for clarification and as an example, in the event Executive is covered by another health plan, etc.).  Thereafter, Executive and Executive&#8217;s covered dependents shall be entitled to maintain coverage for Executive and Executive&#8217;s eligible dependents at Executive&#8217;s own expense for the balance of the period that Executive is entitled to coverage under COBRA&#59; and</font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">the Inducement Option, along with any subsequent options or other exercisable equity interest in the Company held by Executive as of the date of termination shall remain outstanding and exercisable through the earlier of (i) the second (2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">) anniversary of the date of termination or (ii) the original expiration date of the option or other equity interest.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if Executive&#8217;s employment terminates due to a Covered Termination at any time after the Effective Date, Executive will receive the greater of (i) the severance benefits above, or (ii) the severance benefits provided for in the Amended and Restated Severance Plan attached hereto as Exhibit C, which may be amended from time-to-time by the Company at the Company&#8217;s sole discretion, that is in effect at the time of termination. For the avoidance of doubt, all amounts payable under this Agreement shall be subject to applicable federal, state, local or foreign tax withholding requirements.  </font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">4.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Parachute Payments.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  If any payment or benefit Executive would receive in connection with a Change in Control from the Company or otherwise (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Payment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) would (i) constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), then such Payment shall be reduced to the Reduced Amount. The &#8220;Reduced Amount&#8221; shall be either (x) the largest portion of the Payment </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Executive&#8217;s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.  If a reduction in payments or benefits constituting &#8220;parachute payments&#8221; is necessary so that the Payment equals the Reduced Amount, reduction shall occur in the following order unless Executive elects in writing a different order (provided, however, that such election shall be subject to Company approval)&#58; reduction of cash payments&#59; cancellation of accelerated vesting of stock awards&#59; reduction of employee benefits.  In the event that acceleration of vesting of stock award compensation is to be reduced, such acceleration of vesting shall be cancelled in the reverse order of the date of grant of Executive&#8217;s stock awards unless Executive elects in writing a different order for cancellation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">4.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The Company for general audit purposes shall engage a nationally recognized public accounting firm (the &#8220;Accounting Firm&#8221;) to perform the foregoing calculations. The Company shall bear all expenses with respect to the determinations by such accounting firm required to be made hereunder.  The Accounting Firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting documentation, to the Company and Executive within fifteen (15) calendar days after the date on which Executive&#8217;s right to a Payment is triggered (if requested at that time by the Company or Executive) or such other time as requested by the Company or Executive. If the Accounting Firm determines that no Excise Tax is payable with respect to a Payment, either before or after the application of the Reduced Amount, it shall furnish the Company and Executive with an opinion reasonably acceptable to Executive that no Excise Tax will be imposed with respect to such Payment. Any good faith determinations of the accounting firm made hereunder shall be final, binding, and conclusive upon the Company and Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">4.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Release.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  Notwithstanding the foregoing, Executive&#8217;s right to receive the amounts provided for in Sections 4.1(ii) and 4.2, and the Change of Control acceleration in any stock option agreement shall be subject to and conditioned upon Executive&#8217;s execution and non-revocation of a release of claims in substantially the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (as such form may be modified to take into account changes in the law) within fifty (50) days following the termination date.  Such Release shall specifically relate to all of Executive&#8217;s rights and claims in existence at the time of such execution and shall confirm Executive&#8217;s obligations under the Proprietary Information and Inventions Agreement (as defined below).  It is understood that Executive has a certain period to consider whether to execute such Release, as set forth in the Release, and Executive may revoke such Release within seven (7) business days after execution. In the event Executive does not execute such Release within the applicable period, or if Executive revokes such Release within the subsequent seven (7) business day period, none of the aforesaid benefits set forth in Sections 4.1(ii), 4.2, and the Change of Control acceleration in any stock option agreement shall be payable to Executive under this Agreement and this Agreement shall be null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">4.5</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Section 409A.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed by the Company at the time of the Separation from Service to be a &#8220;specified employee&#8221; for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of Executive&#8217;s benefits shall not be provided to Executive prior to the earlier of (a) the expiration of the six-month period measured from the date of Executive&#8217;s Separation from Service or (b) the date of Executive&#8217;s death.  Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this Section 4.4 shall be paid in a lump sum to Executive (or Executive&#8217;s estate or beneficiaries), and any remaining payments due under the Agreement shall be paid as otherwise provided herein.  For purposes of Section 409A of the Code, Executive&#8217;s right to receive the payments of compensation pursuant to the Agreement shall be treated as a right to receive a series of separate payments and accordingly, each payment shall at all times be considered a separate and distinct payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">4.6</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Mitigation.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  Executive shall not be required to mitigate damages or the amount of any payment provided under this Agreement by seeking other employment or otherwise, nor shall the amount </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">of any payment provided for under this Agreement be reduced by any compensation earned by Executive as a result of employment by another employer or by any retirement benefits received by Executive after the date of the Covered Termination, or otherwise.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE V</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:5.7pt"> PROPRIETARY INFORMATION OBLIGATIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">5.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Agreement.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  Executive agrees to abide by the Proprietary Information and Inventions Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Proprietary Information and Inventions Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit D</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Remedies.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  Executive&#8217;s duties under the Proprietary Information and Inventions Agreement shall survive termination of Executive&#8217;s employment with the Company and the termination of this Agreement.  Executive acknowledges that a remedy at law for any breach or threatened breach by Executive of the provisions of the Proprietary Information and Inventions Agreement would be inadequate, and Executive therefore agrees that the Company shall be entitled to injunctive relief in case of any such breach or threatened breach.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE VI</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:1.04pt"> OUTSIDE ACTIVITIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">6.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">No Other Employment.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Except with the prior written consent of the Board, Executive shall not during the term of Executive&#8217;s employment with the Company, undertake or engage in any other employment, occupation, or business enterprise.  Notwithstanding the foregoing, during the term of Executive&#8217;s employment with the Company, Executive may (a) undertake or engage in any other employment, occupation or business enterprise in which Executive is a passive investor, and&#47;or (b) engage in civic and not-for-profit activities, in each case, so long as such activities do not materially interfere with the performance of Executive&#8217;s duties hereunder, and&#47;or (c) serve on one outside board of directors, subject to approval by the Board or a designated committee thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">6.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">No Conflicting Business Interests.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">During the term of Executive&#8217;s employment by the Company, except on behalf of the Company, Executive shall not directly or indirectly, whether as an officer, director, stockholder, partner, proprietor, associate, representative, consultant, or in any capacity whatsoever engage in, become financially interested in, be employed by, or have any business connection with any other person, corporation, firm, partnership, or other entity whatsoever which were known by Executive to compete directly with the Company, throughout the world, in any line of business engaged in (or planned to be engaged in) by the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">, that anything above to the contrary notwithstanding, Executive may own, as a passive investor, securities of any competitor corporation, so long as Executive&#8217;s direct holdings in any one such corporation shall not in the aggregate constitute more than 1% of the voting stock of such corporation. </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE VII</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:14.38pt">NONINTERFERENCE</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">While employed by the Company, and for one (1) year immediately following the date on which Executive terminates employment or otherwise ceases providing services to the Company, Executive agrees not to interfere with the business of the Company by soliciting or attempting to solicit any employee of the Company to terminate such employee&#8217;s employment in order to become an employee, consultant, or independent contractor to or for any pharmaceutical or biotechnology competitor of the Company.  Executive&#8217;s duties under this Article VII shall survive termination of Executive&#8217;s employment with the Company and the termination of this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-right:-54pt;text-align:center;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE VIII</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:9.72pt">DEBARMENT</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Executive certifies that Executive has never been&#58;&#160;(a) debarred by any relevant authorities, pursuant to any applicable law, including, but not limited to, Section 306(a) and (b) of the US Federal Food, Drug, and Cosmetic Act&#59; (b) convicted of any of the felonies identified among the Exclusion Authorities listed on the U.S. Department of Health and Human Services (HHS) Office of Inspector General website&#59; or (c) listed as being suspended, debarred, or excluded, or otherwise ineligible to participate in Federal procurement or non-procurement programs, including, but not limited to, being listed on the List of Excluded Individuals&#47;Entities (LEIE) database on the HHS Office of Inspector General website. If Executive becomes suspended, debarred, or excluded pursuant to any of the foregoing, Executive must notify the Company immediately in writing</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE IX</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:1.04pt"> GENERAL PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Notices.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  Any notices provided hereunder must be in writing and shall be deemed effective upon the earlier of personal delivery (including personal delivery by telex) or the third day after mailing by first class mail, to the Company at its primary office location and to Executive at Executive&#8217;s address as listed on the Company payroll.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Section 409A.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  To the extend applicable, this Agreement shall be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations and other interpretative guidance issued thereunder, including without limitation any such regulations or other such guidance that may be issued after the Effective Date (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  Notwithstanding any provision of this Agreement to the contrary, in the event that following the Effective Date, the Company determines in good faith that any compensation or benefits payable under this Agreement may not be either exempt from or compliant with Section 409A, the Company may adopt such amendments to this Agreement or adopt other policies or procedures (including amendments, policies and procedures with retroactive effect), or take any other commercially reasonable actions necessary or appropriate to preserve the intended tax treatment of the compensation and benefits payable hereunder, including without limitation actions intended to (i) exempt the compensation and benefits payable under this Agreement from Section 409A, and&#47;or (ii) comply with the requirements of Section 409A, provided, that this Section 8.2 does not, and shall not be construed so as to, create any obligation on the part of the Company to adopt any such amendments, policies or procedures or to take any other such actions or to create any liability on the part of the Company for any failure to do so.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Severability.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal, or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality, or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed, and enforced in such jurisdiction as if such invalid, illegal, or unenforceable provisions had never been contained herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Waiver.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">If either party should waive any breach of any provisions of this Agreement, they shall not thereby be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.5</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Complete Agreement.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  This Agreement and Exhibits A, B, C and D hereto constitute the entire agreement between Executive and the Company and are the complete, final, and exclusive embodiment of their agreement with regard to this subject matter (except for the Equity Incentive Plan and the Inducement Plan and award agreements thereunder, the Amended and Restated Severance Plan, and any successors thereto).  As of the Effective Date, this Agreement supersedes any prior agreement between Executive and the Company or any predecessor employer in its entirety. Executive and the Company acknowledge and agree that this Agreement is entered into without reliance on any promise or representation other than those expressly contained herein or therein and cannot be modified or amended except in a writing signed by a duly authorized officer of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.6</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Counterparts and Electronic Signatures.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  This Agreement may be executed in separate counterparts, any one of which need not contain signatures of more than one party, but all of which taken together will constitute one and the same Agreement.  The parties agree that execution of this Agreement by industry standard electronic signature software and&#47;or by exchanging PDF signatures shall have the same legal force and effect as the exchange of original signatures, and that in any proceeding arising under or relating to this Agreement, each party hereby waives any right to raise any defense or waiver based upon execution of this Agreement by means of such electronic signatures or maintenance of the executed agreement electronically.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.7</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Headings.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  The headings of the sections hereof are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect the meaning thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Successors and Assigns.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  This Agreement is intended to bind and inure to the benefit of and be enforceable by Executive and the Company, and their respective successors, assigns, heirs, executors, and administrators, except that Executive may not assign any of Executive&#8217;s duties hereunder and Executive may not assign any of Executive&#8217;s rights hereunder, without the written consent of the Company, which shall not be withheld unreasonably.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.9</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Arbitration.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  In the event of any contractual, statutory or tort dispute or claim relating to or arising out of Executive&#8217;s employment relationship with the Company (including but not limited to any claims of wrongful termination or age, sex, race, or other discrimination, but not including workers&#8217; compensation claims), Executive and the Company agree that all such disputes will be finally resolved by binding arbitration conducted by a single neutral arbitrator associated with the American Arbitration Association in Foster City, California.  Executive and the Company hereby waive their respective rights to have any such disputes or claims tried to a judge or jury. However, the Company agrees that this arbitration provision will not apply to any claim, by either Executive or the Company, for injunctive relief. The administrative costs of any arbitration proceeding between Executive and the Company and the fees and costs of the arbitrator shall be borne by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.10</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Attorneys&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">.  If either party hereto brings any action to enforce rights hereunder, each party in any such action shall be responsible for its own attorneys&#8217; fees and costs incurred in connection with such action.  The Company agrees to reimburse Executive up to $25,000 in reasonable, documented professional fees incurred by Executive in connection with the negotiation and execution of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.11</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">.  Executive acknowledges that Executive (a) has had the opportunity to discuss this matter with and obtain advice from independent counsel of Executive&#8217;s own choice and has been advised to do so by the Company, (b) has carefully read and fully understands all the provisions of this Agreement, and (c) is knowingly and voluntarily entering into this Agreement.  Executive represents that Executive (i) is familiar with the restrictive covenants set forth in the Proprietary Information and Inventions Agreement and (ii) is fully aware of Executive&#8217;s obligations thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.12</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Choice of Law.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">  All questions concerning the construction, validity and interpretation of this Agreement will be governed by the law of the State of California.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.13</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Personal Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">.  Executive understands that the Company may hold certain personal information about him or her, including, but not limited to, your name, home address, telephone number, date of birth, social security number, salary, nationality, and job title (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Personal Data</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  Certain Personal Data may also constitute &#8220;Sensitive Personal Data&#8221; within the meaning of applicable local law.  Such data include, but are not limited to, Personal Data and any changes thereto, and other appropriate personal and financial data about you.  The Company&#8217;s lawful basis for processing Personal Data and Sensitive Personal Data include fulfilling its role as an employer, compliance with law, and legitimate business interest.  Executive hereby provides express consent to the Company to process such Personal Data and Sensitive Personal Data and to transfer any such Personal Data and Sensitive Personal Data to any third parties outside the country in which you are employed or retained, for purposes of administrating and managing your employment relationship with the Company.  Executive may, at any time, review his or her Personal Data, request any necessary corrections to it, or withdraw his or her </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">consent in writing by contacting the Company&#59; however, withdrawal of your consent may affect your employment with the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.14</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Eligibility to Work</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">.  In accordance with federal law, all new employees are required to present evidence of their eligibility to be employed in the United States and this Agreement is subject to proof of Executive&#8217;s ability to lawfully work in the United States.  Accordingly, the Company requests that Executive provide the Company with appropriate documentation for this purpose within 72 hours of the first day of employment.  Acceptable documents include, but are not limited to, a birth certificate, a passport, a visa, permanent residence card, or driver&#8217;s license and social security card.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">9.15</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:16.75pt">Pre-Employment Screenings as a Condition of Employment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">As a condition of employment, Executive will be required to submit to a background check which must yield results considered acceptable to the Company.&#160; Standard screenings include verification of prior employment and education, a drug test, and a criminal history check.&#160; Additional screenings, such as a credit check or Department of Motor Vehicles record check, may be applicable based on job function.&#160; Further, the Company will require the receipt of professional references that are predominately positive in content and character.&#160; If the results of any of these screenings are determined by the Company to be noncompliant with its policies, procedures, or general business requirements, the Company reserves the right to unilaterally revoke this Agreement, with no obligation or liability to you.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#91;REMAINDER OF THIS PAGE LEFT BLANK&#59; SIGNATURE PAGE TO FOLLOW&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">In Witness Whereof</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, the parties have executed this Agreement on the respective dates set forth below&#58;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">GERON CORPORATION</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;   </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Elizabeth G. O&#8217;Farrell  &#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">   &#160;&#160;&#160;&#160;Elizabeth G. O&#8217;Farrell, Chair of the Board</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On Behalf of the Board </font></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;&#160;&#160;August 1, 2025</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Accepted and agreed this 1st day of August, 2025,</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Harout Semerjian  &#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Harout Semerjian</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit102-arseveranceplan.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ic299b2330670419ca0226cb8897be7c2_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Effective August 1, 2025</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Geron Corporation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Amended and Restated</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Severance Plan<br>(and Summary Plan Description)</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">This Geron Corporation&#160;Amended and Restated&#160;Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) sets forth the severance benefits available to Covered Employees of Geron Corporation (together with any successor to substantially all of its business, stock or assets, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#160;whose employment is terminated as a result of a Triggering Event&#160;(as defined below).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The Plan is an employee welfare benefit plan subject to the Employee Retirement Income Security Act of 1974, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).&#160;&#160;This Plan document is also the summary plan description of the Plan.&#160;&#160;References in the Plan to &#8220;You&#8221; or &#8220;Your&#8221; are references to an employee of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">General Eligibility.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;You shall only be eligible for benefits under this Plan if&#58; (a) either (i) your position with the Company is above the Vice President level or (ii) you were hired by the Company before January 1, 2022, (b)&#160;immediately prior to a Triggering Event, you are an employee of the Company and are not subject to an ongoing performance improvement plan (a&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Covered Employee</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;),&#160;and (c)&#160;you are notified by the Company in writing that you are eligible for severance benefits under the Plan as a result of a Triggering Event.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Severance&#160;Benefits.&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Upon a Triggering Event, you shall&#160;be entitled to&#160;receive a severance payment equal to the amount of your&#160;Base&#160;Salary&#160;for a severance period that is determined based on your position with the Company immediately before such Triggering Event pursuant to the following schedule, provided that the Triggering Event constitutes a &#8220;separation from service&#8221; within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and the regulations promulgated thereunder, including Treasury Regulation Section 1.409A-1(h) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#58;&#160;</font></div><div style="padding-left:72pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Covered Position</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Severance Period (Non-Change of Control Triggering Event)</font></td><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">Severance Period (Change of Control Triggering Event)</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">CEO</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Not applicable</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">18 months</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.07pt;padding-right:3.07pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Executive Vice President, Senior Vice President, Chief Financial Officer, Chief Scientific Officer, and other executives that have &#8220;Individual Employment Agreements&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Not applicable</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">15 months</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Vice President</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">12 months</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">12 months</font></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Executive Director, Senior Director</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">9 months</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">9 months</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Director, Associate Director</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">6 months</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">6 months</font></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.07pt;padding-right:3.07pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Senior Scientist&#47;Scientist,</font></div><div style="padding-left:3.07pt;padding-right:3.07pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Manager, Associate, other Staff</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">3 months</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 4.07pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">3 months</font></td></tr></table></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">1 As defined in Section 7 below.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">For purposes of calculating Plan benefits, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean your base pay (excluding incentive pay, premium pay, commissions, overtime, bonuses and other forms of variable compensation), at the rate in effect during the last regularly scheduled payroll period immediately preceding the date of your Separation from Service.&#160;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;&#160;Upon a Triggering Event (and provided such Triggering Event constitutes a Separation from Service), you shall be paid your target annual bonus at the target bonus percentage in effect immediately preceding the date of your Separation from Service, for the calendar year in which the termination occurs, prorated for the length of service provided during the calendar year through the termination date. In addition, with respect to a Change of Control Triggering Event and for the CEO only, you shall be paid an additional severance amount equal to your target annual bonus at the target bonus percentage in effect immediately preceding the date of your Separation from Service, for your applicable severance period as specified in Section 2(a).  For sake of clarity, because the CEO&#8217;s Severance Period upon a Change of Control Triggering Event is 18 months, this means that the CEO will receive an additional severance amount equal to 1.5x his&#47;her target annual bonus. </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Upon a Triggering Event, the Company shall&#160;pay all premiums required for continuation of&#160;your health benefits (as in effect on the date of your Separation from Service)&#160;under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), provided that you timely elect such continued coverage under COBRA, on a monthly basis through the earliest of&#58; (i) the end of your applicable&#160;severance period as specified&#160;in Section 2(a), (ii) the date&#160;you obtain other employment offering health care coverage, or (iii) the expiration of your eligibility for such continued coverage under COBRA (such period from the date of your Separation from Service through the earliest of (i) through (iii), the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">COBRA Payment Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if at any time the Company determines, in its sole discretion, that the payment of such COBRA premiums would result in a violation of applicable law (including, without limitation, Section 105(h)(2) of the Code and Section 2716 of the Public Health Service Act), then in lieu of providing such COBRA premiums, the Company shall instead pay you, on the last day of each remaining month of the COBRA Payment Period, a fully taxable cash payment equal to the COBRA premiums for that month, subject to applicable tax withholdings (such amount, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Special Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, that any such Special Severance Payment shall be made without regard to your payment of COBRA premiums and for purposes of any such Special Severance Payment, the &#8220;COBRA Payment Period&#8221; shall be determined without regard to the expiration of your eligibility for continued coverage under COBRA.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">If you become eligible for coverage under another employer&#8217;s health plan or otherwise cease to be eligible for COBRA during the COBRA Payment Period, you must immediately notify the Company of such event, and all payments and obligations under this Section 2(c) shall cease.&#160;&#160;For purposes of this Section 2(c), (i) references to COBRA shall be deemed to refer also to analogous provisions of state law and (ii) any applicable insurance premiums that are paid by the Company shall not include any amounts payable by you pursuant to a health care reimbursement plan under Section 125 of the Code, which amounts, if any, are your sole responsibility.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Notwithstanding any provision in the Plan to the contrary, upon the occurrence of an event that constitutes both a Non-Change of Control Triggering Event and a Change of Control Triggering Event, your benefits under the Plan shall be determined based on the type of Triggering Event that results in the greater amount of benefits for you, and you shall not be entitled to receive benefits based on both types of Triggering Events.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;The Company, in its sole discretion, shall have the authority to reduce your severance benefits under the Plan, in whole or in part, by any other severance benefits, pay and benefits provided during a period following written notice of a plant closing or mass layoff, pay and benefits in lieu of such notice, or other similar benefits payable to you by the Company that become payable in connection with your termination of employment pursuant to any applicable legal requirement, including, without limitation, the Worker Adjustment and Retraining Notification Act, the California Plant Closing Act, or any other similar state law&#160;and the Plan Administrator shall so construe and implement the terms of the Plan.&#160;&#160;Any such reductions that the Company determines to make pursuant to this Section 2(e) shall be made such that any benefit under the Plan shall be reduced solely by any similar type of benefit under such legal requirement, agreement, policy or practice (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">i.e</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">., any cash severance benefits under the Plan shall be reduced solely by any cash payments or severance benefits under such legal requirement, and any continued insurance benefits under the Plan shall be reduced solely by any continued insurance benefits under such legal requirement).&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Payment and Other Terms.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All severance payments under&#160;Section 2(a)&#160;and 2(b)&#160;shall be made in a&#160;lump-sum&#160;and be reduced by any applicable taxes or any other amounts required to be paid or withheld by the Company.&#160;&#160;Such payments shall be made&#160;on the date that is&#160;sixty (60) days following the applicable Triggering Event.&#160;&#160;Notwithstanding any provision herein to the contrary, if you are deemed by the Company at the time of your Separation from Service to be a &#8220;specified employee&#8221; for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which you are entitled under this Plan is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of your benefits shall not be provided to you prior to the earlier of (i) the expiration of the six-month period measured from the date of your Separation from Service or (ii) the date of your death.&#160;&#160;Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to the preceding sentence shall be paid in a lump sum to you (or your estate or beneficiaries), and any remaining payments due under the Plan shall be paid as otherwise provided herein.&#160;</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Subject to Section 3(a), to the extent that any payments of COBRA premiums or Special Severance Payments under Section 2(c) constitute &#8220;deferred compensation&#8221; within the meaning of Section 409A of the Code and are not exempt from the application of Section 409A of the Code pursuant to Treasury Regulations Sections 1.409A-1(b)(4), 1.409A-1(b)(9)(iii) or 1.409A-1(b)(9)(v), on the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">) day following your Separation from Service, the Company shall make the first payment under Section 2(c) equal to the aggregate amount of payments that the Company would have paid through such date had such payments commenced on the Separation from Service through such sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">) day, with the balance of the payments paid thereafter on the schedule described in Section 2(c).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The receipt of any severance&#160;benefits&#160;pursuant to&#160;the Plan&#160;will be subject to your signing (or, in the event of your death, your estate or beneficiaries signing) a general release of all claims against the Company and its affiliates in a form&#160;determined by&#160;the Company, within&#160;the applicable time </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">period set forth therein, and subsequently not revoking such release within any period permitted under applicable law&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, that in no event may the applicable time period or revocation period extend beyond sixty (60) days following your Separation from Service.&#160;&#160;No severance benefits under the Plan&#160;will be paid or provided until the general release of claims becomes effective and irrevocable.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;You will not be entitled to any severance benefits under the Plan unless and until you return all Company Property.&#160;&#160;For this purpose, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Company Property</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means all Company documents (and all copies thereof) and other Company property which you had in your possession at any time, including, but not limited to, files, notes, drawings, records, plans, forecasts, reports, studies, analyses, proposals, agreements, financial information, research and development information, sales and marketing information, operational and personnel information, specifications, code, software, databases, computer-recorded information, tangible property and equipment (including, but not limited to, computers, facsimile machines, mobile telephones, servers), credit cards, entry cards, identification badges and keys, and any materials of any kind which contain or embody any proprietary or confidential information of the Company (and all reproductions thereof in whole or in part).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Effective Date of Plan&#47;Amendment.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;This Plan&#160;was originally established&#160;effective as of January 21,&#160;2003 and was subsequently amended and restated effective as of December 19, 2008, February 13, 2013,&#160;May 23, 2013,&#160;January 30, 2019, January 1, 2022, and August 1, 2025.&#160;The Board shall have the power to amend or terminate this Plan from time-to-time in its discretion and for any reason (or no reason), provided that no such amendment or termination shall be effective with respect to a Triggering Event that occurred prior to the amendment or termination. The Board may delegate its authority to amend or terminate this Plan to a subcommittee of the Board (e.g., the Compensation Committee).</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Claims Procedures</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Normally, you do not need to present a formal claim to receive benefits payable under this Plan.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If any person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Claimant</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) believes that benefits are being denied improperly, that the Plan is not being operated properly, that fiduciaries of the Plan have breached their duties, or that the Claimant&#8217;s legal rights are being violated with respect to the Plan, the Claimant must file a formal claim, in writing, with the Plan Administrator.&#160;&#160;This requirement applies to all claims that any Claimant has with respect to the Plan, including claims against fiduciaries and former fiduciaries, except to the extent the Plan Administrator determines, in its sole discretion, that it does not have the power to grant all relief reasonably being sought by the Claimant.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;A formal claim must be filed within 90 days after the date the Claimant first knew or should have known of the facts on which the claim is based, unless the Plan Administrator in writing consents otherwise.&#160;&#160;The Plan Administrator shall provide a Claimant, on request, with a copy of the claims procedures established under&#160;Section 5(d).</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Plan Administrator has adopted procedures for considering claims (which are set forth in Appendix A), which it may amend from time to time, as it sees fit.&#160;&#160;These procedures shall comply with all applicable legal requirements.&#160;&#160;These procedures may provide that final and binding arbitration shall be the ultimate means of contesting a denied claim (even if the Plan Administrator or its delegates have failed to follow the prescribed procedures with respect to the claim).&#160;&#160;The right to receive </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">benefits under this Plan is contingent on a Claimant using the prescribed claims and arbitration procedures to resolve any claim.&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Plan Administration.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Plan Administrator is responsible for the general administration and management of the Plan and shall have all powers and duties necessary to fulfill its responsibilities, including, but not limited to, the discretion to interpret and apply the Plan and to determine all questions&#160;relating to eligibility for benefits. The Plan Administrator will have concurrent authority with the Board and Compensation Committee to administer the Plan in all respects as provided herein, except with respect to appeals of claims under the Plan, which will be referred to the Compensation Committee. The Plan shall be interpreted in accordance with its terms and their intended meanings.&#160;&#160;However, the Plan Administrator and all Plan fiduciaries shall have the discretion to interpret or construe ambiguous, unclear, or implied (but omitted) terms in any fashion they deem to be appropriate in their sole discretion, and to make any findings of fact needed in the administration of the Plan.&#160;&#160;The validity of any such interpretation, construction, decision, or finding of fact shall not be given de novo review if challenged in court, by arbitration, or in any other forum, and shall be upheld unless clearly arbitrary or capricious.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;All actions taken and all determinations made in good faith by the Plan Administrator or by Plan fiduciaries will be final and binding on all persons claiming any interest in or under the Plan.&#160;&#160;To the extent the Plan Administrator or any Plan fiduciary has been granted discretionary authority under the Plan, the Plan Administrator&#8217;s or Plan fiduciary&#8217;s prior exercise of such authority shall not obligate it to exercise its authority in a like fashion thereafter.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;If, due to errors in drafting, any Plan provision does not accurately reflect its intended meaning, as demonstrated by consistent interpretations or other evidence of intent, or as determined by the Plan Administrator in its sole discretion, the provision shall be considered ambiguous and shall be interpreted by the Plan Administrator and all Plan fiduciaries in a fashion consistent with its intent, as determined in the sole discretion of the Plan Administrator.&#160;&#160;The Plan Administrator shall amend the Plan retroactively to cure any such ambiguity.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;No Plan fiduciary shall have the authority to answer questions about any pending or final business decision of the Company or any affiliate that has not been officially announced, to make disclosures about such matters, or even to discuss them, and no person shall rely on any unauthorized, unofficial disclosure. Thus, before a decision is officially announced, no fiduciary is authorized to tell any employee, for example, that the employee will or will not be laid off or that the Company will or will not offer exit incentives in the future. Nothing in this subsection shall preclude any fiduciary from fully participating in the consideration, making, or official announcement of any business decision.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;This Section&#160;6&#160;may not be invoked by any person to require the Plan to be interpreted in a manner inconsistent with its interpretation by the Plan Administrator or other Plan fiduciaries.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Superseding Plan.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;This&#160;Plan (i) shall be the only plan with respect to which benefits may be provided to you upon a Change of Control&#160;or upon a termination of your employment by the Company without Cause&#160;after the effective date of this Amended and Restated Plan&#59;&#160;and (ii) shall supersede any other plan&#160;or agreement&#160;(other than the 1992 Stock Option Plan, 2002 Equity Incentive Plan,&#160;2011 Incentive Award Plan, 2018&#160;Equity Incentive Plan and 2018 Inducement Award Plan, and any option or other equity award&#160;agreements thereunder) previously adopted by the Company with respect </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">to&#160;benefits that may be provided upon&#160;a Change of Control&#160;or a termination of employment by the Company without Cause&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, that this Plan shall not supersede any employment agreement or other similar agreement entered into between an&#160;individual and the Company (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Individual Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and provided, further, that if you are entitled to benefits upon a termination of your employment under both this Plan and your Individual Employment Agreement, you will receive the greater of (without duplication) such benefits under your Individual Employment Agreement and this Plan, as in effect at the time of your termination.&#160;The&#160;benefits provided under this Plan are not intended to be duplicative of those provided in any Individual Employment Agreement.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Limitation On Employee Rights&#59; At-Will Employment.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">This Plan shall not give any employee the right to be retained in the service of the Company or interfere with or restrict the right of the Company to discharge or retire the employee.&#160;&#160;All employees of the Company are employed at will.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">No Third-Party Beneficiaries.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">This Plan shall not give any rights or remedies to any person other than&#160;Covered&#160;Employees and the Company.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Governing Law.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">This Plan is a welfare plan subject to ERISA and it shall be interpreted, administered, and enforced in accordance with that law.&#160;&#160;To the extent that state law is applicable, the statutes and common law of the State of California, excluding any that mandate the use of another jurisdiction&#8217;s laws, shall apply.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Miscellaneous.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Where the context so indicates, the singular will include the plural and vice versa.&#160;&#160;Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of the Plan.&#160;&#160;Unless the context clearly indicates to the contrary, a reference to a statute or document shall be construed as referring to any subsequently enacted, adopted, or executed counterpart.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Section 409A.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;To the extent applicable, this Plan shall be interpreted in accordance with, and incorporate the terms and conditions required by, Section 409A of the Code and Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the adoption of this Plan.&#160;&#160;It is intended that (i) each installment of any benefits payable under the Plan to you be regarded as a separate &#8220;payment&#8221; for purposes of Treasury Regulations Section 1.409A-2(b)(2)(i), (ii) all payments of any such benefits under the Plan satisfy, to the greatest extent possible, the exemptions from the application of Section 409A provided under Treasury Regulations Sections 1.409A-1(b)(4) and 1.409A-1(b)(9)(iii), and (iii) any such benefits consisting of COBRA premiums also satisfy, to the greatest extent possible, the exemption from the application of Section 409A provided under Treasury Regulations Section 1.409A-1(b)(9)(v).&#160;&#160;Notwithstanding any provision of this Plan to the contrary, in the event that the Company determines that any amounts payable hereunder will&#160;cause you to incur adverse tax consequences&#160;under Section 409A of the Code and related&#160;Department of Treasury guidance, to the extent permitted under Section 409A of the Code, the Company may, to the extent permitted under Section 409A of the Code (a) cooperate in good faith to adopt such amendments to this Plan and appropriate policies and procedures, including amendments and policies with retroactive effect, that&#160;it&#160;determines&#160;necessary or appropriate to preserve the intended tax treatment of the benefits provided by this Plan, preserve the economic benefits of this Plan and avoid less favorable accounting or tax consequences for the Company and&#47;or (b) take such other actions as mutually determined necessary or appropriate to exempt the amounts payable hereunder from Section 409A of the Code or to comply with the requirements of Section 409A of the Code and thereby avoid the application of&#160;adverse tax consequences&#160;under such section.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Basis of Payments.&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The Plan shall be unfunded, and all cash payments under the Plan shall be paid only from the general assets of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Definitions.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">For purposes of this Plan, the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cause</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean any of the following&#58;&#160;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">your continued failure to satisfactorily perform your duties to the Company (other than as a result of your total or partial incapacity due to physical or mental illness)&#59;&#160;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">any willful act or omission by you constituting dishonesty, fraud or other malfeasance against the Company&#59;&#160;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">&#160;your conviction of a felony under the laws of the United States or any state thereof or any other jurisdiction in which the Company conducts business&#59;&#160;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;your debarment by&#160;the U.S. Food and Drug Administration from working in or providing services to any pharmaceutical or biotechnology company under the Generic Drug Enforcement Act of 1992, or other ineligibility under any law or regulation to perform your duties to the Company&#59; or</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;your breach of any of the material policies of the Company,&#160;including without limitation being under the influence of illicit drugs or alcohol at work or on the Company&#8217;s premises.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean the occurrence of any of the following&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">as a result of any merger or consolidation, the voting securities of the Company outstanding immediately prior thereto represent (either by remaining outstanding or by being converted into voting securities of the surviving or acquiring entity) less than 49% of the combined voting power of the voting securities of the Company or such surviving or acquiring entity outstanding immediately after such merger or consolidation&#59;</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">during any period of twenty-four&#160;(24)&#160;consecutive calendar months, the individuals who at the beginning of such period constitute the Company&#8217;s Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and any new directors whose election by such Board or nomination for election by stockholders was approved by a vote of at least two-thirds of the members of such Board who were either directors on such Board at the beginning of the period or whose election or nomination for election as directors was previously so approved, for any reason cease to constitute at least a majority of the members thereof&#59;</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934 as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#160;shall become the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than 20% of the then outstanding shares of&#160;common&#160;stock of the Company&#59;</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">any sale of all or substantially all of the assets of&#160;the Company&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">,&#160;that in the event of a sale of less than all of the assets of the Company,&#160;the Plan Administrator may determine that a Change of Control has only occurred (for purposes of determining eligibility for&#160;benefits under the Plan) with regard to those employees whose services are specifically attributable to the sold assets&#59;&#160;or</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the complete liquidation or dissolution of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The Plan Administrator shall have sole discretion with regard to whether a Change of Control has occurred for purposes of this Plan, and if a Change of Control has occurred as a result of sale of less than all of the Company&#8217;s assets as described in clause (iv) above, shall have sole discretion with regard to the determination of which employees&#8217; services are specifically attributable to the sold assets and are therefore eligible for benefits under this Plan in connection with such sale of assets.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;shall mean&#160;the occurrence of either a Non-Change of Control Triggering Event or a Change of Control Triggering Event.&#160;&#160;For the purposes of this Plan, the termination of your employment due to your death or Disability will not constitute a termination without Cause or any other Triggering Event.&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">For purposes of the Plan, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Non-Change of Control Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean your employment is terminated by the Company without Cause.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">For purposes of the Plan, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Change of Control Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean any of the following&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;your employment is terminated by the Company without Cause in connection with a Change of Control or within twelve (12) months following a Change of Control&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">,&#160;that&#160;if you are terminated by the Company in connection with a Change of Control but immediately accept employment with the Company&#8217;s successor or acquirer, you will not be deemed to be covered by this subsection (i), unless you are subsequently terminated without Cause by the successor or acquirer within the twelve (12) months following the Change of Control&#59;</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;you resign&#160;your employment with the Company because&#160;in connection with a Change of Control,&#160;you&#160;are offered terms of employment (new or continuing) by the Company or the Company&#8217;s successor or acquirer within thirty (30) days after the Change of Control that result in a Material Change in Your Terms of Employment.&#160;&#160;For purposes of the foregoing, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Material Change in Your Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall occur if one of the following events occurs without your consent&#58; (a) your base salary is materially reduced from that in effect immediately prior to the Change of Control, or (b) if as of the Change of Control you are employed at the director level or above, you are subject to a material reduction in your duties (including responsibilities and&#47;or authority), or (c) your principal work location is to be moved to a location that is either (i) more than forty-five (45) miles from your principal work location immediately prior to the Change of Control or (ii) more than thirty (30) miles farther from your principal weekday residence than was your principal work location immediately prior to the Change of Control, or (d) the Company or the Company&#8217;s successor or acquirer materially breaches the terms of any employment or similar service agreement with you&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">,&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">, that to resign due to a Material Change in Your Terms of Employment, you must (1) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">provide written notice to the Company&#8217;s General Counsel within 30 days after the first occurrence of the event giving rise to a Material Change in Your Terms of Employment setting forth the basis for your resignation, (2) allow the Company at least 30 days from receipt of such written notice to cure such event, and (3) if such event is not reasonably cured within such period, your resignation from all positions you then hold with the Company is effective not later than 90 days after the expiration of the cure period&#59; or</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;after accepting (or continuing) employment with the Company or the Company&#8217;s successor or acquirer after a Change of Control, you resign your employment within twelve (12) months following&#160;the&#160;Change of Control due to a Material Change in Your Terms of Employment as defined above.&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">For purposes of the Plan, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means&#160;any physical or mental condition which renders you incapable of performing the work for which you were employed by the Company (or its successor or acquirer after a Change of Control) or similar work offered by the Company (or its successor or acquirer after a Change of Control).&#160; Disability shall be established if (i) you satisfy the requirements for benefits under the long-term disability plan of the Company (or its successor or acquirer after a Change of Control) or (ii) if no long-term disability plan, you satisfy the requirements for Social Security disability benefits.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="ic299b2330670419ca0226cb8897be7c2_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">APPENDIX A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Detailed Claims And Arbitration Procedures</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Claims Procedure</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Initial Claims</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">All claims shall be presented to the Plan Administrator in writing.&#160;&#160;Within 90 days after receiving a claim, a claims official appointed by the Plan Administrator shall consider the claim and issue his or her determination thereon in writing.&#160;&#160;If the Plan Administrator or claims official determines that an extension of time is necessary, the claims official may extend the determination period for up to an additional 90 days by giving the Claimant written notice&#160;prior to the termination of the initial 90 day period.&#160;&#160;The extension notice will indicate&#160;the special circumstances requiring the extension of time&#160;and the date by which the claims official expects to render a decision on the claim.&#160;&#160;Any claims that the Claimant does not pursue in good faith through the initial claims stage shall be treated as having been irrevocably waived.&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Claims Decisions</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">If the claim is granted, the benefits or relief the Claimant seeks shall be provided.&#160;&#160;If the claim is wholly or partially denied, the claims official shall, within 90 days (or a longer period, as described above), provide the Claimant with written&#160;or electronic&#160;notice of the denial, setting forth, in a manner calculated to be understood by the Claimant&#58; (1) the specific reason or reasons for the denial&#59; (2) specific references to the provisions on which the denial is based&#59; (3) a description of any additional material or information necessary for the Claimant to perfect the claim, together with an explanation of why the material or information is necessary&#59; and (4) an explanation of the procedures for appealing denied claims&#160;and the time limits applicable to such procedures, including a statement of the Claimant&#8217;s right to proceed to arbitration following a denial on review of the claim, as described below.&#160;&#160;Any electronic notice will comply with the regulations of the U.S. Department of Labor.&#160;&#160;If the Claimant can establish that the claims official has failed to respond to the claim in a timely manner, the Claimant may treat the claim as having been denied by the claims official.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Appeals of Denied Claims</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Each Claimant shall have the opportunity to appeal the claims official&#8217;s denial of a claim in writing to the Chair of the Compensation Committee, and the Compensation Committee shall serve as the appeals official.&#160;&#160;A Claimant must appeal a denied claim within 60 days after receipt of written notice of denial of the claim, or within 60 days after it was due if the Claimant did not receive it by its due date.&#160;&#160;The Claimant (or the Claimant&#8217;s duly authorized representative) shall be provided upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to the Claimant&#8217;s claim.&#160;&#160;The appeals official shall take into account during its review all comments, documents, records and other information submitted by the Clamant&#160;(or the Claimant&#8217;s duly authorized representative)&#160;relating to the claim, without regard to whether such information was submitted or considered in the initial benefits&#160;review.&#160;&#160;Any claims that the Claimant does not pursue in good faith through the appeals stage, such as by failing to file a timely appeal request, shall be treated as having been irrevocably waived.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Appeals Decisions</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The decision by the appeals official shall be made not later than 60 days after the written appeal is received by the Plan Administrator.&#160;&#160;However, if the appeals official determines that an extension of time is necessary, the appeals official may extend the determination period for up to an additional 60 days by giving the Claimant written notice prior to the termination of the initial 60 day period.&#160;&#160;The&#160;extension notice will indicate&#160;the special circumstances requiring the extension of time&#160;and the date by which the appeals official expects to render a decision on the appeal.&#160;&#160;The appeals official shall provide the Claimant with written or electronic notice of the appeal decision, setting&#160;forth,&#160;in a manner calculated to be understood by the Claimant&#58; (1) the specific reason or reasons for the denial&#59; (2) specific references to the provisions on which the denial is based&#59; (3) a statement that the Claimant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to the Claimant&#8217;s claim&#59; and (4) a statement of the Claimant&#8217;s right to proceed to arbitration, as described below.&#160;&#160;Any electronic notice will comply with the regulations of the U.S. Department of Labor.&#160;&#160;If a Claimant does not receive the appeal decision by the date it is due, the Claimant may deem the appeal to have been denied.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Procedures</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The Plan Administrator shall adopt procedures by which initial claims shall be considered and appeals shall be resolved&#59; different procedures may be established for different claims.&#160;&#160;All procedures shall be designed to afford a Claimant full and fair consideration of his or her claim&#160;and shall be consistent with the Plan and with ERISA.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Arbitration of Rejected Appeals</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">If a Claimant has pursued a claim through the appeal stage of these claims procedures&#160;and has been notified that the Claimant&#8217;s appeal has been denied (or the Claimant does not receive an appeal decision by the date due), the Claimant may contest the actual or deemed denial of that claim through arbitration, as described below.&#160;&#160;Except as set forth in Appendix B, in&#160;no event shall any denied claim be subject to resolution by any means (such as in a court of law) other than arbitration in accordance with the following provisions.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Arbitration Procedure</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Request for Arbitration</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">A Claimant must submit a request for arbitration to the Plan Administrator within 60 days after receipt of the written denial of an appeal (or within 60 days after he or she should have received the determination). The Claimant or the Plan Administrator may bring an action in any court of appropriate jurisdiction to compel arbitration in accordance with these procedures.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Applicable Arbitration Rules</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">If the Claimant has entered into a valid arbitration agreement with the Company, the arbitration shall be conducted in accordance with that agreement.&#160;&#160;If not, the rules set forth in the balance of this Appendix shall apply&#58; The arbitration shall be held under the auspices of the Judicial Arbitration and Mediation Service (JAMS), whichever is chosen by the party who did not initiate the arbitration.&#160;&#160;Except as provided below, the arbitration shall be in accordance with JAMS&#8217;s then-current employment dispute resolution rules.&#160;&#160;The Arbitrator shall apply the Federal Rules of Evidence and shall have the authority to entertain a motion to dismiss or a motion for summary judgment by any party and shall apply the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">standards governing such motions under the Federal Rules of Civil Procedure.&#160;&#160;The Federal Arbitration Act shall govern all arbitrations that take place under these Detailed Claims and Arbitration Procedures (or that are required to take place under them), and shall govern the interpretation or enforcement of these Procedures or any arbitration award.&#160;&#160;To the extent that the Federal Arbitration Act is inapplicable, California law pertaining to arbitration agreements shall apply.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Arbitrator</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The Arbitrator shall be an attorney familiar with employee benefit matters who is licensed to practice law in the state in which the arbitration is convened.&#160;&#160;The Arbitrator shall be selected in the following manner from a list of 11 arbitrators drawn by the sponsoring organization under whose auspices the arbitration is being conducted and taken from its panel of labor and employment arbitrators.&#160;&#160;Each party shall designate all arbitrators on the list whom they find acceptable&#59; the parties shall then alternately strike arbitrators from the list of arbitrators acceptable to both parties, with the party who did not initiate the arbitration striking first.&#160;&#160;If only one arbitrator is acceptable to both parties, he or she will be the Arbitrator.&#160;&#160;If none of the arbitrators is acceptable to both parties, a new panel of arbitrators shall be obtained from the sponsoring organization and the selection process shall be repeated.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Location</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The arbitration will take place in or near the city in which the Claimant is or was last employed by the Company or in which the Plan is principally administered, whichever is specified by the Plan Administrator, or in such other location as may be acceptable to both the Claimant and the Plan Administrator.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Authority of Arbitrator</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The Arbitrator shall have the authority to resolve any factual or legal claim relating to the Plan or relating to the interpretation, applicability, or enforceability of these arbitration procedures, including, but not limited to, any claim that these procedures are void or voidable.&#160;&#160;The Arbitrator may grant a Claimant&#8217;s claim only if the Arbitrator determines that it is justified because&#58; (1) the appeals official erred on an issue of law&#59; or (2) the appeals official&#8217;s findings of fact, if applicable, were not supported by substantial evidence.&#160;&#160;The arbitration shall be final and binding on all parties.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Limitation on Scope of Arbitration</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The Claimant may not present any evidence, facts, arguments, or theories at the arbitration that the Claimant did not pursue in his or her appeal, except in response to new evidence, facts, arguments, or theories presented on behalf of the other parties to the arbitration.&#160;&#160;However, an arbitrator may permit a Claimant to present additional evidence or theories if the Arbitrator determines that the Claimant was precluded from presenting them during the claim and appeal procedures due to procedural errors of the Plan Administrator or its delegates.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Administrative Record</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The Plan Administrator shall submit to the Arbitrator a certified copy of the record on which the appeals official&#8217;s decision was made.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Experts, Depositions, and Discovery</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Except as otherwise permitted by the Arbitrator on a showing of substantial need, either party may&#58; (1) designate one expert witness&#59; (2) take the deposition of one individual and the other party&#8217;s expert witness&#59; (3) propound requests for production of documents&#59; and (4) subpoena witnesses and documents relating to the discovery permitted in this paragraph.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Pre-Hearing Procedures</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">At least 30 days before the arbitration hearing, the parties must exchange lists of witnesses, including any expert witnesses, and copies of all exhibits intended to be used at the hearing.&#160;&#160;The Arbitrator shall have jurisdiction to hear and rule on pre-hearing disputes and is authorized to hold pre-hearing conferences by telephone or in person, as the Arbitrator deems necessary.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Transcripts</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Either party may arrange for a court reporter to provide a stenographic record of the proceedings at the party&#8217;s own cost.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Post-Hearing Procedures</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Either party, on request at the close of the hearing, may be given leave to file a post-hearing brief within the time limits established by the Arbitrator.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Costs and Attorneys&#8217; Fees</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The Claimant and the Company shall equally share the fees and costs of the Arbitrator, except that the Claimant shall not be required to pay any of the Arbitrator&#8217;s fees and costs if such a requirement would make mandatory arbitration under these procedures unenforceable.&#160;&#160;On a showing of material hardship, the Company, in its discretion, may advance all or part of the Claimant&#8217;s share of the fees and costs, in which case the Claimant shall reimburse the Company out of the proceeds of the arbitration award, if any, that the Claimant receives.&#160;&#160;Each party shall pay its own costs and attorneys&#8217; fees, except as required by applicable law.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Procedure for Collecting Costs From Claimant</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Before the arbitration commences, the Claimant must deposit with the Plan Administrator his or her share of the anticipated fees and costs of the Arbitrator, as reasonably determined by the Plan Administrator.&#160;&#160;At least 2 weeks before delivering his or her decision, the Arbitrator shall send his or her final bill for fees and costs to the Plan Administrator for payment.&#160;&#160;The Plan Administrator shall apply the amount deposited by the Claimant to pay the Claimant&#8217;s share of the Arbitrator&#8217;s fees and costs and return any surplus deposit.&#160;&#160;If the Claimant&#8217;s deposit is insufficient, the Claimant will be billed for any remaining amount due.&#160;&#160;Failure to pay any amount within 10 days after it is billed shall constitute the Claimant&#8217;s irrevocable election to withdraw his or her arbitration request and abandon his or her claim.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Arbitration Award</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The Arbitrator shall render an award and opinion in the form typically rendered in labor arbitrations.&#160;&#160;Within 20 days after issuance of the Arbitrator&#8217;s award and opinion, either party may file with the Arbitrator a motion to reconsider, which shall be accompanied by a supporting brief.&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">If such a motion is filed, the other party shall have 20 days from the date of the motion to respond, after which the Arbitrator shall reconsider the issues raised by the motion and either promptly confirm or promptly change his or her decision.&#160;&#160;The decision shall then be final and conclusive on the parties.&#160;&#160;Arbitrator fees and other costs of a motion for reconsideration shall be borne by the losing party, unless the Arbitrator orders otherwise.&#160;&#160;Either party may bring an action in any court of appropriate jurisdiction to enforce an arbitration award.&#160;&#160;A party opposing enforcement of an arbitration award may not do so in an enforcement proceeding, but must bring a separate action in a court of competent jurisdiction to set aside the award.&#160;&#160;In any such action, the standard of review shall be the same as that applied by an appellate court reviewing the decision of a trial court in a nonjury trial.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Severability</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The invalidity or unenforceability of any part of these arbitration procedures shall not affect the validity of the rest of the procedures.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="ic299b2330670419ca0226cb8897be7c2_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">APPENDIX B</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">ADDITIONAL INFORMATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">RIGHTS UNDER ERISA</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">As a participant in the Plan, you are entitled to certain rights and protections under ERISA.&#160;&#160;ERISA provides that all Plan participants will be entitled to&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Receive Information About Your Plan and Benefits</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt">Examine, without charge, at the Plan&#160;Administrator&#8217;s office and at certain Company offices, all&#160;documents governing the Plan and a copy of the latest annual report (Form 5500 Series), if applicable,&#160;filed by the Plan with the U.S. Department of Labor&#160;and available at the Public Disclosure Room of the&#160;Employee Benefits Security&#160;Administration.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt">Obtain, upon written request to the Plan&#160;Administrator, copies of documents governing the operation of the Plan&#160;and copies of the latest annual report (Form 5500 Series), if applicable,&#160;and updated summary plan description.&#160;&#160;The Plan Administrator may make a reasonable charge for the copies.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt">Receive a summary of the Plan&#8217;s annual financial report, if any.&#160;&#160;The Plan&#160;Administrator is required by law to furnish each participant with a copy of this summary annual report.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Prudent Actions by Plan Fiduciaries</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">In addition to creating rights for Plan participants, ERISA imposes duties upon the people who are responsible for the operation of the employee benefit plan.&#160;&#160;The people who operate&#160;the&#160;Plan, called &#8220;fiduciaries&#8221; of the Plan, have a duty to do so prudently and in the interest of you and other Plan participants and beneficiaries.&#160;&#160;No one, including the Company, your union, or any other person, may fire you or otherwise discriminate against you in any way to prevent you&#160;from obtaining a&#160;Plan&#160;benefit or exercising your rights&#160;under ERISA.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Enforce Your Rights</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">If your claim for a&#160;Plan&#160;benefit is denied or ignored, in whole or in part, you have a right to know why this was done, to obtain copies of documents relating to the decision without charge, and to appeal any denial, all within certain time schedules.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Under ERISA, there are steps you can take to enforce the above rights.&#160;&#160;For instance, if you request a copy of&#160;Plan&#160;documents or the latest annual report from the Plan, if applicable,&#160;and do not receive them within 30 days, you may file suit in a Federal court.&#160;&#160;In such a case, the court may require the Plan Administrator to provide the materials and pay you up to $110 a day until you receive the materials, unless the materials were not sent because of reasons beyond the control of the Plan&#160;Administrator.&#160;&#160;If you have a claim for benefits,&#160;which is denied or ignored, in whole or in part, you may&#160;proceed to arbitration, as set forth in Appendix A.&#160;&#160;If&#160;you are discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor, or you may file suit in a&#160;Federal court.&#160;&#160;The court will decide who should pay court costs and legal fees.&#160;&#160;If you are successful, the court may order the person you have sued to pay these costs and fees.&#160;&#160;If you lose, the court may order you to pay these costs and fees, for example, if it finds your claim is frivolous.</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">Assistance with Your Questions</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">If you have any questions about&#160;the&#160;Plan, you should contact the Plan Administrator.&#160;&#160;If you&#160;have any questions about this statement or about your rights under ERISA, or if you need assistance in obtaining documents from the Plan&#160;Administrator, you should contact the nearest office of the Employee Benefits Security Administration, U.S. Department of Labor, listed in your telephone directory or the Division of Technical Assistance and&#160;Inquiries, Employee Benefits Security Administration, U.&#160;S. Department of Labor, 200 Constitution Avenue N.W., Washington, D.C. 20210.&#160;&#160;You may also obtain certain publications about your rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:13.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.975%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.430%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:100%">ADMINISTRATIVE INFORMATION</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Name of Plan&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Geron Corporation Amended and Restated Severance Plan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Plan Administrator&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Executive Severance Plan Administration Committee</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(authorized by the Board of Directors)</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Geron Corporation</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">919 East Hillsdale Boulevard, Suite 250</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Foster City, CA 94404 USA</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; 650-473-7700</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Fax&#58; 650-473-7750</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Type of Administration&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Self-Administered</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Type of Plan&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Severance Pay Employee Welfare Benefit Plan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Employer Identification Number&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">75-2287752</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Direct Questions Regarding the Plan to&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Chief Legal Officer</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Geron Corporation</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">919 East Hillsdale Boulevard, Suite 250</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Foster City, CA 94404 USA<br>Tel&#58; 650-473-7700</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Fax&#58; 650-473-7750</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Agent for Service of Legal Process&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Corporate Secretary</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Geron Corporation</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">919 East Hillsdale Boulevard, Suite 250</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Foster City, CA 94404 USA</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; 650-473-7700</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Fax&#58; 650-473-7750</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Service of Legal Process may also be made upon the Plan Administrator</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Plan Year&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Calendar Year</font></div><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The date of the end of the year for purposes of maintaining the Plan&#8217;s fiscal records is December 31.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">Plan Number&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:100%">510</font></td></tr></table></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>exhibit103-2018inducementp.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i6970ca37a93a4a31892d52d88cabf8f6_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">EXHIBIT 10.3</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:139%">Amended 2018 Inducement Award Plan</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">GERON CORPORATION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">2018 Inducement Award Plan</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">Adopted by the Board of Directors&#58;  December 14, 2018</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">(with 3,000,000 share reserve)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">Amended and Restated&#58;  January 29, 2019 (added 5,000,000 shares)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">Amended and Restated&#58;  February 11, 2020 (added 1,300,000 shares)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">Amended and Restated&#58;  February 1, 2021 (added 800,000 shares)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">Amended and Restated&#58;  May 91, 2021 (added 5,000,000 shares)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">Amended and Restated&#58;  February 2, 2022 (added 1,000,000 shares)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">Amended and Restated&#58;  July 15, 2022 (added 5,000,000 shares)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">Amended and Restated&#58;  June 21, 2023 (added 13,900,000 shares)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">Amended and Restated&#58;  January 1, 2025 (Added 5,300,000 Shares)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%">Amended and Restated&#58;  August 1, 2025 (Added 11,000,000 Shares)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:139%;padding-left:28.5pt"> General.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.34pt">Eligible Award Recipients.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Awards may only be granted to Employees who satisfy the standards for inducement grants under Rule 5635(c)(4) of the Nasdaq Listing Rules.  A person who previously served as an Employee or Director will not be eligible to receive Awards, other than following a bona fide period of non-employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Available Stock Awards.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The Plan provides for the grant of the following types of Stock Awards&#58; (i) Nonstatutory Stock Options, (ii) Stock Appreciation Rights, (iii) Restricted Stock Awards, (iv) Restricted Stock Unit Awards and (v) Other Stock Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.91pt">Purpose.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The Plan, through the granting of Stock Awards, is intended to 1) help the Company and any Affiliate secure and retain the services of eligible Stock Award recipients, 2) provide an inducement material for such persons to enter into employment with the Company or an Affiliate within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules, 3) provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and 4) provide a means by which the eligible recipients may benefit from increases in value of the Common Stock. The Plan is also intended to provide long-term incentives that align the interests of our eligible Stock Award recipients with the interests of our stockholders.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:28.5pt">Administration.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.34pt">Administration by Board.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The Board will administer the Plan.  The Board may delegate administration of the Plan to a Committee or Committees, as provided in Section 2(c).  However, notwithstanding the foregoing or anything in the Plan to the contrary, the grant of Stock Awards will be approved by the Company&#8217;s independent compensation committee or a majority of the Company&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">independent directors (as defined in Rule 5605(a)(2) of the Nasdaq Listing Rules) in order to comply with the exemption from the stockholder approval requirement for &#8220;inducement grants&#8221; provided under Rule 5635(c)(4) of the Nasdaq Listing Rules.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Powers of Board.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:17.22pt">To determine (A) who will be granted Stock Awards&#59; (B) when and how each Stock Award will be granted&#59; (C) what type of Stock Award will be granted&#59; (D) the provisions of each Stock Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive cash or Common Stock under the Stock Award&#59; (E) the number of shares of Common Stock subject to, or the cash value of, a Stock Award&#59; and (F) the Fair Market Value applicable to a Stock Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.45pt">To construe and interpret the Plan and Stock Awards granted under it, and to establish, amend and revoke rules and regulations for administration of the Plan and Stock Awards.  The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or in any Stock Award Agreement, in a manner and to the extent it will deem necessary or expedient to make the Plan or Stock Award fully effective.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:11.68pt">To settle all controversies regarding the Plan and Stock Awards granted under it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:12.22pt">To accelerate, in whole or in part, the time at which a Stock Award may be exercised or vest (or the time at which cash or shares of Common Stock may be issued in settlement thereof).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.99pt">To suspend or terminate the Plan at any time.  Except as otherwise provided in the Plan or a Stock Award Agreement, suspension or termination of the Plan will not materially impair a Participant&#8217;s rights under his or her then-outstanding Stock Award without his or her written consent except as provided in subsection (viii) below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:12.22pt">To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating to certain nonqualified deferred compensation under Section 409A of the Code and&#47;or to make the Plan or Stock Awards granted under the Plan exempt from or compliant with the requirements for nonqualified deferred compensation under Section 409A of the Code, subject to the limitations, if any, of applicable law.  Except as provided in the Plan (including Section 2(b)(viii)) or a Stock Award Agreement, no amendment of the Plan will materially impair a Participant&#8217;s rights under an outstanding Stock Award without the Participant&#8217;s written consent. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:9.45pt">To submit any amendment to the Plan for stockholder approval (to the extent the Board determines advisable or to the extent required pursuant to applicable laws or listing requirements), including, but not limited to, amendments to the Plan to comply with other applicable laws or listing requirements, provided, however, that any amendment provided in Section 9(a) relating to Capitalization Adjustments shall not require stockholder approval.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:6.68pt">To approve forms of Stock Award Agreements for use under the Plan and to amend the terms of any one or more Stock Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Stock Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion and applicable laws or listing requirements, including Rule 5635(c) of the Nasdaq Listing Rules&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%"> that a Participant&#8217;s rights under any Stock Award will not be impaired by any such amendment unless (A) the Company requests the consent of the affected Participant, and (B) such Participant consents in writing.  Notwithstanding the foregoing, (1) a Participant&#8217;s rights will not be deemed to have been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant&#8217;s rights, and (2) subject to the limitations of applicable law, if any, the Board may amend the terms of any one or more Stock Awards without the affected Participant&#8217;s consent (A) to clarify the manner of exemption from, or to bring the Stock Award into compliance with, Section 409A of the Code&#59; or (B) to comply with other applicable laws or listing requirements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:12.22pt">Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Stock Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(x)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.99pt">To adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees who are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Stock Award Agreement that are required for compliance with the laws of the relevant foreign jurisdiction).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.91pt">Delegation to Committee.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">The Board may delegate some or all of the administration of the Plan to a Committee or Committees.  If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as applicable).  Any delegation of administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable).  The Committee may, at any time, abolish the subcommittee and&#47;or revest in the Committee any powers delegated to the subcommittee.  The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated.  However, notwithstanding the foregoing or anything in the Plan to the contrary, the grant of Stock Awards will be approved by the Company&#8217;s independent compensation committee or a majority of the Company&#8217;s independent directors (as defined in Rule 5605(a)(2) of the Nasdaq Listing Rules) in order to comply with the exemption from the stockholder approval requirement for &#8220;inducement grants&#8221; provided under Rule 5635(c)(4) of the Nasdaq Listing Rules.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Effect of Board&#8217;s Decision.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.91pt">Repricing&#59; Cancellation and Re-Grant of Stock Awards.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Neither the Board nor any Committee will have the authority to (i) reduce the exercise, purchase or strike price of any outstanding Option or SAR under the Plan, or (ii) cancel any outstanding Option or SAR that has an exercise price or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">strike price greater than the then-current Fair Market Value of the Common Stock in exchange for cash or other Stock Awards under the Plan, unless the stockholders of the Company have approved such an action within 12 months prior to such an event.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:26.01pt">Dividends and Dividend Equivalents.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Dividends or dividend equivalents may be paid or credited, as applicable, with respect to any shares of Common Stock subject to a Stock Award, as determined by the Board and contained in the applicable Stock Award Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">, that (i) no dividends or dividend equivalents may be paid with respect to any such shares before the date such shares have vested under the terms of such Stock Award Agreement, (ii) any dividends or dividend equivalents that are credited with respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of such Stock Award Agreement (including, but not limited to, any vesting conditions), and (iii) any dividends or dividend equivalents that are credited with respect to any such shares will be forfeited to the Company on the date, if any, such shares are forfeited to or repurchased by the Company due to a failure to meet any vesting conditions under the terms of such Stock Award Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:28.5pt">Shares Subject to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.34pt">Share Reserve.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:17.22pt">Subject to Section 9(a) relating to Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Stock Awards from and after the Effective Date will not exceed 51,300,000 shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.45pt">For clarity, the Share Reserve in this Section 3(a) is a limitation on the number of shares of Common Stock that may be issued pursuant to the Plan.  Accordingly, this Section 3(a) does not limit the granting of Stock Awards except as provided in Section 7(a).  Shares may be issued in connection with a merger or acquisition as permitted by Nasdaq Listing Rule 5635(c) or, if applicable, NYSE Listed Company Manual Section 303A.08, AMEX Company Guide Section 711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Reversion of Shares to the Share Reserve. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">If a Stock Award or any portion thereof (i) expires or otherwise terminates without all of the shares covered by such Stock Award having been issued, or (ii) is settled in cash (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">, the Participant receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of Common Stock that may be available for issuance under the Plan. If any shares of Common Stock issued pursuant to a Stock Award are forfeited back to or repurchased or reacquired by the Company for any reason, including because of the failure to meet a contingency or condition required to vest such shares in the Participant, then the shares that are forfeited or repurchased or reacquired will revert to and again become available for issuance under the Plan. Any shares reacquired or withheld by the Company in satisfaction of tax withholding obligations on a Stock Award or as consideration for the exercise or purchase price of a Stock Award (including any shares subject to a Stock Award that are not delivered to a Participant because such Stock Award is exercised through a reduction of shares subject to such Stock Award (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">i.e</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">., &#8220;net exercised&#8221;))  will again become available for issuance under the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.91pt">Source of Shares.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:28.5pt">Eligibility.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.34pt">Eligibility for Stock Awards.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Stock Awards may be granted only to persons who are Employees described in Section 1(a), where the Stock Award is an inducement material to the individual&#8217;s entering into employment with the Company or an Affiliate within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules.  For clarity, Stock Awards may not be granted to (1) Directors, for service in such capacity, or (2) any individual who was previously an Employee or Director, other than following a bona fide period of non-employment.  Notwithstanding the foregoing, Stock Awards may not be granted to Employees who are providing Continuous Service only to any &#8220;parent&#8221; of the Company, as such term is defined in Rule 405, unless (i) the stock underlying such Stock Awards is treated as &#8220;service recipient stock&#8221; under Section 409A of the Code (for example, because the Stock Awards are granted pursuant to a corporate transaction such as a spin off transaction) or (ii) the Company, in consultation with its legal counsel, has determined that such Stock Awards are otherwise exempt from or alternatively comply with the distribution requirements of Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Approval Requirements.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  All Stock Awards must be granted either by a majority of the Company&#8217;s independent directors or by the Company&#8217;s compensation committee comprised of independent directors within the meaning of Rule 5605(a)(2) of the Nasdaq Listing Rules.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:28.5pt">Provisions Relating to Options and Stock Appreciation Rights.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Each Option or SAR will be in such form and will contain such terms and conditions as the Board deems appropriate.  All Options will be Nonstatutory Stock Options.  The provisions of separate Options or SARs need not be identical&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">, that each Stock Award Agreement will conform to (through incorporation of provisions hereof by reference in the applicable Stock Award Agreement or otherwise) the substance of each of the following provisions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.34pt">Term.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  No Option or SAR will be exercisable after the expiration of ten (10) years from the date of its grant or such shorter period specified in the Stock Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Exercise Price.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The exercise or strike price of each Option or SAR will be not less than 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Stock Award is granted.  Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair Market Value of the Common Stock subject to the Stock Award if such Stock Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Corporate Transaction and in a manner consistent with the provisions of Section 409A of the Code.  Each SAR will be denominated in shares of Common Stock equivalents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.91pt">Purchase Price for Options.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The purchase price of Common Stock acquired pursuant to the exercise of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below.  The Board will have the authority to grant Options that do not permit all of the following methods of payment (or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">that otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method of payment.  The permitted methods of payment are as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:17.22pt">by cash, check, bank draft or money order payable to the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.45pt">pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:11.68pt">by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:12.22pt">by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">, that the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued.  Shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that (A) shares issuable upon exercise are used to pay the exercise price pursuant to the &#8220;net exercise,&#8221; (B) shares are delivered to the Participant as a result of such exercise, and (C) shares are withheld to satisfy tax withholding obligations&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.99pt">in any other form of legal consideration that may be acceptable to the Board and specified in the applicable Stock Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Exercise and Payment of a SAR.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  To exercise any outstanding SAR, the Participant must provide written notice of exercise to the Company in compliance with the provisions of the Stock Award Agreement evidencing such SAR.  The appreciation distribution payable on the exercise of a SAR will be not greater than an amount equal to the excess of (A) the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant is vested under such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B) the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date.  The appreciation distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Stock Award Agreement evidencing such SAR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.91pt">Transferability of Options and SARs.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The Board may, in its sole discretion, impose such limitations on the transferability of Options and SARs as the Board may determine.  In the absence of such a determination by the Board to the contrary, the restrictions set forth in this Section 5(e) on the transferability of Options and SARs will apply.  Notwithstanding the foregoing or anything in the Plan or a Stock Award Agreement to the contrary, no Option or SAR may be transferred to any financial institution without prior stockholder approval.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:17.22pt">Restrictions on Transfer.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  An Option or SAR will not be transferable except by will or by the laws of descent and distribution (and pursuant to Sections 5(e)(ii) and 5(e)(iii) below) and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">will be exercisable during the lifetime of the Participant only by the Participant.  Subject to the foregoing paragraph, the Board may permit transfer of the Option or SAR in a manner that is not prohibited by applicable tax and securities laws.  Except as explicitly provided in the Plan, neither an Option nor a SAR may be transferred for consideration. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:14.45pt">Domestic Relations Orders.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by Treasury Regulations Section 1.421-1(b)(2).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:11.68pt">Beneficiary Designation.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, upon the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise.  In the absence of such a designation, upon the death of the Participant, the executor or administrator of the Participant&#8217;s estate will be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise.  However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with the provisions of applicable laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:26.01pt">Vesting Generally.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The total number of shares of Common Stock subject to an Option or SAR may vest and become exercisable in periodic installments that may or may not be equal.  The Option or SAR may be subject to such other terms and conditions on the time or times when it may or may not be exercised (which may be based on the satisfaction of performance goals or other criteria) as the Board may deem appropriate.  The vesting provisions of individual Options or SARs may vary.  The provisions of this Section 5(f) are subject to any Option or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.34pt">Termination of Continuous Service.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates (other than for Cause and other than upon the Participant&#8217;s death or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date three months following such termination of Continuous Service (or such longer or shorter period specified in the Stock Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Stock Award Agreement.  If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR (as applicable) will terminate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(h)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Extension of Termination Date.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant and the Company or an Affiliate,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">if the exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause and other than upon the Participant&#8217;s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier of (i) the expiration of a total period of time (that need not be consecutive) equal to the applicable post-termination exercise period after </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">the termination of the Participant&#8217;s Continuous Service during which the exercise of the Option or SAR would not be in violation of such registration requirements, or (ii) the expiration of the term of the Option or SAR as set forth in the applicable Stock Award Agreement.  In addition, unless otherwise provided in a Participant&#8217;s Stock Award Agreement, if the sale of any Common Stock received upon exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause) would violate the Company&#8217;s insider trading policy, then the Option or SAR will terminate on the earlier of (i) the expiration of a period of time (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the Company&#8217;s insider trading policy, or (ii) the expiration of the term of the Option or SAR as set forth in the applicable Stock Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:26.57pt">Disability of Participant.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s Disability, the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date 24 months following such termination of Continuous Service (or such longer or shorter period specified in the Stock Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Stock Award Agreement.  If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR (as applicable) will terminate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(j)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:26.01pt">Death of Participant.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant and the Company or an Affiliate, if (i) a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s death, or (ii) the Participant dies within the period (if any) specified in the Stock Award Agreement for exercisability after the termination of the Participant&#8217;s Continuous Service (for a reason other than death), then the Participant&#8217;s Option or SAR may be exercised (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of death) by the Participant&#8217;s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&#8217;s death, but only within such period of time ending on the earlier of (i) the date 24 months following the date of death (or such longer or shorter period specified in the Stock Award Agreement), and (ii) the expiration of the term of such Option or SAR as set forth in the Stock Award Agreement.  If, after the Participant&#8217;s death, the Option or SAR (as applicable) is not exercised within the applicable time frame, the Option or SAR (as applicable) will terminate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(k)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Termination for Cause.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Except as explicitly provided otherwise in a Participant&#8217;s Stock Award Agreement or other individual written agreement between the Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service is terminated for Cause, the Participant&#8217;s Option or SAR will terminate immediately upon such termination of Continuous Service, and the Participant will be prohibited from exercising his or her Option or SAR from and after the time of such termination of Continuous Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(l)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:26.57pt">Non-Exempt Employees.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  If an Option or SAR is granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">will not be first exercisable for any shares of Common Stock until at least six months following the date of grant of the Option or SAR (although the Stock Award may vest prior to such date).  Consistent with the provisions of the Worker Economic Opportunity Act, (i) if such non-exempt employee dies or suffers a Disability, (ii) upon a Corporate Transaction in which such Option or SAR is not assumed, continued, or substituted, (iii) upon a Change in Control, or (iv) upon the Participant&#8217;s retirement (as such term may be defined in the Participant&#8217;s Stock Award Agreement, in another agreement between the Participant and the Company or an Affiliate, or, if no such definition, in accordance with the Company&#8217;s or Affiliate&#8217;s then current employment policies and guidelines), the vested portion of any Options and SARs may be exercised earlier than six months following the date of grant.  The foregoing provision is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay.  To the extent permitted and&#47;or required for compliance with the Worker Economic Opportunity Act to ensure that any income derived by a non-exempt employee in connection with the exercise, vesting or issuance of any shares under any other Stock Award will be exempt from the employee&#8217;s regular rate of pay, the provisions of this Section 5(l) will apply to all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">6.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:28.5pt">Provisions of Stock Awards Other than Options and SARs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.34pt">Restricted Stock Awards.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate.  To the extent consistent with the Company&#8217;s bylaws, at the Board&#8217;s election, shares of Common Stock underlying a Restricted Stock Award may be (i) held in book entry form subject to the Company&#8217;s instructions until any restrictions relating to the Restricted Stock Award lapse, or (ii) evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board.  The terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Each Restricted Stock Award Agreement will conform to (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:17.22pt">Consideration.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  A Restricted Stock Award may be awarded in consideration for (A) cash, check, bank draft or money order payable to the Company or (B) any other form of legal consideration (including future services) that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:14.45pt">Vesting</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">.  Shares of Common Stock awarded under the Restricted Stock Award Agreement may be subject to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:11.68pt">Termination of Participant&#8217;s Continuous Service.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  If a Participant&#8217;s Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant as of the date of termination of Continuous Service under the terms of the Restricted Stock Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:12.22pt">Transferability.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Rights to acquire shares of Common Stock under the Restricted Stock Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">so long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement.  Notwithstanding the foregoing or anything in the Plan or a Restricted Stock Award Agreement to the contrary, no Restricted Stock Award may be transferred to any financial institution without prior stockholder approval.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Restricted Stock Unit Awards.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate.  The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical.  Each Restricted Stock Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of each of the following provisions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:17.22pt">Consideration.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award.  The consideration to be paid (if any) by the Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:14.45pt">Vesting.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:11.68pt">Payment.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:12.22pt">Additional Restrictions.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:14.99pt">Termination of Participant&#8217;s Continuous Service.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&#8217;s termination of Continuous Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.91pt">Other Stock Awards.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Other forms of Stock Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">e.g</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">., options or stock appreciation rights with an exercise price or strike price less than 100% of the Fair Market Value of the Common Stock at the time of grant) may be granted either alone or in addition to Stock Awards granted under Section 5 and this Section 6.  Subject to the provisions of the Plan (including, but not limited to, Section 2(f)), the Board will have sole and complete authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other terms and conditions of such Other Stock Awards.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">7.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:28.5pt">Covenants of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.34pt">Availability of Shares.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The Company will keep available at all times the number of shares of Common Stock reasonably required to satisfy then-outstanding Stock Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Securities Law Compliance.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The Company will seek to obtain from each regulatory commission or agency having jurisdiction over the Plan the authority required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">, that this undertaking will not require the Company to register under the Securities Act the Plan, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award.  If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Stock Awards unless and until such authority is obtained.  A Participant will not be eligible for the grant of a Stock Award or the subsequent issuance of cash or Common Stock pursuant to the Stock Award if such grant or issuance would be in violation of any applicable securities law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.91pt">No Obligation to Notify or Minimize Taxes.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising a Stock Award.  Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of a Stock Award or a possible period in which the Stock Award may not be exercised.  The Company has no duty or obligation to minimize the tax consequences of a Stock Award to the holder of such Stock Award.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">8.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:28.5pt">Miscellaneous.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.34pt">Use of Proceeds from Sales of Common Stock.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Proceeds from the sale of shares of Common Stock issued pursuant to Stock Awards will constitute general funds of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Corporate Action Constituting Grant of Stock Awards.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Corporate action constituting a grant by the Company of a Stock Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Stock Award is communicated to, or actually received or accepted by, the Participant.  In the event that the corporate records (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">e.g</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">e.g</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Stock Award Agreement or related grant documents as a result of a clerical error in the preparation of the Stock Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect terms in the Stock Award Agreement or related grant documents.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.91pt">Stockholder Rights.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to a Stock Award unless and until (i) such Participant has satisfied all requirements for exercise of, or the issuance of shares of Common Stock under, the Stock Award pursuant to its terms, and (ii) the issuance of the Common Stock subject to such Stock Award has been entered into the books and records of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">No Employment or Other Service Rights.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Nothing in the Plan, any Stock Award Agreement or any other instrument executed thereunder or in connection with any Stock Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Stock Award was granted or will affect the right of the Company or an Affiliate to terminate (i) the employment of an Employee with or without notice and with or without cause or (ii) as may be applicable after the grant of a Stock Award should the Employee recipient&#8217;s service capacity change to that of a Consultant or Director, (1) the service of a Consultant pursuant to the terms of such Consultant&#8217;s agreement with the Company or an Affiliate, or (2) the service of a Director pursuant to the bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.91pt">Change in Time Commitment.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services for the Company or any Affiliate is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a full-time Employee to a part-time Employee) after the date of grant of any Stock Award to the Participant, the Board has the right in its sole discretion to (x) make a corresponding reduction in the number of shares or cash amount subject to any portion of such Stock Award that is scheduled to vest or become payable after the date of such change in time commitment, and (y) in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Stock Award.  In the event of any such reduction, the Participant will have no right with respect to any portion of the Stock Award that is so reduced or extended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:26.01pt">Investment Assurances.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any Stock Award, (i) to give written assurances satisfactory to the Company as to the Participant&#8217;s knowledge and experience in financial and business matters and&#47;or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Stock Award&#59; and (ii) to give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Stock Award for the Participant&#8217;s own account and not with any present intention of selling or otherwise distributing the Common Stock.  The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A) the issuance of the shares upon the exercise or acquisition of Common Stock under the Stock Award has been registered under a then currently effective registration statement under the Securities Act, or (B) as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws.  The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.34pt">Withholding Obligations.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Unless prohibited by the terms of a Stock Award Agreement, the Company may, in its sole discretion, satisfy any federal, state or local tax withholding obligation relating to a Stock Award by any of the following means or by a combination of such means&#58; (i) causing the Participant to tender a cash payment&#59; (ii)  withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Stock Award&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">that no shares of Common Stock are withheld with a value exceeding the maximum </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">amount of tax that may be required to be withheld by law (or such other amount as may be permitted while still avoiding classification of the Stock Award as a liability for financial accounting purposes)&#59; (iii) withholding cash from a Stock Award settled in cash&#59; (iv) withholding payment from any amounts otherwise payable to the Participant&#59; or (v) by such other method as may be set forth in the Stock Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(h)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Electronic Delivery.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Any reference herein to a &#8220;written&#8221; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:26.57pt">Deferrals.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Stock Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants.  Deferrals by Participants will be made in accordance with Section 409A of the Code. Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise providing services to the Company or an Affiliate.  The Board is authorized to make deferrals of Stock Awards and determine when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&#8217;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(j)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:26.01pt">Compliance with Section 409A of the Code.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Unless otherwise expressly provided for in a Stock Award Agreement, the Plan and Stock Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Stock Awards granted hereunder exempt from Section 409A of the Code, and, to the extent not so exempt, in compliance with Section 409A of the Code.  To the extent that the Board determines that any Stock Award granted hereunder is not exempt from and is therefore subject to Section 409A of the Code, the Stock Award Agreement evidencing such Stock Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code, and, to the extent applicable, the Plan and Stock Award Agreements will be interpreted in accordance with the requirements of Section 409A of the Code.  Notwithstanding anything to the contrary in this Plan (and unless the Stock Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded and a Participant holding a Stock Award that constitutes &#8220;deferred compensation&#8221; under Section 409A of the Code is a &#8220;specified employee&#8221; for purposes of Section 409A of the Code, no distribution or payment of any amount will be made upon a &#8220;separation from service&#8221; before a date that is six months following the date of such Participant&#8217;s &#8220;separation from service&#8221; (as defined in Section 409A of the Code without regard to alternative definitions thereunder) or, if earlier, the date of the Participant&#8217;s death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(k)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Clawback&#47;Recovery.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  All Stock Awards granted under the Plan will be subject to recoupment in accordance with any clawback provisions in a Participant&#8217;s employment agreement or other agreement with the Company or any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  In addition, the Board may impose such other clawback, recovery or recoupment provisions in a Stock Award Agreement as the Board determines </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause.  No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term) under any agreement with the Company or an Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">9.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:28.5pt">Adjustments upon Changes in Common Stock&#59; Other Corporate Events.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.34pt">Capitalization Adjustments.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust&#58; (i) the class(es) and maximum number of securities subject to the Plan pursuant to Section 3(a) and (ii) the class(es) and number of securities and price per share of stock subject to outstanding Stock Awards.  The Board will make such adjustments, and its determination will be final, binding and conclusive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">Dissolution or Liquidation.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  Except as otherwise provided in the Stock Award Agreement, in the event of a dissolution or liquidation of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the shares of Common Stock subject to the Company&#8217;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous Service, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">, that the Board may, in its sole discretion, cause some or all Stock Awards to become fully vested, exercisable and&#47;or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent on its completion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:24.91pt">Corporate Transaction.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  The following provisions will apply to Stock Awards in the event of a Corporate Transaction unless otherwise provided in the Stock Award Agreement or any other written agreement between the Company or any Affiliate and the Participant or unless otherwise expressly provided by the Board at the time of grant of a Stock Award.  In the event of a Corporate Transaction, then, notwithstanding any other provision of the Plan, the Board may take one or more of the following actions with respect to Stock Awards, contingent upon the closing or completion of the Corporate Transaction&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:17.22pt">arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) to assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award to acquire the same consideration paid to the stockholders of the Company pursuant to the Corporate Transaction)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.45pt">arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:11.68pt">accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may be exercised) to a date prior to the effective time of such Corporate Transaction as the Board determines (or, if the Board does not determine such a date, to the date that is five (5) days prior to the effective date of the Corporate Transaction), with such Stock Award </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">terminating if not exercised (if applicable) at or prior to the effective time of the Corporate Transaction&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">, that the Board may require Participants to complete and deliver to the Company a notice of exercise before the effective date of a Corporate Transaction, which exercise is contingent upon the effectiveness of such Corporate Transaction&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:12.22pt">arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the Stock Award&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.99pt">cancel or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective time of the Corporate Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:12.22pt">make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the value of the property the Participant would have received upon the exercise of the Stock Award immediately prior to the effective time of the Corporate Transaction, over (B) any exercise price payable by such holder in connection with such exercise.</font><font style="color:#0000ff;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">For clarity, this payment may be zero ($0) if the value of the property is equal to or less than the exercise price. Payments under this provision may be delayed to the same extent that payment of consideration to the holders of the Company&#8217;s Common Stock in connection with the Corporate Transaction is delayed as a result of escrows, earn outs, holdbacks or any other contingencies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">The Board need not take the same action or actions with respect to all Stock Awards or  portions thereof or with respect to all Participants.  The Board may take different actions with respect to the vested and unvested portions of a Stock Award.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">   Change in Control.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">  A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration will occur.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">10.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.5pt">Termination or Suspension of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:24.34pt">The Board may suspend or terminate the Plan at any time.  No Stock Awards may be granted under the Plan while the Plan is suspended or after it is terminated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.78pt">No Impairment of Rights.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Suspension or termination of the Plan will not materially impair rights and obligations under any Stock Award granted while the Plan is in effect except with the written consent of the affected Participant or as otherwise permitted in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">11.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.5pt">Effective Date of Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">This Plan will become effective on the Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">12.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.5pt">Choice of Law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#160;&#160;&#160;&#160;The laws of the State of Delaware will govern all questions concerning the construction, validity and interpretation of this Plan, without regard to that state&#8217;s conflict of laws rules.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">13.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%;padding-left:23.5pt">Definitions.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">As used in the Plan, the following definitions will apply to the capitalized terms indicated below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405.  The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Capitalization Adjustment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Stock Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto).  Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Cause</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">will have the meaning ascribed to such term in any written agreement between the Participant and the Company or an Affiliate defining such term and, in the absence of such agreement, such term will mean, with respect to a Participant and for purposes of the application of this Plan, the occurrence of any of the following events&#58; (i) such Participant&#8217;s conviction of, or plea of no contest with respect to, any crime involving fraud, dishonesty or moral turpitude&#59; (ii) such Participant&#8217;s attempted commission of or participation in a fraud or act of dishonesty against the Company or an Affiliate that results in (or might have reasonably resulted in) material harm to the business of the Company or an Affiliate&#59; (iii) such Participant&#8217;s intentional, material violation of any contract or agreement between the Participant and the Company or an Affiliate, or any statutory duty the Participant owes to the Company or an Affiliate&#59; or (iv) such Participant&#8217;s conduct that constitutes gross misconduct, insubordination, incompetence or habitual neglect of duties and that results in (or might have reasonably resulted in) material harm to the business of the Company or an Affiliate. The determination that a termination of the Participant&#8217;s Continuous Service is either for Cause or without Cause will be made by the Company, in its sole discretion.  Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Stock Awards held by such Participant will have no effect upon any determination of the rights or obligations of the Company or an Affiliate or such Participant for any other purpose.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; will be deemed to have occurred upon the first to occur of an event set forth in any one of the following paragraphs&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:17.22pt">As a result of any merger or consolidation, the voting securities of the Company outstanding immediately prior thereto represent (either by remaining outstanding or by being converted into voting securities of the surviving or acquiring entity) less than 49% of the combined voting power of the voting securities of the Company or such surviving or acquiring entity outstanding immediately after such merger or consolidation&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.45pt">during any period of twenty-four consecutive calendar months, the individuals who at the beginning of such period constitute the Board, and any new directors whose election by such Board or nomination for election by stockholders was approved by a vote of at least two-thirds of the members of such Board who were either directors on such Board at the beginning of the period or whose election or nomination for election as directors was previously so approved, for any reason cease to constitute at least a majority of the members thereof&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:11.68pt">any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) shall become the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than 20% of the then outstanding shares of Common Stock of the Company&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:12.22pt">any sale of all or substantially all of the assets of the Company&#59; or </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.99pt">the complete liquidation or dissolution of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Notwithstanding the foregoing, if a Change in Control constitutes a payment event with respect to any Stock Award which provides for the deferral of compensation and is subject to Section 409A of the Code, the transaction or event with respect to such Stock Award must also constitute a &#8220;change in control event,&#8221; as defined in Treasury Regulation &#167;1.409A-3(i)(5) to the extent required by Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">The Committee shall have full and final authority, which shall be exercised in its discretion, to determine conclusively whether a Change in Control of the Company has occurred pursuant to the above definition, and the date of the occurrence of such Change in Control and any incidental matters relating thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Notwithstanding the foregoing, a Change in Control shall not be deemed to occur solely because the threshold voting power of the Company&#8217;s then outstanding securities in Section 13(e)(i) or (iii) is acquired by (A) a trustee or other fiduciary holding securities under one or more employee benefit plans maintained by the Company or any of its subsidiaries or (B) any corporation which, immediately prior to such acquisition, is owned directly or indirectly by the stockholders of the Company in the same proportion as their ownership of stock in the Company immediately prior to such acquisition.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">For the avoidance of doubt, the term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Notwithstanding the foregoing or any other provision of this Plan, the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant shall supersede the foregoing definition with respect to Stock Awards subject to such agreement&#59; provided, however, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:26.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Code</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Committee</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means a committee of one or more Directors to whom authority has been delegated by the Board in accordance with Section 2(c).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(h)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means the common stock of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means Geron Corporation, a Delaware corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(j)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:26.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Consultant</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means any person, including an advisor, who is (i) engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii) serving as a member of the board of directors of an Affiliate and is compensated for such services.  However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#8220;Consultant&#8221; for purposes of the Plan.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form S-8 Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#8217;s securities to such person.  Consultants are not eligible to be granted Stock Awards under this Plan with respect to their service in such capacity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(k)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Continuous Service</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated.  A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Director or Consultant or a change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s Continuous Service&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%"> that</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate.  For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of Continuous Service.  To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their successors.  Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in a Stock Award only to such extent as may be provided in the Company&#8217;s or Affiliate&#8217;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(l)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Corporate Transaction</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:17.22pt">a sale, lease or other disposition of all or substantially all of the assets of the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.45pt">a sale or other disposition of at least ninety percent (90%) of the outstanding securities of the Company&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:11.68pt">a merger, consolidation or similar transaction in which the Company is not the surviving corporation&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:12.22pt">a reverse merger, consolidation or similar transaction in which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">merger, consolidation or similar transaction are converted by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">Notwithstanding the foregoing definition or any other provision of this Plan, the term Corporate Transaction will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(m)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:21.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Director</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means a member of the Board. Directors are not eligible to be granted Stock Awards with respect to their service in such capacity under this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(n)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Disability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means, with respect to a Participant,  the inability of such Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(o)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means the effective date of this Plan document, which is December 14, 2018, the date the Plan was approved by the Board.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(p)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Employee</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means any person employed by the Company or an Affiliate.  However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(q)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Entity</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means a corporation, partnership, limited liability company or other domestic or foreign entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(r)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(s)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:25.45pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means, as of any date, the value of the Common Stock determined as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:17.22pt">If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a share of Common Stock will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:14.45pt">Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.35pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:11.68pt">In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(t)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:26.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Non-Employee Director</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">means a Director who either (i) is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Regulation S-K</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221;)), does not possess an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item 404(b) of Regulation S-K&#59; or (ii) is otherwise considered a &#8220;non-employee director&#8221; for purposes of Rule 16b-3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(u)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Nonstatutory Stock Option</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means any option granted pursuant to Section 5 that does not qualify as an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Officer</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(w)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:22.12pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Option</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(x)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an Option grant.  Each Option Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(y)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Optionholder</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(z)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Other Stock Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section 6(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(aa)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:19.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Own,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Owned,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Owner,</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Ownership</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:128%">  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">means a person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ab)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Participant</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means a person to whom a Stock Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Stock Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ac)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:19.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Plan</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means this Geron Corporation 2018 Inducement Award Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ad)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Restricted Stock Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means an award of shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ae)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:19.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Restricted Stock Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant.  Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(af)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:21.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Restricted Stock Unit Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">means a right to receive shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ag)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:19.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Restricted Stock Unit Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">means a written agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant.  Each Restricted Stock Unit Award Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ah)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Rule 16b-3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ai)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:21.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Rule 405</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means Rule 405 promulgated under the Securities Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(aj)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:21.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means the Securities Act of 1933, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(ak)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Stock Appreciation Right</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">SAR</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section 5.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(al)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:21.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Stock Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means any right to receive Common Stock granted under the Plan, including a Nonstatutory Stock Option, a Stock Appreciation Right, a Restricted Stock Award, a Restricted Stock Unit Award or any Other Stock Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(am)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:16.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Stock Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means a written agreement between the Company and a Participant evidencing the terms and conditions of a Stock Award grant.  Each Stock Award Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:128%">(an)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:18.78pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-style:italic;font-weight:700;line-height:128%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:128%">&#8221; means, with respect to the Company, (i) any corporation of which more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution.</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>gern-20250801.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:25fa4f69-406d-4151-a9ea-b9f9bcd7abef,g:efe183ff-839b-4971-a706-0b89d8e1c50a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gern="http://www.geron.com/20250801" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.geron.com/20250801">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gern-20250801_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gern-20250801_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.geron.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>gern-20250801_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:25fa4f69-406d-4151-a9ea-b9f9bcd7abef,g:efe183ff-839b-4971-a706-0b89d8e1c50a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_28dc6ab7-7aea-4232-85a3-95f5968cdf1c_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_6de0bc8a-4c6e-44bc-96e6-fb07bb011199_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_edd736a5-604d-4f0c-ba4a-08ca34b4922d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_2b5b6f60-33da-4633-a97f-765d1636f4fa_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e563e6e1-1929-4a45-936d-4e03f29e6b5e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_8eeb9b10-a2c4-4293-9c9d-73eb704e02c2_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3d815cad-cb36-419d-be06-5b2ea3c81f4d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b2a8e38b-51ea-48de-b01d-85efe15df307_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_c30bc157-5244-4e7b-97a2-b97832567ca5_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1b8b5823-ad16-49e5-b5d4-22857e26bd16_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_0bb13e07-91e0-4587-a43e-0be6b32b9e52_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d9aa4221-9b24-4e7b-8c5e-2c15dd7503b2_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_19dbd3a5-b1c6-4f17-8362-35c5846a3daf_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_bdc859d0-fa94-4be4-9605-fe04381f1c28_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_4a2cae90-4abe-47c2-b60c-947fbb91d768_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_855089d9-6e59-43b9-96ea-46d406260482_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4c09d3e3-36bb-4363-bab8-1ac00427d28a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3cd64231-a62c-4740-b4cc-dde518cf4d1d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8f49cece-1864-4cfb-bce2-421c80bd13c5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c8f02e51-110a-402a-9064-d4645cf9307e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_24991fd4-84ee-4db5-b5f3-3f6e20104a62_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_e3e4ec3b-7706-4b5d-89dc-fc066ec66a3e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_bdbdf6ce-c97d-4c54-bc9a-370824b5514e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6ec9452c-9f53-4fec-a061-8f0127c6bbb9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>gern-20250801_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:25fa4f69-406d-4151-a9ea-b9f9bcd7abef,g:efe183ff-839b-4971-a706-0b89d8e1c50a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.geron.com/role/Cover" xlink:type="simple" xlink:href="gern-20250801.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.geron.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ec367f33-270f-452b-b18f-a0720a989912" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_DocumentType_ec367f33-270f-452b-b18f-a0720a989912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_dfc3909d-21c1-4462-82f6-56e8204c734b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_DocumentPeriodEndDate_dfc3909d-21c1-4462-82f6-56e8204c734b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_91ff95be-a395-401e-b2dc-62aa14bbc067" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_EntityRegistrantName_91ff95be-a395-401e-b2dc-62aa14bbc067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_091d2ae4-dbec-412a-a08a-3b46d0680c9b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_EntityIncorporationStateCountryCode_091d2ae4-dbec-412a-a08a-3b46d0680c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5f45c945-32b3-423f-b41f-795cbb12285c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_EntityFileNumber_5f45c945-32b3-423f-b41f-795cbb12285c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_80d620d4-72c6-4809-ba98-dfe2ff587247" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_EntityTaxIdentificationNumber_80d620d4-72c6-4809-ba98-dfe2ff587247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5c7889ad-7e6a-455f-8ddf-9e7492d3bf7f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_EntityAddressAddressLine1_5c7889ad-7e6a-455f-8ddf-9e7492d3bf7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_4e3208aa-4034-4aae-891d-02935b1a72aa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_EntityAddressAddressLine2_4e3208aa-4034-4aae-891d-02935b1a72aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_cc36b3fa-c8de-42fc-a7ac-409862ba9444" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_EntityAddressCityOrTown_cc36b3fa-c8de-42fc-a7ac-409862ba9444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_190d6659-d4a7-491d-a727-91ea02a30f3e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_EntityAddressStateOrProvince_190d6659-d4a7-491d-a727-91ea02a30f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2dba1ca3-83ac-41d6-990b-acc349594c6c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_EntityAddressPostalZipCode_2dba1ca3-83ac-41d6-990b-acc349594c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_5924e586-a4ae-44d4-8a27-6dcbca6bd83e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_CityAreaCode_5924e586-a4ae-44d4-8a27-6dcbca6bd83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f667b657-873c-43c0-97a3-10944a41d2cd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_LocalPhoneNumber_f667b657-873c-43c0-97a3-10944a41d2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_a2d1a50a-b00b-4391-9967-b2c613877386" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_WrittenCommunications_a2d1a50a-b00b-4391-9967-b2c613877386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_6e31d666-dee4-45c6-aa92-795b3ca693f9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_SolicitingMaterial_6e31d666-dee4-45c6-aa92-795b3ca693f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f064fdb4-6d7a-4837-be83-3200a9807df2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_PreCommencementTenderOffer_f064fdb4-6d7a-4837-be83-3200a9807df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_29df95c2-9d4a-4ed4-8fd9-3e6f3f09fc5f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_29df95c2-9d4a-4ed4-8fd9-3e6f3f09fc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_bbbec62b-ce3d-4fc8-aa1e-0192fd78013a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_Security12bTitle_bbbec62b-ce3d-4fc8-aa1e-0192fd78013a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_58ecedf0-3136-4c5f-bb55-fb2634a1e3fa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_TradingSymbol_58ecedf0-3136-4c5f-bb55-fb2634a1e3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_452e5f38-8925-4c36-af89-132baf3ead18" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_SecurityExchangeName_452e5f38-8925-4c36-af89-132baf3ead18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_56b765c1-2f22-4ad9-8a7c-1d6cb0224667" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_EntityEmergingGrowthCompany_56b765c1-2f22-4ad9-8a7c-1d6cb0224667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_96984dc3-d5df-4493-b461-556b89e9645b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_AmendmentFlag_96984dc3-d5df-4493-b461-556b89e9645b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7d8c21b8-13a4-4ad7-b7a2-593cb53d755d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fd00eff4-2907-455a-962a-750e402087bb" xlink:to="loc_dei_EntityCentralIndexKey_7d8c21b8-13a4-4ad7-b7a2-593cb53d755d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
MB5!.1PT*&@H    -24A$4@  !1L   *'" 8    !N)\&    "7!(67,  $SE
M  !,Y0%USO"5  !!84E$051XVNS!,0$   #"H/5/[6$-H
M
M
M                                  !N    ___LP3$!    PJ#U3^UA
M#:
M
M                                                    ;@   /__
M[,$Q 0   ,*@]4_M80V@
M
M
M         &X   #__^S!,0$   #"H/5/[6$-H
M
M
M                          !N    ___LP3$!    PJ#U3^UA#:
M
M
M                                            ;@   /__[-V_;TUA
M& ?P0XD?036A/\Z/MEI"L" D%@DB86$0B<1_0&)DHX/$+I:&NN?<VXM<0Q<&
MDW_ WV'#0'O/VPZOGBLF=&/Z?)(W)WF3LSSC-\_SO$D"
M
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M6$H]2V7$K(P]M2.NZ%)45N?"BOICY.E70T>-!*[ZUOS&,25S(ZD!
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M.7GQ<L-&Z1@8F%VT]E,S']B\_?C5_8_,K.C;-75#_V-'LVE?/^@OFU_E"
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MX40DI*Z$9*>G7Y[KGDTB=74.UOV537T_5;_JW:=GY]FJWW_?>E[:V@
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M_0.MOCLRR,Z3U7(TJE;6ARL9)=VZ7U+-@J2R1Z(:VQ:,;0BW6:,+
M    IP"[0*^H&\+F.8.6[#P]T"C168^)_\VK8=A(CX>-W#;(LTZ>W%O/"VMX
M1?PP+RUM?[^P\>H-Q0]*?58BJIDI6;7NEC1S5%+95%1E3P;/3#B^JH^M0!<
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M=.N3LF9]7=:MDJRQ_<'S%Y)6/21KU?V2QOXIJE5[5GSI@3/#P+&YPA$
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MMDEZ[>G8P/3+B:%];UV]^7&G=]/^V<30WADE-?4]6:^EP]6-L62Y&QT"
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MUG9)LP[&4I.S\8V[#_<./>HFAO8>CJ=G?B4GQWXL:>9H5+.&(GV55>@0
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MT5:W:\<_3N^# UC5]8O AMW=JBW7(QPI*HWP[]KWD(R++39>S)Q ?7)I4(%
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M?]L3VR/KBF0C6TT]GH/?Z(7M!CC^/ISW+MQK#>CS:W#O9? <"T%OGP7GZ-%
M;4<W/&<"CK6"8_EW<"K_+!CV32S-3G."&'6$\_TA^<CFY5,M;N24N?N6%2=_
M+Q".."\=D@(8Q<72M SG$G"L_@8.]1SXKR_ [Z]%HK$X/4%QE?>B,)LJDHUU
ML_*P?0L<%7!\HG- [N:UJ(H$!*:J[XIDX[C"M [%]#QP"$=CM!=+3]82*J\Z
ME_!J_#K!2-X"CMI?D!P 7;*@+D&_LK/E8,=CL'T&ZO5Y*.>7P+%[%>KS=5%/
MK 8=6\MT0'?60YU^P/1-9[JQL52$S0+'X!PX_P.\!AS'=4Q748= ;T&W7P-Y
M&1S7Q2#/L:A5T"7V'"%XGB 22<DP7',?Z,$?!,/YM:3'+I-TV_2BN)(_8L0\
MSA,W(>Y#TM$CL7>=:'!&\*G684CHB6KT7+DV.ZFR;O;-8R;/:Q@S::XUIFZ6
M%0AV6%!^0R10VVF-F33'&COY$93I8R;.N0'*,^37K'/\1OMHG/NM[!-$ *&S
MSD@AN(X- F"YZXFS/2+)N03L_3<\1EP;J;]!.] $[94-[54GU.,CH%]/P[[G
MI&!ZL6BD7Y%!GZ#.5F'T/US[#D9>@SZ])VCV>D%S/-'M]= &>M'61@+.0=U+
MK 9=> /L>SGHYE+XGR_ ?9Z1:SL?@S+H#@2S#NA0"Q(@DIZZ%0D::'/JL.V!
MWSR-S4.**:MU'C&SLP\6X#R;2/@@@8+S([*459QJP$A,Q*DLP*YOQJ@O^'\S
M<'H)*91-2*'.+B@3*//L4\RFS,PB**^7)0/:;"/UIE?FB7>\2'9LT^T/16;#
M\8U;V[$G\8T2LV$\SWY?8O7A>#9L)E>R=U P_1)&D$/Y/XM35TBACH>@_<A(
M9B8*]VX$G;@/"2)H?Z['J$>,B /;/1^>[71,AT5]0M(1(Q]9*FS5KIL*ZZ5/
MSV=S,H^N28Y@<][6Q&_D:V)-4,<M^*X/U'9%T'YEM&O6-F?89]R'QZ"\VZ$.
M6@4EVLRSE./HN1C)BV6'NO/)HO6]N2/QVB//>_";V(ZR 4_4-R-U+K2Y-9*6
MN)A%K)J)VZ!.[Y71OH/9&.A9%F0NV-Z3<BBS(!!,OPBVMPQT8P7HV4K65T"[
M1?O5T)9+[%MC[Y#W"OM1IT GG;5P'=,K:"-6>.^&]!)HMYZ7/-UZ G3\(7;?
M8#:.SR$%4W^33><.28]#?\F^"OI.=="7NE (>N\&G(/8&\CM.F!7GE:!0" 0
M" 3"YP!WNG_W_C!W2M],[C>]#;[N7*/OQ8%6WRHWXMN8C^R ; 3IQ^A&CW#,
M#S1C=*,OU]_LV]#?Y,O"=NJF1I_4TUA^V(>83CUMQ)Y;.PBX@ 6O6 K.-06.
M5PPZC?/E4->[X AY45A(C.R ;(3.TT8)'7L]_H2H6):H1*;"]E2,;*":W>4T
M=1B+.,/%7H+)DP33^5_H$/\2"2!13SX G7,;.M^/2+K]/.C'$NADOP).QNL@
MJ\#A6(MZ%0AUK >=^1 Z_QO B>R!:_I <J!G ^"H#X+COH5H+(A0*GI!2O8-
M/=_.P_%!< 0&P"'HQ[D0P7GHA7MM\B)VLQ_ L[P'^OT./-=;@;KN-\$)>$T,
MIE^!_[$$GN&?X P_#,]A@\P Y^(604O\4C82OY#U=!6+LF.+!\S?O:PD+18G
M?,?(*S8WE1X?+X(C 4[./,E,K )9!^6Q:>@\J+&M;"KF+< 4RKJ5==TNE-,Z
M<%Y>]M(&(_ <5IU8TWX\II'NBF0C1J:@XXZD"EO$!TE&/3D)MC="/6)J-*:F
MS1;TQ!-0G_\$QW4IE-7R0&U'0;^ZWV)U&NI<QP9+@ID/V4)6P32V3SVBF>QE
MNJ [.=!1D$3_]L4I2O&\/KQ6\J:6V 2R$9Q(3X] E_%^(&_+J$OP''#O-Z10
M9CDC2LSD"Z O_P!=G ,V$0>Y7S)0GYPK!9PG3G-.XQ7[&.%"="JM T;L0M'@
MJ*<8B>O'11246*U<V_&',1,?CI\XY='GQTZ9MWS,Q#E0=]W+L0Y+)5 W:_F8
MR7.7C[WX,9!Y3U=.FM,FAS*_]^/"45KT-)Q*X).D6^+@"$;7\37)(S&-DLV5
M:#A3!3-Y%]AG,^A#MV X"T0C]:(4RBZ5Z[I60#VNE$.=:UB]LOK-8IOU 6NS
M3- G@^F!IU-&4:\*8A3$9&U.#Q.\!JY%G2P,Y!7:GV[0F<XW08]>"P0SK\IF
M&O0E]1B;FU9+A-FB4GIB"F_8/T&;8 M,8'3C3HAB9#>;2@/G.E22/$9WP_\P
M1+:0EWTG2#/8,LZS^RC8,_Q79QG8YZM0[Z\'ZCK?+)8YLZF@5^;89F];YCBG
MM)/#A>RDS?:ZQ8:+^POGY* ,^V2H)YP>1D8;#FZI"V@_H"XZO'=!;3?8;^<;
M<-\5\%S,?N'WGH3KN^'9HYAR+1BIFT0]=2FT3=5(;&&D,LZEBX3CSDH$?U9D
MLK?84_<WA/'09ZR)7>*OB49X);8$RF(IE-DK:+OP/ET.;2'8<J<G\!GWL?W0
M'X#R?-FO6LN@S]G(V@7%/JJJ>NXGC^!SW6'%"-I1U3,.]D^PCI6TU)F"GM(%
M/7VMH(-]:TXK]&EG@8T^ 3KT'+0C+T-=KP#;6PGUO1H$^B2=[V[1M?1'[)WA
MM?,]I?HVQ,8+?8K2]X+,!/7*>S<PW<)WD=?/6 MVOAKNM1)M'8XO@_,72J8S
M']X)CX(D),.> >^*/PH8_1E,C,>(:W]=XEBT)6S#J.])(! (! +A4Y&-/4@V
M-G#7@W3DFGPO#+3ZWLS_&V3C9L*QD%*-<S@.ME;DX)J'^UNXW_8W#S^SK^'0
MD6Y;1?GJZ>7[;-V!Q/FP_#61GV(J-3@!#TC![*,R=L)V2#;&62HHB]0R,WW0
M<7H;'.I71"7VC*C%[I34^ 4825*<7XY6IOZ2 >J++<A1NI*L:A_()O6OS9X0
M""9_Y*4<IZZ3S,2]T-EVH//]#] )3%5>"[J0PWD)P6$;Q A9Z&A[$NIT\3MT
MM@NZDP(]2A92H8=&*7H2*Z0:?[QL13ANB88LIE[#_62/'&?/P:3P7/!,>=%,
MYP7#&00GN <<E+<$]E\23\.S.9@"!<[JK\%)-3'R8)1I'W]<*.X[)I0\!$DB
M= ;\6OOWO54HHS_!^0/!<8B"P[ <) _WSV_Y?_'-*[QO0S::R<% *#M06=?=
M#X[9&ME,+!2TZ%Q!C=PK*);.*^W'%*- OIQDHS=7+)N\OVX^IMGN@TXZTRTS
M\[W-T8Q&ZB(HOZMD(W4G2V5E*96)YP7-7BWB')YF$@G$05:?J$^L'KL*]0KZ
M%O1TS*OOE+<(C[DE_5[<+,YV13*<H6G[>*WI_8Y<HD=,MTOTJ*!+7L0WTVUT
M2AV,PH+GMI>"4_FXQ/0I>3^FCH)S7(<I?D)-M)*E6(-.(6E=3)_#%,$OZSR/
MV&Z,QL4_<$5@)7XEU,F#8R;.^<>)4^:]/W;R(V[EQ#FLSKQZVB*!NFYWS*2'
MW;%3'@69MZ9RTNQ'H!VY'^S@*K:8F6D=N4.R$><B'C>-D2(L;1KGC\759C6'
M$1%0[C?"[^'T"=W@V"\ .W\#['T3M&5]4&\#<J@SOTU[%2H\'TX;4FBWMNA3
MZ;0.R1)]0?G_    __]<&Y9^  !@34E$053L70EX7%79!@477!"%-LE,!157
M9&OF+I.BU@U_5$1_K$";F;O,)(B*_"@JXD)51)%-$,6RM4G;++-O29INH6RE
MM+24M7M+]WU?LL[\[WONS&22)FD*!1JXYWG.,]N=NYSSG7.^[SW?]WZ)C&(F
M4)-6]:4RJJ\AH_H;,VI%4\9=,0WOFU#Q'7\SDX=P_#9%CZ]2].BSBAZ+*D;L
M'LF,_A+?7:F8D8MD3^ 3LC?RL5%F_$.C]8GO&S,F\.X3QH]_UPDG9$X\X<TL
MN&9IY8*3W=<'WL][*?-$AI7YPF>6ZJ'/J5I\E&(D?Z@:L9\K>N)O>(Z)LAYK
MDO7H<[(6727KD>VR'FZ7C9AH%SZ_6[0'JM^JHHU\5KODVX]M:<2S%?\UHJ+*
MO:KU?:Q7C8O_J[R>+VFU-Z^+Z[@K&O/7MZZ;$L?*1KQ-,>,[<?_K45_!YT=E
M,QY0C=2_9#UQ$SYK+CWR3=4(CT2??.9"L[:DM#)PZGF>Y@^<?4GC>]^ROGD#
MRNC1+2>-UEO>-WI,RP=+/2'%-2[T.U=Y:([+$SHHZ_$V]%6GN[(YXZZ<EFU'
M2\Y%NV:_5WS)+O1YA\L;:'=Y M,E+7B#7!XY7QG7^&'WF,#[>8TCR=PY8P+O
M*:V<< K;^4(S7B)[ZS[C\H8NE(W(=R4C?@WD[E;92$Y"WTQ#?4XR8AO0ESM0
M#V+\I7/WI59,$^//DK=N61.R(<9LKL8+9"[>+4M"GN+YXWK(%<[E]C5F9:NI
M0+8;L]=*=>$:K3C7?HR#'8H>68;SS56,1 /D_ '(V'C9E_1+OMBELAEQNWWQ
MLV7OS(_QF4LKDZ=PW(T>/?XD2[9.&/*R91>[V,4N=K&+7=[@DIE0>O*AB<[1
M;9,<OVVK<B3;)SN>ZZIQKLW4._>GZYV9SAIGIF.*(X/?#JOMV=HQV9'IG.K,
M=-6BUCL[.NN<3W;5C;B[;4KQV(XI):,RDYUG9^*G?ZBG[I9YES0V_,E2;_U7
M)3V@PR#X!Q2A)BACZZF0"85;CV8D;[!GU4+X/I*QC(5$!Y2D/5"6-J,N@U)>
MC?H3M3P\TNT-."X:._4T*HAV+P^=<O:UC>\]=VSJM//1?Z[RP&==WJBLF-&+
M8?3^2/$E?J+ZD^,A)_]&K84!T:R:#<] 2:;"O $RM$?6(ITP^KKP.6T9V<D^
M#48<*^1+R)+&&L[6D*C245;K?^&"&LF>/VK)JA'O:?SG[TT8EFE)CZ+2"([N
MYK/@^^4P(IY1? W-& ]UBK_A/ME,WDRC9J01OL+E#5[BTL*CW'KL7+Z7O4$_
M7F^6]= DQ8P] 6-D,\Z1%D:P;CV?N%=O*#^6Q'WR-SV6QCB"T98Z@&OMAN&R
M$/<0QO&WRY[Z'TM:[==+O8&/<RP5&!I#JM#XIFSA&3Y8>E7-Z>YR&%&>N$OU
MQKZA&K$K%"WV4_35S6B'>R!GD]$6#6Y_PY/H@Q?0/Z^B?W:AG?;C?2OZLZM'
M?QX!E,C+@6CKHZDY^8GV BYZR9*O6Y;X&^6-AC7^=P!UEVQ&-^+[)90G&*(S
M\9\@GG,"KO%WU%_!X#05(W(9GN]+E"?VM3)NRH=++Z5A/>'D$S)#"[ XSU/]
M@=)Q 8Z+RUR>T/4PP!\LJYSQU$4_GKV[[.J9%M F^BS>HPJ HG)Z9M0ULS.C
M?CQ[D[NR>8[J2SSHTH*_YKD(9O4#WIS([\^^Y-[W8BTK4CV1STM&K$PV8S^0
MC.@U>/\GV4C\!]<,8#S/5OS)Q9"Q5>BC[9"K-AS7 2._"_V2/FR^ZB5/HF_U
MZ"!K]O@\0)'H0V9SYX^UXW6O:L2WX+M5JI%X!O+2B.,FH]Z.]OFE9$;&05:^
MB7N^0!D7=G(L$70\(E!S[+05M',6]+DJ>;IDAC\I[L6,?U71HI=C'/M5/?8;
M/-<_(.</NWT-,3S#HWB>Y_!\:Z ;;%'TZ%Y9BW:P?11+A^BU1N3:I&"M.*S-
MCWX,X]J]P*)$K_[H:_S&]N,_.W#\>OSV$HZ9Z_8W3E/,AAK,T?^B7$E&Y.>2
M-UKN,J.7*'I8I8R6EH>+":"QG03H.,0!QVZP,?!!U]B +'G"ORWU!&=A;*,O
M8P<5,]4N@#1_0QZL%2!<%M3%N(8ND.B4]$B;Y T<0ITF>8*_Q%B]X!N5,P2(
M-GK\P#),.?^2$3BC5(M^B@ OY.UB2>-XB%Z'.>(6W,,$7">""GE+/8?K0=[B
M.]&?^P1P;"32/?NZO_4BEAWG@QC?O=<%4?N2J\+Y!/.,M3:T8L['O<4VX?ME
M8LTWD[/$VB">)?57O/Z?9";'R4;J6RX?]# ]]&FNG;G-AA.@P]L:JUWL8A>[
MV,4N=CDRV%CM_$I'E?,W;56.>,<4Q[-=M<Y7TSFPL;9_L#$/.!)LK!% 8R8=
M=G:D R,6X'\/MT\IN;9SLN,[;37.\S)3/W[:"3W1QG=Q=WBD%B@MU0+?@2)X
M(Q2=$ S#-32$9 $(1;( 22'@2' G#^9TP4AKQ?_V0['<1H! ->/CH=A_F[O6
MDE$[@H:GW<M#I]" A1$U8J0W=)YL1+X&9=ZCF+$;53-V+PS'*9"/1K6B\6D8
M%R^BKH!1N0']OD,U$WNA.+="9KI@3*8A&^F^E?1N<%'*UU !$-<3D!M\+?AO
M'H0L !][ TB'WQ/N-]()@X$>1GO%,_E2&_",*]T5TUY4_(U/P7!HP#B94JI'
M_NGR!F_">7VJ%O@>KO5S2:N_VZ4%HK(>GHMSKA @O#!<>7X^8^&]!O*@/0T4
MM&LGKGD ;4CC:".^:R00I>C!*UU:_2AZ<)P[=NII0]E;AJ#9*//A#]%8(DA!
M8 UR<I6B)6Z X7@'ZF3%B,[ \S\-PVNQNZ)Q69E_VEH8JULPOQ  /H3_M*%M
M.[/RU7]?YFH/\#G<M\P=$;3N#6 /)$?=UY<X#HQH.PS+0S1XT<?;(4L;($NK
M5%_C2WBF!7B>QW!L3#*B$RS@(GJ-JH6_IV!.EO2)11?H$S]"T&+\$#,J.>>[
M/)$O2I[0I1B/U^'9'\!S/^FNG+';7=$LO'^4[/I26 5 X6_*E%T](^.^>L8F
M=T738SCN8=D;_(VLA[X_TE/W^3YD7P"-XS$N1H_Y]P<)-!*(@(SXT!_C^7_4
MZ3CW?%SW)<Q=JU$W8RSOPGQUD&->]-5 \U5^SHH,(!OAUR$W>';*M8&UU$CL
MAVSLXMRC^AN7J_YIBW'?LS$WU&,>OD_6@[]Q::'+"=00\",H34^Z-Z%;!=#(
M.:CTTN0I F@T8F6*&;T<<OXSC-U;\3I)-1()W'M+F;]I <;O$LC\&GS>;(WA
MQ'Z9X*Y8(P8WCOIO\X'&[P!C6#]R7_0:OP>Y'D!>MJ$_UD&.5^#U>0*/&+\S
M<4R]HD7ND;3H;W/>COC/%SAV":*)S=8AN#ET.-@X48"-W" J+8<,>H+32SW!
MG>@? >:I9LH"\PJ!X>X-H;0 ;[7P(9<GL!]K8"/!QC(]>L%H/?J1P8"-!-@(
MMM'#5S'"/T0?_0)CYF[(71CSRPRADU0TOXS^68,U@^.;:\9!7-=:,P:S7NBO
M8WP/:FU %6N7D"T"[FUB;1"Z1N,FS'UB;5#]J6>SP&.M;";N1;W)!3T,=33'
MG7)5S7".^R.UF5WL8A>[V,4N=K&+!39.&O'ECJJ27[55.2,=4YWSNVI'K,X$
MG/O2@1%9L-'9+]C8E@,;Z=48=&8RT1&=Z?"(%SH#CD#;E)(_M545EQ^L<KCW
M/5)T1L\+9TYD2-9(7^!LES<@2V:T4C;C5;*1)%"2]2:(% !!?0 \4+2H7'('
M&TI>!Q2EI_'^/[(W[)>TX-=I^#'\P^[EXUX*A<%.HX@R@?X^9Z0G\C6\UR '
MM\!H@*$;?U;U)5>@?[>[*QH["L/>&#;$4")%CW<#B:\),'QK:MXX%>!?3'@C
M"(^,7(A=Y32^A]&9W"(9D94N+3P/LA] O4/QAJZ#K-_G\@:;)6]@E:S! -.C
M^]%>'3GO8*L] CVJG!T[BN7]@6-3PJ,2[;<4[?ZPXHV8#,^[X/LP6B^=<,J;
MY[WT1H 4F1,)FE&VZ+572L\4AH9JL3_*>GR*HL=:8#@NHR<@/6*M^:0I4U;1
M;(6>F:DL.!45\O7: >DWH>;F2SUL>50)@[L[7+2L<CH!-7K]6AXN>G0+QMA"
M/'M2,:/_IJ<.C.ION\LGGUU:/KFX= S#YR:<G 79A@3(3/" <XCL#7X7]5JL
M)_]5?0U/J!5-N_->\Z(?>XU#MA?&G@C%K)BV&7+P.-KH$44+_E;V!GZ@]@DV
M9DX4 %CIA),A8Q]5M? HM*<?Y[I39BBR'E^,<^RS/*UR(;O31'^(S8 >7L=O
MA<Q8LFS-/[$"C[!&:VX58Z!A%STQ%2/R+.2JUJ6'?L7U];QQ8:<84Y<F3WG#
MQS#!W-'C3R)XQH@%X5UFQ'X(N?VU;,;NA]PV*T9TF6K&M[O]J7UHX_8RAM"*
M<-7N\&0!1N4!Q-#0&;^^[O&+?NG$G-2&>>N@K$77X;@G)3U:)]%368OZL"Y\
MF6/W@AR01F_T(31^#P<;QY]TR;6-[[W8T_P!18N60E_\E<L;:L2:MU72(GOP
M[ P+3G>O=06;?9:'+P&V-GP^@#;>C3DA)7M#OR#8>-$UJ=,NIB>TF./Z7CO$
MQK@1. -](DE:]$=B8]R(/HS*^6$+9&L/^N20N[*Y2X1M<_[(A</KL>-LS<BU
M2Z1@O#?DP[H+* 0P9R57RD9BKF3$P]3#)"T^CLX!!!S9'HP4&,IR91>[V,4N
M=K&+7=XDL+&CNN2BUDF.7[95.0+MDYU/=]6.6)D^6K"1GHT!9R83&=&9#CF7
M==0ZFUNK'?>W5A?_O+6JY!L')I]9W-M(X^XHN888+BL9X2LD/78?%.C%,I5H
MX8' '>%(MR=0'XJY!38F:5!T0D%Z&<IY# KG;;(G[)/&UG^986T%WEBV4G2<
M $#TEN+..$,/>X3$Z?%ORF;2*^N)WRA&\I^JF0Q Z7V<0"->-^'S'KSOM/B-
MNFLW&!0>A&+?[8$H#]K[\$CU<$^8P[TF^[^?;L"Q5WB?X&$2(8]MLAG?+1FQ
M33!VEF&L/$$P0S42#V+,I/#?A9(6W(SS[,/OK<)322\ [ 7(&.SVOM$C:1$.
M;"8Z<>Z]>%V"Z\[&_4^1O9'?*)[0MQDJ22\Q]I$5CC>T"@UM 5X;L1%*UE.6
MX?AHXVM5(WX;#/8IJMGP*-KP!0&T&M%6$5*> UQH=/60K<@ \M6/3 W6X^0H
MO"1[>N'V!UB$\]?,R5/W,Z72>*8NX1FN1W?+1GRE%;*?;,!Q$Q0S_@?%B!B0
ML4O1?FYZ]$AZ0Q$W;H8"+<6Q !O=!!O]J2<Q1JKPVQ]<WL /%2/PA=S&B)B_
M1K><Q#91]>A9:GG=2(R[_Q%4#[[DG0SAI?<9VGDU/9SRO'WY\9RPO(Y[S!&O
MQXOZ]7AF=\M+7E:R )?@=?0U8'X@345D">:8.-KT)LD;_L:%5]:6D/*"0/X;
MTX\33N9&A] 3<"WA-:J'5<CD=V5?XFK<UU_4BH:)@G[%3"Q4<8\B%-Q,'N0&
M2C?O8J([#%TO!!I#1UP?>H[GR%%Y%_?G'3FX\1OJ=_R2?Y 4,EE/Z^UXME?P
MW6.*F6(([-TBY-T;NX(4$?12)M<FP2%ZYPU%6IG7!#9Z>X.-X79\=Q#MNT?V
MAAKPVR\)6+M]TSXZ^B>!#W:#C1:XR/7N(L@VQS;U$H82H\TKT0>W*/YD%;T9
MT<XOX;K"@Q'?MT'FNL0F@@A=CA=LF ^DDQ2N&Z%!>3*^[C%?L+DI]Y"MPG#K
M)#<W-Z$N@4P])=.SV4C<CK7TY]35Z>7(\4C]G>#_)=>^*=[-=K&+7>QB%[O8
M92B"C0<GE8QJK7;\7]LD9TW'E!%/=-4YEZ>#SKV#!ANKN\.H,Z$17>EZYUK\
M;VY'M2/45N4<WU95<MG!1TI&] :<&!K#W7?EJOAP&FI0F/X&I?!)05QM1/<)
M93H;%F,I;'WQ-T9SGCM=4 #7*7ILGNP)125/\"^H_TM%^^U$EOXVD;H3J=RS
M_T5HJQ[ZG*1%OZ[H"0_Z[T;5;+B'AI/@/_(U+%)\J950X+>CG_= $3YD<>9E
MN8IZ<"\.'FCL"005\"KVYC8[8DWTX%:3>_"J1?HP, <R^ N, #V7="#/X]2)
M]WSVO;(1WRIXU<SD\S ^YPH^+SVV'O_;2Z 1Y^B0]'!73X^I0"\C0_!:=EA\
M4O$M(@&!'KN?GI(,&27Q/8VMH<S32*"1WID",-,8;AFY'O4NQ8S5HN^:W?[&
M9]S^IA5N7XJAXWL4P>568.#WU8\#&8T]0.N!>-H&*4_Y) %]R]2 @(G6Q_WD
M[D6,&1C@6C1-[R@8D=O=_H97W15-+PIO/C,9E\SH1,$U:$9]I5KP8AK<6=[.
M#[ZMP48S#S9NL4)5HU-QCO$XWX]<GKHOYH!&SE\TL EDTY,,Y_,J>O0/#-E6
M?8V-[HKFYP4EB)G<03[$PK&<[\NC AI#!7-7?\!$J$ FCA9T#/62E6Z/.@$\
M&+'M^'T=GG6Z[ W?3+!1&A,HXOHM^-O>@&)Y(U=]3!DWQ<GYR*6%O^?2(C^5
MC/BMJC_UD.IO2J"?YJ%/7X;<KA-CF#04@G\RRZM:&%:K108Q%X=ZCF4M-Y:C
M W N]E%[)?;HB\;CM8Y?68^3B[=+MD+?&?:^V>UK(-W&(K3)#-67K%/T.#=N
M;R2OH*35?YE>N02&AB*MS.L#&T7;66"C%CZ([_<RC%KVAGXEFR'7Z,KDZ:-_
MTO)!)CX1F]'T4L;8%ORKW #U1+Y"*A<FY6'4#-8,R%S3,] WEZIF8K.UD2#D
MK5/P1.?Y%JU^E@;T6B[417IO3 U(N3+ N!_LYD(/.J+N>:F[M@LZ%[-A"\.K
M%2NT>@:3%$E&] Y2%^#:W\F!V4RT8^NU=K&+7>QB%[O8I4^PL:/*X6ZM<E[;
M7CVBJGV*<TY7G7-I.C!B3SIX%&#CU"S8&!S1A?]O[:@9\7)[M?.Q]BKGO6U5
MSK&'JL_\1.]KB_ S9K?36]XG>P-NR1/\K>0)P)@)$CC9D>4KLI2??"A*7V"C
MV)E-PS#?C<]KH4B^*)6')DN><.5($4H]X>1NP-$N;WE!/]!XH$<!C4D1>JA%
M?8H6NUW5D\RX^20,]M5N7],>&)+[W?Z&5AB7# L6R5^D?G?WC\*HUB*')V\I
MR!0JPHERH80#U-QQEL=)SZ0+.<\&<B8>7:AD7WQ@D;0%$,;(K]@.@[(5USR
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ME< %/N-:<<AR?#'D)"H;B;OP+-<QN[)J)$>ZO0$'0<<W*GSVN $;S>0SZ,\
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MQ2YV>4/0Q<R)HA:"C5.+2P]5E9BMU27W=$QU)+OJG(O3X1$[!PTVHG8PE)J
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M?8RRDHLUPO(H^P2!),F,_HAC&//T0[B?:;B_%S%G[2(XB';O4@0%1($G^)%
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M'L)Q[9+%)9SWNNN>L^A53\,]3N\S9JI>PTS0JLFD0K$'\/O-#)FE'(M,WM[
MQR\2/)]O+JT'@2V"TK(9.=_MB_\/ULD*M-%?E(II_\0Z>X-+CU_)I%D7,M(
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MB%V==<ZG.VL<5?C])M0?XEKG9P+.]Q\&-(P1F?M.IV("A= +8^1!*)4$"'9
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MV69XC1KXVSR:EY]@!?E.ZSW%_Y,,7'3G9P"@B\OT?AL#&@2#H"]?MSE+%T!
MN$4+(DN3F:9#E-?T %VA!/QM#!S8>AC#N5IVGO\1&(N?<)+WVPA*C(<@0W-$
M=>L+^&*?8%8  5:DP+6,&+B+<?C^#'TX"_JS%AS\K3 6"0@X$]K:.&P\^F<
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M.1J"C)8%ZRXPSV^\V%S;.ME8N_%1TY(VQ;1D8[-IR:;MT Z:EFZ*:Z(PS1K
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M&NW.)O8] HT$T+H[F,;8_5D,[YT.3OFGX&3N8L5 ^]%*V7LRGEPDXPG+*UO
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MF3&[#=5\63'X!/11.03QN\FM-F;^#.IH>E. $"FW@0 T#L'G+GA<S#K\[T#
M\AL,6A <T'D:3]PP&,=@B>9E'@*HOT*PJ,"<7@OS.XX9::DLA,/'J2>+RX$9
M:1B(!@Y!$+$/UE(MM.?@^8^Q3!L!HHQ'ABL[4,M8QL".4"0(GN\C2&KEY3"\
M]S6PEC=RSK+V?IR- U$B8):*IB:*2JN;X/?6P,\68 8.+<IW7'E/L6&D2\"_
MC(;9>IB!B"K+1"%>##P'\V(Q)P5V$5!7(ME^?;*9O4<*0?5POJ%84:@6YM^+
M1.3+Z;\&2^>PG/ID!!O9?LKFI=WP.7?!?M4(WU_-2,I;<#9DV:222Y'/C61G
MCDRV[Q=K[W$$T]+M)=>G"QX[]-4SL-^$;-FSFXXJ')8JLQ0U_CPXQ[MLV64=
ML&\MA:_?A'GD(O0*O/L*I-C05^8QGMNW5IR!O@L*Z6 6(A%W$7T!S%HGF=_.
MX$%8&PEV*'J-WLQ&W%^WP?ZZ!GRCV8SH>04!8!R3D>1?'3FP4>,H1@Y+>/X^
MS#V/-<OS'&-W9V$VJ"X>UL>2PD,9+OE\!!PQPQCZ_34\H^%Q+_1[.ZMQ<"=Y
M/H\"-N;,[83'_R"?,HS5\PPO2R@ZA,)&>F?KIIMNNNFFV^=AJCKVP@7K+C?.
M7W^784']<X;J1K^Q=N-*X_)MFTWO[U!-RS8/##:F2JA1%&9Q"X*.W<:J!@0:
M#T%;;*RLGV:J;+K!N'CK15BF/;ZB_@@EP8Z9YK2N//,/HGGF^Z-%EE=C;JHB
MX4UK(&"C?&)@X^& 8ZS8TATOH3KC'NI@S$.M@.>O10JIS.C,2]([\R^Y;&_N
MI4?PJZ%J'=ZFHV(TEE-SSL _P6FI@=;).D(1UH'E0<A%=&R 8V]Y+Y9NE:'0
M3#.Y_1>4(+S&G[%L)$5>31Q0=?2!%>AH<I+WV^ 4?@^#;-89>LGF"%=# +^/
M(X3_P4$YN/KRGD%0$X._[6:Q;,D9"I'23-YS&QE+1TF:SL%UXH89J%AJ2-N5
M&SG!ZX2 \BV8TRM@?G=CYE\*&#Z"7ZFG')ED<R%H'X% M)-UEJ[&@!^"BBRD
M%4" !<O+ABN((8(2,+\PBT[+R)1?M KR,EKP;43Q)RR_3&5%#5Z>KY5_0_!X
M"#[GI_#>Y\#GF0X!S(,X9TD0TPLTZF#C,1K9\Z;(9V.0R3B"DUC!JX$5HJ^>
ME8);.50)'Y0+M _GFR.<X)RH0ESV/JS]MU/@$<[3D0"/A@=L[#T7,K++NVRN
MTE;6X5_)B'(IO.93^-I)(:O3IN@9L\10@1KY?#%;"?:+=UEG>*'-5;'9-E1F
M<M]R=4<@GN1U/ !S"T&@"L[A_XM55&Y!^A2MO\/ZA=0Q@W0HK)=[YG5WS/@Z
M9B=S1.##^S8K^&I07=[F#.] T:.A^'![>/8T#DT$EIKA9ZL902Y"\3#,2"/[
MQ,C1:PPOV'@894@&<M Z2N?!?O R:U>R&<'W ^0GUC.5^P4D8_N>T[@>&5[Y
M&[2%T%^MK!C8Q4FA3NU"\"CG- $;YW1QKG+DDYX#^^@[N$?3DG*C]9[B"_6^
MUDTWW7333;?/ 6C$-FY!T]7CYJ__M6%^7:&QLN$#X^+6)M/2S7M)"?723:H1
MP<1!P$93+]@8A>]U&"KK]ALKZZM,E75_-E<V3*+FM)U_4?7:LR?(:X\ =P[-
M2#-WYILG1PLL0G>1Y6\Q#^57O=1ZU3],8&.J:6(QB;B;BB>\5"SA3?LTKE %
M745ICQR:0=W:GFNYMOW=RXY0IA[_T.MG(-AAG5I@8IUR!B-Y_\!(_MG@S!P$
M1P?YVJ+);#M-!>]8Q6*<*%Q2&H5@9R\XGIL@L/Z4.$*\+Q/Y:C";BX!AHS"#
M!;G5,!.)%>0[M6S2TIFV[/(5DW+F',P8*GCO V!II3:!;H:4< 6:X??S.,GO
MQ "59$VFLD=U.R%#CBG,9,& ";F0H.^GP9JH9!W^:%*5.JYEF_D&)73']8,9
M+Y@-">.[/L,5SF>=@8<8L>1F+)/$UQ\>L%$]15-\E\]!?C&:5^ZV\LJ_K;S<
M $'Q05KT8;E?K"> $8]:GK\? L@5-D=H%JS=WW.8@2')UR:YH'20\3C.HA17
M+JK/8C!.H\@+[UT)P7T]1X2YCL(%FBS#S,A!FHO9_T&%<1C7QQG>_;_IHFS%
M3/63$VSLD_V4,[O#EEWV*><,5-"BYVU&<-_/B)X;$(35 >Q>0Z$<VJX(,$=>
MAGV^%,9Z-?3WSJ/3(&AB'2R*ECB"[?#U+ECO;7!^EZ!8!V;/Z5R^QP<2H;^"
M?8:71*0:A)?_ GN\&_IY"7)BHKJZECD>3/I+AP/!A->:* [#8P><)[OA9YMH
M7IY'"TC5(6=@=N](<F@.&]@H>GO!1K(OA1%P;+$Y2STV*?0[!!H1E"6E^GJF
M\L!G 8S%Q'OD#-HN8_ES"/KZ$_ GVF!//6AS#EV!D"K)A_T A;::2*:[X/7
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MEGE!)-?\%)92JR]37U7E":>K\IA3U<."#>1N9++<C)7W98+C.0T"PA)P>CZ
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M,8*8A!)A!/;:$P<;>ZERT%]!%6[XG%O@=398>4\@G7<_C*7!Y+VK.JA]U+.
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M"%"C>',+SE0)*=6V>W^.O'6$$/W+&DA"GV+FV36";&$<RB1:"TSF@^/>!8V
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M"?OEZ:P@W\_P[K^RO'LK])<.&W$N<+VPD1T!-C+#8*-7Q1Q?K+.(YJ2"&_L
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M([AVW^DL,ML$^3M@MV3"& ^"=K&BIV=\L+%_C3X"ZK5BFA3]-(1*(8@FL)'
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M&.^'=,C>ZTP.<PK$WMR;<0 8@?[LPH(RX(QNA\=7K'SQ(NORPID8B:;WX03
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M25DV.3E(XW.!620;$6+#O'N%X>4/6$%M9R7_AUP\G<$X(';\>#[GJO#!]66
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M;J]2:YL/COQX1N=0/W">U'PO(I,^6(B,\-R Y VMM3VOU%MG$%"I=[1 OQP
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M[URQI+J9'ZS0V&.4NGPC@D$ [5X DAM5IJ*# X'*4\#%)A".A&QT!U4F3R>
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M4P!23PE6%"Q4&;UKU+%+C_6D@IT#V2BDI))(C4[&X-ZCU#NV*K36U>#43D,
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M%4:[/3K6=H]2YV18SFUDC=Y4 .@; (P<(T(Q!CSOB./?!]%%HAN[4^=,GC
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MC\"QGF0P[:_/6J!GUGP3""/X[%[6Z-X$_T.E\T4T9W\-YN,3I\B*U!O$76V
MN0WC ,6L,%422QG07.&C*I/[,1@_CZMBO3\;\<JR.W&\FB^S^GDBV7C)V,8>
ML2>L>ZS06L8JM?F)2JWE4^C;C2RN5Z:B\*F(=]O92CWX&:/[!&/T'(;KLA'6
MA R8OV^A,)9"DQ<S_*5<F5BW\91AWV.9"-PW'AV;?0_TX>^A363T+@?+%?B@
MW[>S1EA+P7]A^O5?3A&^I-0&KKM&-_;_/GCTPO_>90P%OU3HG7<3 ;'G+_P:
M*I*-(MDHFFBBB2:::-\)FS5KXP\2DJOO05&824E5XZ8N6#]KVL)-RV=\L.7
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MOZ=@.F>,+N=A)%6P;N.5/"=&"2F6MV/T$]96I/7.=VB]>RGTUS&&0U$ MQ^
M2Y@="."<EE)M%P0"8C$5=FD ^OPP?'X7@,QZ^$XKK;-/8'76WS%:FQ*%=C"U
M\]M$-F)$(T:GH,--ZIYQ]M>4G&,^1I5 7VQ4Q2X]J(Y=RO=6G>Y7]9L0*/:(
M,CK6:2P(05\BT>AG# 6;6<[U(8KPH'A*C,8R#*_CI3[_[L@H+#6@U%K_#L?F
M4NIMS8S!N1>.^?BI\W;VDTX=(2IZD8ZLJ8!G3)XF&(-YK,'Q3Z4V_UFE+G<X
MDOWBKM:_H9(M28?56Y]F# X]K&/_98V>^2JC9Q&T5]C8 I5Z=.+WD7"\G$H:
MB&3C97 -QN0,P0AE4O>8<_Q'%>O-&C&^>(/ZY4]#ZIYK8#][>0V3!_<!K!EX
M!)XWTIRK@M;:LH4ZP1;U:%$DIL>PW$&,)G.84I,[DAZ7KZ'UCEDP7Y?#6/Z"
M9&,8>Z6O#Y!E0$IMH (UJ>U8L _6WFT*?7Z54I^?!.OF"TAH7LSS$LE&D6P4
M33311!--M&^Y\5<1<9C9OB'OSZEX<E)2U1L3DZH_F#)O7?'TA9NVS4S=VHDI
MTAB]>(ILK#I%-LZMY2>GK"4B,5/FKS^6D+QVYZ3$FBWP6L&DQ,I_39Q3K<+O
MY_E3]:^0^+NSI/'NJ-(&5EK6/$ZRICU%6K6K6EJU.R!=TQZ4EK>%)"N;!<+Q
M7$A'?&]Y*TFEEE2V^Z45;0?A?VU1)0T;)"4-*9(5C2]$+6NZ<Y"/OW:0A;_Z
MZX J/E5V Y\=]9.32V2/=:7)1X=RJ!GA?*HD;*&.AO(H/IA-D71F$F5XJ<C&
M'(H/62B>=T0'PS;J\V!>= '\?T[G$FI\QV+J%\?3ADK.)#Z0S*+U^4^ $Z2A
M#<ZIJ,3(QA;M8(54L+"0AF0;.)4Z0GBH4)##4%".BK\T.+G=9!F*GES9CF?J
MM2/A'!!<H@HIHW/HE3I7"JUW53 &UU8 E7M1_$6HP=5/JF\OD!D1C(F ?F^0
MB)@8"@ZRG'LGM J&<V4!X$B ?GR--=A?@+]_CA& 1%R$*Y1TUY-# N2R3;'C
MA71IC"!$LAG3Z=4ZCUQ(5;73J,"-()TV.M]B#.YYC+' PY@*Z@ P;D<2I#?A
MUD,T?B5UND>A&>MFPGA%DM']!7Q?$TFI,[ASH._^ V/Q&9+RJ+%+'[CDQ*T0
M&85]<RH-TYH(<ZP8SF$]B>:,+3P55=R/HFT/X1B)Z"3O-[IW,T;7*OC?)S O
MW\$(1Y:SJY!PQ A'4O_M.U[#42!Z/3>H39;;,465](_!_B*,I7_#_)T-XVZ)
M.J[8 \VKCBM,5)L*7U9QSI&,T?$(JA"3=> RJ*4JDHV7 5$]KNAF4L]7;W\,
MUORQ,'=GL[&%)>JXI5]"WZ(P51?6 \3K\-4HY5XWGHA B1>OQPF5R;,+/K<5
MUK 2EBA=NPQ(/F%*+Y;5$-;\[QKQ<VK_Q7JT+.=XBL%(>+UM%LLY[8+ZM/<(
M25T?\(9?C\C6J;J^IJ(.^%P]?&:%4I>_6*G-^[M"E_\D[E<BV2B2C2+9*)IH
MHHDFFFCG"0";(ZE!$V=4R"8EKOF=.:EJ\J2DJJ*$%-_:J?,WM$]?M-E/%*A3
MUO*3(J(P7R4;?:1NX^1YZT[$S_7MFY14TV2>4_7I^W.JWC7/KG[<8L':5_S@
M".$X",5:[BC;(I&O^/RGTM*67TM7;9\L+6\MDU:TG83'+LGJUJ!T=4L8(Q8E
M9<UG)QR1;%S=PDLJVJ#M",#GC\%G#D2MJ-\>M:+A$\GR>IUL^98?X>\^L(6_
M#D#5.0-O'M6<TRFY_Q/Y(YUILJ<"6;+W@SG4TE N=9@0C5E"[<1 )*WY4J13
M$[(QG^)Y6W0H;*%: SG1Y5WI5$[7$OF[G4ODS_%9<NI,0@B)"(Q )$Z0P?$F
M;73G,L8"%)T@8A6$R-$/)%AA[UU#+@ ._!J6*TC"5&#EN/S',)H,H]BN=()B
MV*BBZS&E"@D'I<;QE%+G_(M2[Y@/?52(0B\ 6$Z2R+J>E-\!"$?]5VI&82HV
M@%-2MZL9GM?!]Q1#2V>,KND .O_&FMPOJ8RN_U.:;,,1./P<@"<"L,LUZJ5W
M$?_AAJ([D&14&%PL"L  6#2R!HP.=22S,-Y8HCA=N%D5Z\4TPB]@[$72X)P"
M8=(7T4A(-@%8,49WB"@TDPA3=R.TY0SG_AA VSOP^@L80?BP-N-.) >&7?KZ
MH3WB.)B&B?-.J;>]KM394Z O(H(X14001Q >LO>O3GU&2C6F \+Y-D*_K(&6
M#_T["0E'DB)LM/_D4JAO7X[$!9(V,1KW,+P9@B01])\9^BN'-7DQ#;9JQ/A/
M-X\8OWS3B/'%7AB3"UF#_1T8LR]U$[>*YR-$_R6<>R+9>.EM)%?V/5+33^^\
MF]%8?PY]^1:L7?G0OZWP>$!E+#BF(E'6W='9MJ^*E?2^88 E.4S>PW!=]L#U
MV:HV>5WPG3,9O=,$:]G3JEC'SR(W2RX[P:(+::2^+@IKC;'=A_5H&:WC%5;O
M2F8YYZ>,P;T>^J@=]HT.QAB)!N]OS3RME FNEQYHWN-PO6I@7U^LT%O?BM%9
M_H"1SA?;9Q')1I%L%$TTT4033;1O+]6($8UF?K#97';-Y-EK[IJ4M$8[<4[E
MQ^8YE5OBY];NF)RR]M"T!1N"4^:MYQ.2??RDI+[(QAKR&D8^HHA,?'+=07-2
M3;LYJ7J5>4Z5.3ZQ\A=E9677"(2C4(/H <N6ZX:XM]TD\]0/D99M4\I*&_XM
M7=E4)%G9>%2ZJOFD9/5VO[2\-2Q=U<(+A.-9R$9\'=^'A&-Y:TBRJKDKJK3I
M1%1)PX&HDOK\.\L:7K[CT^9[;BUKN57F\=TP"([GG/O(\L!U?(YL2&?JG7?[
M,Z3*0(;\K4"FW!W(I X%L^1A0C1F]B(<+P79F!TA&ZW16+MQ7RB'VNS/H$H[
MTZBY76G1+W5DW/7C,TEFC)(CI < 5R5GU]*<XT-PO#^G#8X03>HP$K5IOE_"
M$?[/<BY"CJA-14&5L;":Y3SS < :6)W]2:*P/-IRRQ4^0WJBT4@TRSC7_3%:
MVZ\5&FLL1N6Q)@_6&,04. 'D1Z(K>@C'/LDB[#MK=Y1C2&5T!P%D!E0":7D4
MVD$ 3]O@M1*&D(Z.*?#XLLKH'#7"Y'@0Q7<>?]5[V\B1YSZ&+RIX@K4$G>E[
M > \RCF',CJ'&J-=L<86 *<D $).:  4"QK9V,+=ZKBE1U6Q2U$%W0__#]$]
M:=.V 2-#40U<J+M5@"G\G3 6:V#,?L3H[&\@$8,U2;'N):H*(Z"[G.J?8?0,
M D$ E*,8G?,OK,'SB3JV:!V6,.B.[*3U X^A7G5 22U0K.'(<*XOH0\;!,+1
M^0[Y?JU-B43YL"M<K.E_)XC2OC=\K/TNI<[)*/7VW\)8>1?Z)8]$*)N\>]5Q
MRPX^]O**8X^_6GIH1-RR1K7)6\D:'&X [_$X?O'F":YG6'/T4LX]D6R\](;[
MP:C(3:@1,*9@;1L'UV2A4F_;1'.N-NCG+Z&?_1A!1VZ*$)*H'V5D0EXXPRJ3
M)P#7KPO&WB%8"S;"YPM8O6L^S.-7:;W["1)QQ_/?*;(1B3^,(&5UCL?Q)B:C
M<\U$HE'%N5$ ["C6N24B;6>):A362OLI0D[8/PZS1D\QK &3<)TD-:S!'[K8
M1)!(-HIDHVBBB2:::*)]:PU)1G-:V?=FS*BX*3ZQ]H%)2=6OFY.JK9/F5N^*
MGUM[,"'%=V+*O'4AC&K$",9N!>K>#0E(5*3&]R0D^[KBDVN/3$JJV@^OU9@3
MJZ?!=SV5FNJ[(26E\7K\/4+@6/BKAQ4U7H^1AM+E#3^3EC6\(BEIR)66-NR0
MKFP^(%W=>ERZICV$M1L)X7A.9&,S$8J!%HY:N3T8M;+9#^UH5%ES 7SG/V0E
MC3$_+*F7#RUKN17)SG.FF\H&7?-EZFVWG,@<(N4S9??Z,^2O^-/E>8$,V=Y
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MMW:F4RYX_4V,R.0_&7)3>R+U?21/\;P(6!EMN1$=;(Q$5.KL$Y5Z6RDXKWL
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M7ML"OU?.ZNUN:&GPO8EP'=Y3ZAVO R ;BV0?IMQA9*&:L]VGXIQ#D13!XT7
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M,PO&^!B<5XRVX,>H]BV2C=]=PTC:A\9Z;T-21ZG->Q!3?F'\?(*U0*$=9H@
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MG,K7FO.7DP\NO&\_ZFSW]\>9P5H7:6O4!VC[HXS)MPW>2:NA[3VP;22\OU[
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M _Z:Z"\P[/,5R,C7L-^W<$PZW,,<M<&>J]';W7"/!1H#G ?&!!P;R+AN=&_
M4&91?V$,B0O ?6#(M.\XW$,C>O*3(F81'['.ZJ$=X8DL%F_R"_!\\)XL.(%
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M ZZ'[=N =\)Q>RG.<9 8U0@TXC@C?MAH[Q(B:@KGEO1&5'!W=<L?VGO8921
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MK$[,VS4(.#XP-.MFG+3_E"&M__\':,O5^'P8DH\? L) -<N[GZ5-WF'0_U]
MNSF@W2HPY)@A0$578*Y#9\_%P[%';L^>\D")(<MM!!0T.)MA72/(TPG,P09\
M%/KI,,-[#L&U#P(? /G<3Y;B_X.A[4=".=M.P+E/H4%-(8@.YQ6+!SF#I\\M
MZNP%?+&?$:Q@(JI,A[TE">!F]N^ MEH/7(BY[!#$A7OA-)S]+VIH9\S/B)ZU
M&#I]L10HDL#&2_?# 1:Z0B #/65A#(N!?GP5^NI=AG.EL+S'R?+>Y2"+NT%G
M#D,_-79X D9X\9X=<.P%8.^B-R'/>(ZDLFB%=:##F#?2 SI,\I6";G;3X3 ;
M\;\/=-A[&#]^87Y3/ [' /1(#IVO3=1?QVG'$+I[_N<SI7L( 9:B1Z0/0<:@
M"#AZ=L'ZFE NRB_A??<>S?E>1, NQN"Z'Z,(.G(T7L3Y?B6P40(;)9)((HDD
MDNBRI4\G5-V;D%+UUY$I%1\D3JGZ-FGJRJ+Q,]=LG?#5A8&-'8!C2E7(R[$Z
M.&K*4N2FQ"E+YR5.7OI?R\3*I]"C\N/4)7=9+-U#TX2K^A4UW'#;@LVW1,VK
MZRM;O.4Y65'=1-GBNN6RXOJ3P,V8@Y&$4B/@B+D9SQA272?(2[8*\LK=@F+9
M04%1<V"+O')O0%&R;:*\L"X^JG#S,[*BAG[GTV9K+8]>MV="U"\.I_2[]<1W
MBF<;TY1)C6GRJN9TQ;'63.6I]BQEJX!%6K)4/QW8"-<6LE5"<(ZJN2U3<;0U
M0[&W)9W<X]C63,4?A=G];B" (WHXBF&H5UE"N>(0R*$--CT8H=_!A*D.)D^[
M$42 B7T;<R:PT9R_BN']V;#^4XW.]AIZ!6'XIZ1EIX6NK\+V?G2PY3K5X.2?
M/\FY^C&<@Z5-KA<IDWL$S3O'T$97&F5T%5!&9S48AYLISGF(YMW':9,/O;+$
MZKMQ^=#^!=@'XC*N@(2M:4G86J #A.P.0G4O0M.E^G3WA/U="L5T+Q)S86'7
MH2JB8K@? 4@#0:TY'SC02L 0HV<O&$X-T 98J&@.&+7C*<X] @''_D;KK]6O
MS[KS83#>+Q:/LQ]#7M #^;GG M>C0:35NVC&X#9B?C+H3Q>TXS+&G+>?#?=[
M*.=GUUR./R 4ODN%\S"(X Z! 9V>D&P'^!WBB-RCD6!X%R_%+H4QNGO27O@]
M=Q2!X3T=]T)T W0%QJL#C-F_D>:]Y:!3&2!G'Q"0D<M^1*M/5V)AHCX788B^
M!#9>'H0@-JG,/C1W(/27GC&Z)C*<>UXHS^&>F/AYQV.&+0B2% (8_GS6ZNKG
MKL>1'I#GKK^1'/$^,7J))W37#Q(_4'\CB\"@S(9#L>$=@57G,<P<QHU:RN *
M8$$I?"^0?)@P=^ESB:75D,!&"6R42"*))))(HLN6+%-J[DZ86/G'SR=6O#UJ
M2DUJTM15!>-GKMU\H9Z-(E=V (Z)4Y9B=>K@F"]7-,-R2>*4F@D)DY>^/#*Y
MG![U9=6]EFE%/2M3UPC7*FIVW8B HWQ1_6_E176?R(KJ"F3%]0VRDH9]\M)M
M)TE5ZI*M(<#QS-Z-!&RLV"5@@1G%TGT[Y96[ELB*&]*B%M5]HBBJ>U&Y</-#
MYV7RHT=@Z@/7[\F(^@6&)#>G*S]K3),7-64H]K1F*8^TSU$U(="'WH4(_/WH
M8&.&"#8&X?K!+%5+6Z;R1&NZXF!SFF)%4[I\4E.:\J^"Y^%?"E;5SPG@*(0G
MYP(!'(DWC\XQ!"9(,S%_$TQ<MX:\'"*JWG8#&^,*VK1Q@16,R9L)1M2'FEC[
MRYC[$0TJ2<M.2U<1SS4P-A!PQ/R6&M[S, *.8'3^18/ALKSK'3 V$BFC<PK%
M.=-@Z:1X3X Q^0H9LZ\"VKX&JV^R<?EKV;C )OA?KXW+VTH* IC\>UC>OP\]
M4< @[/ F SZ.GFA8M10,DU.=[$9N1(8^;B(L>JZUB%YLCC:Q4%!OU:U=9_%
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MH6AM3E=L:4Y3SF[)5.H;K5'WGLCN&[7_VSM_B45B(I^)3+3 D-7HK*/!F"B
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M CB"+)/QEO?\GN3D,[A,L/PW;72.!IV<PO#NV="G#JS:#/I2R)KSRX"7L:;
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M"!A)@(QAO@>U)A>M-7G^AS)XAE(&]S^QL S(Q&3T+ <=<D%?SZ<X>QG%V5:
MGJX'?:P'7=U)Z1S[0=\.P_]C(!.@SU;03<)-R# ?0&X$W3P%RQ.BWMH. ^^#
M?7>B[L+O#7#\"A@'RBF]:P'(G%.\KBL5QM\$]#PF'P?(1PX'B^-.S'!G7W6\
M]181$+MBTEQ$@(WA?,PUUY)0>3WF3K8-AKYX2Z-SO -]\V_T^H1V!!VV?8A
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M?_M+DHX&@=\K(V>T1&>C_P<  /__JWHA10  ?XE)1$%4[)T)?!-E_O!!%/!
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MIZ;_,4Y5_[-8P\@_\<;CQ5CSR5-XTW$[MW[8R:T9]'"K^P'7W.>-Z\G&^F,
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M"C(!<7"9C3EF1RB%L9.2&?914L,64JX+()3Y#\$;8'AC!V\JT-=Q<T!! &_
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MN.'XC=ZF,=<9PY&5C49VG%&QNMPC5I7VD\JB"F;>#P22O+\0@?0+L(0;-2I
M(! (! *!0" 0" 3B%J"9*(^#V8V:N*95(3$-@9JXQJAP;1L=E7R@+?K]PV>C
M=WW"2L+PA+9OV)G:*QN]S6(.P(8QYZ.2NRS,.G(WQS1$;(YK6@_7K='<0%J9
MP>T^%0./<RKZ7N5664.QVJ$]6/.)9JSM]!FL]10[)B,[=N/U.E*SS6/Z8>:C
MA\UNK#_FPIN.P\[4%<SS,,P\^ )G_Z>/\2M[>+"<^D;["]#\.\%N[A(X!N)X
M&N]99SHOS)&.US@R>"YG!L_MG)"-5X3C3,C&B1)JSQZVE-OARN1==*3AG]G3
M\ Y;&K[#EL%_"1@?7<!N>XK@CJFRD1UC3:+[-2')VT%*='64S'"$4AI/0MD(
MF\-<$8[JLK/,M"I*49A 2G5J82#]'.Q,"<LDT9F$^'^X"+%-"QZ79-P-&Q#
M3L6DPO ,*2]<1\H+-)3<F$_*C3W,XQ@SS4[)"US>#M7Y$\)QJFS4P^[40*0L
M!B+U7@_S>(I4%!YB7JL42/*TA%0?*)#KO\\V)H$E@0#)1@0"@4 @$ @$ H%
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MV2B[CFR4>64C?)V)RZ2\\ 0IR^\A)'G[V<9(LKP?7S5&*VIXA$ @$ @$ H%
M(! (Q*WF3:UI7LCV!I_PA.:'0V*:1>%:R^N1VHX/HY(/6**2#AR-3.KZC'EN
MBTSJ!,QK[/B-(3&--RT<H6QDQV],/@@[5 ]%)G:4A<6UQ6V.:7H]=$?S<^]N
M;YG>D 2 .<O-@_,7UW<OP,V#W^?46)6<*NO'''/?(6[MX%&L_M@YK/&XBVT&
M4SLQ?N/5LA%&[2 LMW9SZX^YL/JCG=S:H43<W/<JOZ+[<=B YOYFZ[W35WNM
M;!S_-\E&*!KA^[MA5F,VW\'$&//W!6<FKXZ)2&>V[T^A:(19C8#F3RM#I];G
M\P72_*>%@;H-I+P@1AR\KV3U)K-US>_KW?X;S</BH+(69GH!(=%%D7)= "77
M/^SWIFF>(#CE#K:!SG\P:^6I\^'G9\>KE.;]A%(8?D&J2U\3J4K5I*IT ZDH
MW""4YF^ ^^::D!8RKQ5M(%5[-U#JO8$B5?'+A,SX8S(P]PG_=:B\_%:S(H"^
M1RC)_1$<MU$@U;U)*8M2*%5)HSAX[Q<B=2E;*GW=,FIF&CMNHZ((EEJ/DS+#
M&5*J'V2^^QI"0H<*I'E/!P30<Z[JL(Y (! (! *!0" 0" 3B5J)A;L(UFL-S
M8;.6J*26!T)BFE\*C6O1A,6W[@W76@YN23XPO'77H<M, "@<878CE(TW(QPU
ML=YF,; 4.WK78;!UYZ%3S'-+6%Q;0<CVQFV;=S2M#XMM73%MHV F$F"[1L_A
MF:U\G_V?_L:GHGL;IZ+;S*T=/,AM&!G%6DXYL*91;V=J.%;CI&R<%(ZU@X#;
M,.S!FHY[L,;CGV -PQ_B]4,JO++/GU?1_PB_;/C^Z:N=D(VPE#K[P66.3%^%
M/8.?88.R,9-W:B9DHV,BHY%9%P Y? _S:'-E\BXX,WAGG.EX.;,]_W!D\"F0
MY7<O%(W /&M:)J)(GK-<$ @;ON2]1<@*=XLW[#>O>:-NZ*G_;7:O>:.VVW]#
M>3&I,,22DKR-E#3OZ96OYN"LC '_^=E?:P/H>R@%_4.A-/=%2D8'DW+#6Y2R
M>(M(;=I%*DL^(A1%'Q)2PX>"0-TUP>RG#TEYT4<B]=Z/J*"]VRE5R5\I>8&$
MDNF>IZ3ZQV&&([I:W#H$P<5WP7%&5RGH9P12O8Q2%L6)U*75HJ"]YUG9J/A7
MLM$(F\C82)GA'#-]A)#F-0FEND@HG&&V[I?"$8% (! (! *!0" 0",2, 3M#
MA\36"T-C&U6A,4W:\(36XLBDSLZMNPZ=9L(9E=SI@N,O:MA2ZN:;&K^1S6Q,
MZ@105F[9>?!\A+:C+SS>TJ2):<K6Q#3_41/3Z ^;Q$#A2=-@SM3L(Z[)NL2G
M_,AS/ON[_\:IZ,[BU@Y5XXVC?7C;:1O>?.):V7BU<*P= ECC",!:F'E:3WR*
M-8UD8G6#?\ JK<_[5'0_#DNTIW[^*[+1_&5FXW@Z/],V@YF-CHR)<1KWP'$:
M^1[W'MX%5R9_U)[&ZW6DX[E,; (9OC\"](JY4#3"IC93/P?,5(3EJ$))7C0A
M,QC%07M;5[]N/O;4[^O'UKQ1W>*_<=^'I++@39A%!C/WUJPK6?3?<@S#L?](
MB5Y(RO2O41)Z,ZDLU(K4IFQQ<'FY**BLBE*65)&RPBJAU'!-D(KB*DJUMTH4
MO+]*'%2N$ZM,\:3<^#?X/D)9_FI"D>.+KA"W#G$ ?:= EOL]@9)>0\CTOQ.I
MBJ,I=6FE6&WZ7*0JN0G96 @?[:0\_SPS_00AH5N9QZT"F>YY. XI.SQ  -N!
M'F4W(A (! *!0" 0" 0",5- V1>N;?A>:$+KLYJX)G580NOVJ*3.XJBD WU1
MR5V7(Y,Z;1%:R]<:OQ'.YQVSL1-*Q\OAVO93X?%M?6&QK16A<2T13/SLG<@*
MCB;.?)]7.EZ;?;2PY. B3E4OY;._1\JILD9RZX[J\.;1+KSUU-AU9>.D<*P;
M EC3<8"UG@+,O+W,,C16._0.5M7[:VYE#[EX7S<^]?-?:1!C7GL[R/ERS$9;
M.N_HC,K&[,D.U'PW\PC7>]B9B=<XTO%$9GL"F>UYA!6-]*PY<)NO^@AL9B(A
MTZ\@9?DJH4S_$2$WU(M4)8?\@\N.^6^H^,Q_P[XR<; IC% 5OBQ0Y*X22.FE
MCTO*[_YO.8;7K,M>Q,I!"1U,2'1Q(D5QMCBH;/_JC56P0<X1<5#Y$4I9<H12
M%%T5Q4=$:M,1<?#^(_ZOFX_X;ZRL%:O+LTF%,9I8K]M$K=<]3ZS+?PA=(6X=
M4#;",39)*2TFE?F_HE3&*)&Z9+]857J5;#3\"]E8:&?F^8*4Z4X24MK"O-<V
M0DZ_L%R>.A\*1S:[$952(Q (! *!0" 0" 0",7- T0=+J;?$-OK!#M7A\6VJ
MB(2VE,C$CO8(;<?GS.,E)AP1B1WL^(VP 8Q7*C;>8.S&%E8XPOG#$RQ.YO$R
M\WB>B4.A\6WOA\0W!S+K\GLGKA;3:)OO#:#9[*,K+#9V+^!66'^XI*+[!1]S
M[P:L860GWGRR'F\[??%&LA&K.PI@F35N.0.PME,#S+Q&K'XHDEO5(\4J>W^,
MU_1-RU2[(AM3!'>,9RQ[T)'&5]G3^%F3W:C=6?Q+,R(;F?=WTWP \GW='AW_
MJ"N'UV#/X-'V=#S$E8;_G_&/L&4PHY'=WB\SM5C1" "8+9;J5PKENC^2,GT!
M(==WDXJ"?DI9=$RD*AD6J8IS*%71)DJM?YQ2[^%0;YKN%01;[OAO.89)J>$!
M4F)XA@RD_TP&ZM/$2E.9_X:*KC6;:DZL?KWZ'//\G#AH[SF1JO2:\ \N/[=Z
MH_G<FC?JSJW>5-WC'[1OGTA>])$P4/<.N9[^E3"0?A1=(6X=L#G1RG79RPAY
M/D'(\UZF%,9P2E5<+E(SWX^R^"K9J+]19J.#E!LN$#+]:>:U#D*FVR&4Z%^"
M)=I^+YKFP>9!2#8B$ @$ H% (! (! (QHX#96JUI7G1T_0(H'</C6IX)3VA]
M+R*^S1218.F/2.R 8RY>BDKN A&)[2 L 68WWGQG:E8Z>KM3>\*U[<?#$RPZ
MYOW_$!)3+WHWNO[1*&WM$LV4;LC\QN$[84,7K*I/P*WJ_QG6.!*&-9\HPUM/
M?8XUC[JQ^F,>5C9.=J2>"%8V-H\"O/TL%(Y'L9;1,F9:/+>B9Q->W?L<IZ9[
M6F,:*/#,FK6W'Z97S+5E+WW(D<Y7VU/YV?8TWC%7)N_,C,C&3!YPYGAEH\?
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MRWAAR3 L/X6N12@L"DXNA6$-J>"B:3GWLD3%/0SW@;T:KY>RWS#P;(9&<G=
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MQ488$A.C<_!QZ6W^F%3GL#:Y^4QT4N,748GU&Z-6-_XU*JE.HLFP3]5DVZ?
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M:":BP@_=BM#12(X;YG,%L3%R?2^C+C<RRM+WH2 LD5LHJ9S#T4PC$ @$ H%
M(! (! +Q'>/]U?7W124U_?C#U4UO1B>WI,>E=90MS]RQ*V'-KK/Q&=N'XM+:
MW3&I#G]T2LM(#\<+I=3:U!;!X0B&![P>BDEQG &C-CJU)5Z3VO(337+CS'=U
M-=,T6<ZO"&=8==<CHLHN=GKEGC7!6WOLHKK]N["F@>-8RU%^3'"\(#:>P.P]
M_:-B(]@^*XB-_ 6Q$?9'=.6(9GMRQ3]T%^"O^8J)3WF.:.<-(8(+41 ;_P57
MHQ *4Q!P-7J+")=73YSS&T*^]'(A+>#U)^Y"XD_#:[$77+G$XWQ>\/2OF_.
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M9#Q'F;S[4-]U%._VZ'#H-.?\ \DZ?H'#R%/&V50XUR1\N
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M\&+%V.YF^U:CKFKVZ'?;E?>3/\B^-B>C]6\,E^Z>E]%WJ0JWI[- SFE:<.U
M5HV.<VC>_3;.ETF/E>X=^;)M\(@Q4GQ*FJ=/2EK.=6/&2-=<"J$&
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MH'W:3PNN>EIP6K& 2W&N_Z4$Y_,DYW@@98S4;]CC!7UC16! 8 0
M    X&]$":G.KK]YBB6@$6<'[IZ:W?B;:0MVSIP^?^>::?-V?)KQ4>.127,W
M'Q,M@4_%S,#2=$O@Y?19&Q)B8=@QP;%+;/3ON1L7@%&M/O2_26L.EB>M/7@H
M<>VAFL2UA_\Z8,-1_4LKEJIK2YX9^GG!ST:%<P<^%RE6981+U2LBY<27D3(B
M@KT7(Z6*-R,6&L/14FT0M6VH/8#:#>$2PAHJT<P.%FE>#>6K'^TH&'P/SM$H
M+QUT$[S)_SZP5QT.X\65JFFC=9@25LTZC0SO>I<1/+/UYLI\)M7G8\Q5&VF3
MIYD6W,>5BLV\JQWG<\0%56+AU3'K'I+\SQ =8X+C581']IOB8G?[^X5&ZU7S
M,-+=<C_&<CLZHR1GCY"LO8/FG&?0'AQAS-[=M,D;0/?X*-Y=C,YE42;G7]!>
ML23G>@+M;4J*T9.<\DQ.GR%/9O?"'J8@-@(             \'>!<S?.FK6]
M+ZY./65NPRAD;T^9L]DZ><[F[9.R-NV;:*D_(5KJOA S \43+75L1M9:E2A*
MUTN2?$VGV!CO/YBD6G/HGOC5!QY.].__,[+"I-J6W8G^%G?BJOU_3EA[9%B)
M)VW0\;R[4\[GJEX(Y@UZ,U*J6A*6-/51*W$>652N(*)17&4Z%C(=BI1JVR,E
MQ%?A4F)3N)@H"!5K_MI11(P+%1*CVPN)(7)Q<G\E?#HGY3IXB_^5'V9/[-V(
M\SA21OM AG,HHB/#NAZB6?>O:<']9T;PSJ9-WE*:=_MIWK6;XEQGT/GSC,G;
MCJLXQPJM="NVTE5HQ?9W5G3^;H_'[[:*?WBL[D+CE<5E*CM#I:/H7(3BG&&2
ML[=2O.,(+3BWT[S33YM<A93@G$X)CC=(P?$BQ;O_#VUV#<,BX\.\+Q[O\^C1
M_FN5L&E<'1P              . ?!7LWXMR-XNSU\]#Q2C%SPS8Q,W L/7/#
M5ZB5)EH")L4+4O3WQOD><1CV%6)CS8&'XVOVO)98LR<GL69O'6H+$U?L,1-K
M]M\I+R$&A'+C'PXN2W@EE)LX)UJB=LL5Q*ZH3=LFV[71J%4;E25M1"[7=D3+
MM.<BI<3GD1+MP7 QX0@5$^D=N=KG6G.U9%MNTJWR_/@;X6W]M,">CBG/>/K@
M4%_=.-==V-,1%S2A>.<4BG?E49QC%<D[FVG!<X@Q5YYDTJK/,JG5%YC4JHMZ
MLP^+CT':Y FA^R,4%\NE^(V\B-]F_Y"0^ .>_P%SN.PIZ8CB-3"\.\R8O"&T
MK@Z]N:I-G[:\%;5?H?5_27'.4R1G/XSNW8SVI9+F'+FH3:=X*TOR]I_3O'3O
M",&EQGD9X<L"             .!?Q@>S-PP69P:>F#![_9OILS8L$"T!GY@9
MV#TQ*W &'9>+L]>;Q;GKDT71TT>I9BW*/6-AU#L3!]4VWY7H/\@DK&HQ)-2V
M3$Q8M:\D<57+]*2:YM_<M7SC;7)N?%(X+^GI4%[2A%">RAXNU=1%*S2'9(>V
M0[9KP[)-VQZ5B-9H.:XX3>P,EQ*KPD5$2:B(F(@]&H/+"+I]"3'D?$%B BX&
M V_KIP7VN'OR25\O+#@^)+C4E. 9S@C.1RG>_3N2=_Y1$1TYYR)*<)<PYDJ/
MWNQ;PYBK&IA47Q-CJCQ("^Z3M. Z@^Z[0''V(+(PQ3DBW2M"7ZX*?=FZKG?9
MI4K25^1(_"%FO_QL]TK4RMB.;XS;99U5L+'(&,M%&4+G6VG>A?-4?L$(GL.,
MV;=';Z[:CMHZ]+L&77>1K+T(V5R:M4^@!?MKZ-DQ.JYB-,E:A])F&X%#U(>\
MX>L%7Q8              /\RIF:OC9^4&1CQ8>;Z9Q7!,3.P5+34;53"J"UU
MI6)6G1G9K>)\_XW9V2V]L  TM*GI^J2U+?'Q_GU#!OGWZP;6MOQJ8.W^/PQ<
M?2 C?O6^-]0UGSQ&+E^N;<M1)X?SU+\+YJKG!_/46\*EQ+Z(E3@EN[2AJ",Y
M&+5IST<EXE2DC-@3+B$J0\7$W& 1\49'(?'K8)&&:2M0)V/O2"5TVA]W+;RM
MGQBBV!-_;]C#$8?\DEQE4@KKN(,2[,,ISODPS3F?TG&NEVC!\QIM\DY@S-YL
M1O 4T29/)2VX [3@:D+W?4IQCE,49V]#QQTT[PJC^Z-*B+42COQU\\B,T%7!
M^<K\CXH0>34Q\EOL"C$3]W.I3]2_,HYBWJZPZ*YC)?S;'47/16C6'J;1W&G6
M<8;F',>4RMR">S,6&-$S5F0?,[QG!IK77TC6ED:RCA>Q!RC#6VF=R7X?99!N
M&VFP)Z2D2?UPU>]8;D8              (!_$:+HO_$#I5A,_;T3LC8^G6ZI
MFXQL97I6W<GTK/J2F-BX^79<5$;,/=A;DJ1KADI-UVLV'AV8N*;YMH3: \,'
MK3[TR"UKCKS0;^T1\X#:_;^^??4N\JE**4G.2[@CF*MY-92GL0;S-5^$2XAS
M$:NV378G1Z+.Y/:(37LF4DX<1><W!HLU"]L*B-36Q4GDN5SB3EQQ&N=FE.6X
M'G)<'!2N 'HH!4QP7D?1?^TP0T'?^U\N[I\RKE"E,UI'8.&1YEP"Q3L_H#G[
M/)JWVRC>O@[93HJU':58^WF:=[71@C<8R^WHDYG4*EF?5HULN:Q/12W^C0U?
MB^5#O)S[L5-\[%: YGM-Z"XN=@J*E4K?^E3?I?&JOS8'9.8JF1'0''EWF.8<
M033_"\A.H#7LZ0J3YIW+*,XY':WY3XK :/2,TG/6N_5&CP:'G7?E851R,2J%
M7^!O"             " ?STX%Z-H"0SX('.-=GS6!GVZ)?"Z:*G+$S,#F\3,
MNNQTR\:7%;$QRW^+*#;TP56IX_S^:P?X6FY.J#^0F+CFT&W]UQX8-F#-L9$W
MUQ[^Y?":AD?2*G-H;]GS]X4*DGX>*M=\B&Q%N%R+A<8O%8'1H3T5L6OWA:U$
M7;A,XPZ7:.8'"XD_A0I53YQ;$C^D-6>0ZG3V@)ME*>X:>$/ 53[:GD/'2-?C
M_(-86,/>>[BZ,LW9'R-YYV])WO%[BK5_0/.VV>C<8I)SE)&LW4?QKE6TX%G'
MF"LWT6;?5KW9MTMOKFK6IU;M8U*K#C)FWQ&]N?(X8_9\1IL\.%SY-"VXOZ1Y
M]SF:=WVEA&/SK@M*!6S.<3%FBL?D)>L\ARQ6)?L"+3BQR(GS*N(0Z"\9P7M:
MZ=OL/1D;RW<8CXWGH,Q%F1.:FU"YB>%=&VC.X4=KJ4+C2&@-RVC6/A?U+Z+S
M?T;KXAC6]2QMM(]B#/9[<*CYJ)>]_;$'(WPD              #\6TC+:;CN
M[5G+E<K42K$82]V+8F;=%#&K7IJ0&1B/SCVGB(V6P("W9VWOJXB-LMSS5O_!
MWEAPQ!Z. U?MT?1;]^GM-ZXY?L]+OOP1)9*@/U0\_)&.$M6XD)68&W4F!R+N
MY(MAA_9TQ*X]$K%I]X0EHC9<KED6*E%/"!9KN%"1ZO&.7.)^Q:.Q:,#-.$>C
M+,9!A5S@*L@]E'#^,=+U6%C#E:M3C%*RGO/<C45''&)-<O8GT/&O*=[.TISS
M#Q3K>)?B7"(M>&;20N4\U"ZCS94EM*G2P9@KJVB3MY81O!MHP;T%V79:<'Y"
M\\X6FG,<I#C'89)S'$/M28JU?T:R]B]0>XKB;*=1>^9*4\[A8BV?XWLISGX"
MS>=H+)S;=8#F77MQ>#>R[;3)W< (G@W*V"9O%9Z+'LV)$2J7H;G,1_?.ICG7
M))JSOT<9':\SG(/#>1@IUO4T>OX1FG,SM-$U#(>6*R'F:5(_18!-RX%J[0
M            _'N09;G'&$FZ!HN.&7/J$R=9 C]/M]2]FFZIGSDA<^,K$V;7
M/Z:(C;,;!HGSFVY4Q$8<EBG+/;&'8UR#?-V0%KF7VM/0)][?=&.5XZ5;CQ4-
M?>A\7O*+D3+U>Q&WMB1:G;Q37CDX%*D<_'G$F=P<*B<"P1)-?JA$_4Y[4=*3
M'<N2[L7Y'>7BY/ZR-/1Z68R[%H1&X'N^7"6D&A<L2DEKN&XTY^\]S+"\+SW6
M=S/V[DM)\PQ*2;.IL!"G,]CO(SDW2;*.7U"<YSE*<!J5/(^"YSV:=TU%O[,I
MWK&4YAUEJ'63G'T%Q=K6D$;;1M)H;43M3M0VZUC;/M0>H(RV0Z@]0AHKCNK8
MBF,Z8\5Q;"1K/1H[;SM,LK:#Z/=^G=':@I[[!!WO(#G;%M1O'<795R-;3O-V
M%\W92RG.L83BG-F,X,Q \WF?XEVO,[R+93C7"[@@#LW9&#WGO)\4;+>3G)0T
M@I?B]:;J 0]PCEMP+DLL, YYTM<+AY<KX=.R#"'3              #\^\%Y
M&2=9 O=/M-0]@P7'"9;Z7XV?54?_9?KZY"L\&[^&DE=1C.N)PY[E@L3;POE)
M3P;S5&\&2]3SPTZM.UH]>*N\\M:34=_@K>AW5;!$LZRC4/-77 BF(R]IZ-D%
M_?HK16!RXL C"_CG?<^BW%,IBL(Y;J%_YTJ,%9?Q#->QKH<HWOE+FK?]!H<B
MTX+S-8JUO4MQCG2*M\T@.>L<BK4N)(T5RY 5DD:I3&>P6G7&"B?)6MWHN)(T
M5%211FLU.K=<9RQ?J6.E%?@8W5N-SOO0L1>92V>0'"1KDW2LM80R6@M0OTM0
M'PN4,3C;=,IH2Z<XZSLT:W^-Y&P<S3O1G%Q/T()]U$C.\8#>Y!KR\#B;"@NH
M6%"%MPH             P(\&BR5P@SBW(3G=LEZ7;MGP^ >6 /5^YKJ?O9_=
M&/_NC.:;Q%Q_;^P%^?7G%)$Q)^XZ.3>N=T=^PK!@OH9%-B=41#C#$E$==6M7
M1ZN2-T2\VI*0G9@6+-6\VEZ@?B98H-)=S"<T)V<E]I6SA_2"'(W /Y5NN1VQ
MQZ-2E=GH2:8YSYTIV%.0LY%*R+5@>Q07F*&,MN=)WO9;DK6/I8Q6EC)6F'7&
MBE=(8\4?4HP5;Y!&ZY]TK/5-DJUX6V>H>!>=^TN*47H/_7Z?-)2_CX_Q.9W1
M^@YIJ'A+9\#W6O^H,TJOH_;WN%HTQ=I,N&_TS%AT[D6*LSY'<]:G2".:@V ?
MA>=$&ZW#**/]9Z/2T%S-KD0LEN*".-B#$UXJ               _&G H-2X$
M\X%EE2;=$A@B9M<3[V>O583&-RV!&Y3KHOR-\&;9'W<M%AIE*?[&T#+UR/9<
M]3L=>6I'1S[1$"PA_"%)ZPX[B,*(0SL^7*%]*5BF?K"M(/$VN2 Q 7LT-F"A
M$@N6,E3,!?ZI],#?*PXO[LSOB,..<?@QSO.(Q<<1@DM-\D[M2)-M, Y3ICGK
MG;IQTET/&LKNH7GI7IVA[+X43KH?"X D)SV0,J[LP1$&JTYGE"AL*08KC<.<
M'QQ;QN!C?(X<6T8^R$HIN$HV-:YL^(/HV92QTOTD:QV*^TSAK'=C,1%[+>(Q
ME;'1'/!<\)SPW+J'2#_YAJ\7SL-XM;\]              " _UAP_D8<)OU&
MMJ^7*'KZ8(&1$_V]W\ANZ86%QC&2_(U\<')<7 \Y.ZZ7O'3037+^30/;\A)_
MT9&K%MOS-#4=>>I='87JJF"Q^N-(F7I"6%+_-EBJ'G$\1]T'=AOX$=(C#HN7
MHV/B)38E5R*7VQL;/HYY4N9<I^1.%$40!P$           #@G\K_ P  ___L
MW#MK%%$8!N#9;"Y&08VW9&=F<T$%(8)%%!&;*-B(E;"=8)=.L;&PFUZP2"$&
M-+NSN1#G!]CF#Z2ULA1L32/9W02.F8T67E L@\\#'V<X<Z;YX&M>9B:*.%1"
MI5$4U86EK:%'B^]&LNS]<'E=5J,(U2P+ ^69'YX(426TQX^%Y8FS8:TVM=M.
M;G=:M<>]/'G5S=/U[DKZO+>:/-G;2!J[;^.;.\7X3"AFA_6:0RG+!J)&49V?
MSP;GYS<'YQ:6AN86MH8.UJ6A<J^Q?[]_[J=9 0   /COA! J95A2%*%:!H]E
ME2%C5H8GX=?PI!\V%F,GPG)<[[8F9LNPL9NG#SIY_+3;2I[U\N1A9R6^T]VH
M7PY%/+F]-CD6BJBJTQS2":GTJYR'_2IGHYR7@X Q#'S?_Q8T"AL!    _D7(
MHH&0)Z<[S?1BKSU^?3=/;G7:Z=UN.[V_ER?W>JW:W)<W];@,&/MG@P &
M /B-_IN-JZ>.ASQ-NLWX4F\EN=)KUZ[NYLF-7K-^K=.JG]]^.3FF4P    #
M'X4HJH3F])'/S>F38?W<>!DZAG8\&=I3,SNO:U-A/3[S:2D^JE,     P%_U
M/X_>C 8_+%X8*8/'CR_2T5"DHP?K[+!_- (
M
M                                                A\U7    ___L
MP3$!    PJ#U3^UA#:
M
M
M        ;@   /__L%*.&    _1)1$%4[,$Q 0   ,*@]4_M80V@
M
M
M                                         &X   #__^S!,0$   #"
MH/5/[6$-H
M
M                                                          !N
M    ___LP3$!    PJ#U3^UA#:
M
M
M                ;@   /__[,$Q 0   ,*@]4_M80V@
M
M
M                                 &X   #__^S!,0$   #"H/5/[6$-
MH
M
M                                                  !N    ___L
MP3$!    PJ#U3^UA#:
M
M
M        ;@   /__[<$Q 0   ,*@]4]M"%^@
M
M                                                     &X#?0ZZ
1VHYQ9OX     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  01,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GERON CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-20859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">75-2287752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">919 E. HILLSDALE BLVD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">SUITE 250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">FOSTER CITY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">473-7700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GERN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886744<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="gern-20250801.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="gern-20250801.htm">gern-20250801.htm</File>
    <File>gern-20250801.xsd</File>
    <File>gern-20250801_lab.xml</File>
    <File>gern-20250801_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gern-20250801.htm": {
   "nsprefix": "gern",
   "nsuri": "http://www.geron.com/20250801",
   "dts": {
    "inline": {
     "local": [
      "gern-20250801.htm"
     ]
    },
    "schema": {
     "local": [
      "gern-20250801.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gern-20250801_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gern-20250801_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://www.geron.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gern-20250801.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gern-20250801.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.geron.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000886744-25-000054-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886744-25-000054-xbrl.zip
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M?\L5>D4N:E&C2%+2\:OP$_Y<2GA,?\E[_$=3JBK5S8.H?3U3R2S0?Z#[M$E
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M#$"L+X[69$[2 ,GQTIZ$8*0VSP@?F[D O<3F\-68L=8,;*XC\E]\D7W=>6F
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M;Y<7)V]'T='QY<GO)Y<GHQ]?;GRQ67+C:1&=D>[ETB"NS^&CTXQ;-L9V?L3
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M/GF24X@K7,OO=>#ZM1P#1Y0\<FW;TAV*RJ8_J4@B@'F;O2!10>)P4_W!B5-
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M;/.9QW%:] L7&>QF3*LJPGWB$@]/IDV/U/%I%*'<J-0'>EL,O"2M85-F.E;
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M,+M<L)V55 O,ZX*ZI8OIMAW!A,J=?CSAR(]HW4M"NM-WC28;E.'. PE8E(N
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ML_X\=M,)0'G9R%PX<DW>GMR3&E%3F2Q:CZ2-*D89A^[B>91.A OT=,-%[?3
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M5.I+Z?C"!/>^1Q)=IS<Z< O1%;8Y5112Q<I*SX]J .@ZWC:RW;&1!&NZ!!N
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M:UF. 1((\MFP(8+G<L/1,/Q)W8NQH!CV/$B8&$(I<%D W*93>J0RHP&FQ)B
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M[1-HH>(<DM93W*;)9;=2FCM:"6D9-TLL+L,$>-8:S70[FV;L#=D0A)R#!3I
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M5-:AS<@Q"AIJK[^:>_=]T\L_^I)8O0^'_(@U(>6(>I)H*PF3 \&XM!')B2[
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M('']UO2)4A@^/6)DSJ-L[3*"P<#Z)5 $0C&=0DR;*5"<)JM@'M:Q&PEJU6>
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M7C[]1KQ7^M?%-V&3'(.285>,C6)&10Q_32B%D)O K@$B>&(X9SEE"\$42<
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MMSXDFB]P.QFQ37^4>&$-YGN_OE&",">Q.]/8'%/E+_8I<WP$U,%5R/YYGX"
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M;E5"6!XK2YX56!V!MY$PB6T8.V\ZW.UJLG*P_?Y@3L4D4/:3Q6W\R(;.-,Z
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MT%=*6SCOZU:MQ:NV(1+ZV+\^9;5F];DXHH^Z%3WX\S*X]F\3DWZ$&8GA]>F
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M*04?QCA"^PS@6""=;K@-9%EH8'N8O&/]!&CR'S@#W36#-^8R(,J&64R39C1
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M8 ,>EI(CZ:+LH6($[KX +1&$4IE=C_=8I=N_9O>SG>09(SP4'K)XGNL(.D.
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MQH,T8*[N1'E5#CL(OE92\!L:FU20 RO>\I?X>-GU2'*SV&2]/C>[9D:M;Z-
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M=C-OL.Q^9/^+-]/"_Z;AS#WY?U!+ P04    "  3@@9;\\B)(EL"  #P!@
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M+Z^T)_>0=X@YJ?*V.IUW*.LHK3?ZR?6;%0U7J_M_MG[.T.WT>O0'4$L#!!0
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M %!+ 0(4 Q0    ( !."!ELV%GN;QS4  $9' 0 >              "  0
M  !E>&AI8FET,3 Q+65M<&QO>6UE;G1A9W)E92YH=&U02P$"% ,4    "  3
M@@9;5/T8\@Q&  #GWP$ '@              @ $#-@  97AH:6)I=#$P,BUA
M<G-E=F5R86YC97!L86XN:'1M4$L! A0#%     @ $X(&6ZV4I@A040  6G0"
M !X              ( !2WP  &5X:&EB:70Q,#,M,C Q.&EN9'5C96UE;G1P
M+FAT;5!+ 0(4 Q0    ( !."!EMURGX",1P  '.@   1              "
M =?-  !G97)N+3(P,C4P.# Q+FAT;5!+ 0(4 Q0    ( !."!EOSR(DB6P(
M / &   1              "  3?J  !G97)N+3(P,C4P.# Q+GAS9%!+ 0(4
M Q0    ( !."!EL&6>.68 H   E9   5              "  <'L  !G97)N
M+3(P,C4P.# Q7VQA8BYX;6Q02P$"% ,4    "  3@@9;S:PVQ=4&  #R,@
M%0              @ %4]P  9V5R;BTR,#(U,#@P,5]P<F4N>&UL4$L%!@
0   '  < Z $  %S^      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>gern-20250801_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gern-20250801.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-01</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0000886744</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-08-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">GERON CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-20859</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">75-2287752</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">919 E. HILLSDALE BLVD</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">SUITE 250</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">FOSTER CITY</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">473-7700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">GERN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
